C534422 | 10-(2-pyrazolylethoxy)camptothecin | 10-(2-pyrazolylethoxy)camptothecin results in increased activity of CASP8 protein | 18708040 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one inhibits the reaction [FADD protein binds to CASP8 protein]" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in increased activity of and results in increased cleavage of CASP8 protein" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "CASP8 protein affects the susceptibility to 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "CASP8 protein affects the susceptibility to [10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one affects the localization of BID protein alternative form]" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "CASP8 protein affects the susceptibility to [10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in decreased expression of BCL2L1 protein]" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "CASP8 protein affects the susceptibility to [10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in decreased expression of BCL2 protein]" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "CASP8 protein affects the susceptibility to [10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in increased activity of CASP3 protein]" | 20833157 |
C554291 | 10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one | "CASP8 protein affects the susceptibility to [10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in increased activity of CASP9 protein]" | 20833157 |
C552819 | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate | 10-(octyloxy)decyl-2-(trimethylammonium)ethyl phosphate results in increased cleavage of CASP8 protein | 23001822 |
C449673 | 1,1,4-tris(acetyloxy)-2-nonene | "[GSTA4 gene mutant form results in increased susceptibility to 1,1,4-tris(acetyloxy)-2-nonene] which results in increased activity of CASP8 protein" | 24353929 |
C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of CASP8 protein" | 24515801|2603571 |
C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "Glutathione inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of CASP8 protein]" | 24515801 |
C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "NR4A1 protein inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of CASP8 protein]" | 24515801 |
C447943 | 11-keto-boswellic acid | 11-keto-boswellic acid analog results in increased activity of CASP8 protein | 21056033 |
C412791 | 1,2,3,4,6,7-hexachlorinated naphthalene | "1,2,3,4,6,7-hexachlorinated naphthalene results in increased activity of CASP8 protein" | 27501765 |
C504897 | 12-(3-adamantan-1-ylureido)dodecanoic acid | 12-(3-adamantan-1-ylureido)dodecanoic acid results in decreased expression of CASP8 mRNA | 19435785 |
C539551 | 1,2,4,5-benzenetetraamine | "1,2,4,5-benzenetetraamine results in increased cleavage of CASP8 protein" | 22276220 |
C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]" | 29111403 |
C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]" | 29111403 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein]" | 15799720 |
C070379 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein]" | 15799720 |
C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in increased activity of CASP8 protein" | 21903591|2382612 |
C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in increased cleavage of CASP8 protein" | 21903591 |
C569107 | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | "CCAR1 protein affects the reaction [1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one results in increased activity of CASP8 protein]" | 21903591 |
C472829 | 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | "[Bortezomib co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased activity of CASP8 protein" | 15070698 |
C517232 | 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane | "1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of CASP8 mRNA" | 23958786 |
C517232 | 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane | "1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of CASP8 mRNA" | 24375616 |
D014013 | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [N,N-dimethylphytosphingosine results in increased activity of CASP8 protein]" | 19481559 |
C582286 | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP8 protein | 26208482 |
C582286 | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP8 protein] | 26208482 |
C582286 | 1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea | "4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP8 protein]" | 26208482 |
C552420 | 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane | "1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased activity of and results in increased cleavage of CASP8 protein" | 20674558 |
C552420 | 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane | "Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased activity of and results in increased cleavage of CASP8 protein]" | 20674558 |
C552420 | 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane | "[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane" | 20674558 |
C038983 | 1,3-dimethylthiourea | "1,3-dimethylthiourea inhibits the reaction [lead acetate results in increased activity of CASP8 protein]" | 22033380 |
C037413 | 1,3-dinitropyrene | "1,3-dinitropyrene results in increased cleavage of and results in increased activity of CASP8 protein" | 17240030 |
C416442 | 1,4-anthraquinone | "1,4-anthraquinone analog results in increased activity of CASP8 protein" | 17912452 |
C416442 | 1,4-anthraquinone | "1,4-anthraquinone analog results in increased activity of CASP8 protein" | 17912452 |
C035342 | 1,4-naphthoquinone | "1,4-naphthoquinone results in increased activity of CASP8 protein" | 20138029 |
C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 results in increased cleavage of and results in increased activity of CASP8 protein" | 15498850 |
C548433 | 1-(acetyloxy)-3,5,6,6a,7,8,9,10-octahydro-10-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)naphtho(1,8a-c)furan-3,5-diyl dibutanoate | "1-(acetyloxy)-3,5,6,6a,7,8,9,10-octahydro-10-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)naphtho(1,8a-c)furan-3,5-diyl dibutanoate results in increased activity of CASP8 protein" | 25452174 |
C095284 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | "[1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one co-treated with Dithiothreitol] inhibits the reaction [[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein]]" | 10792026 |
C095284 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | "1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein]]" | 10792026 |
C032668 | 1-nitropyrene | 1-nitropyrene results in increased cleavage of and results in increased activity of CASP8 protein | 17240030 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether affects the activity of CASP8 protein" | 27589474 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether affects the expression of CASP8 mRNA" | 27589474 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CASP8 mRNA" | 26808241 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CASP8 mRNA" | 25462306 |
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CASP8 mRNA" | 16488489 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fisetin results in increased activity of CASP8 protein] | 21964635 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased cleavage of CASP8 protein] | 21165570 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tobacco Smoke Pollution results in increased phosphorylation of and results in increased activity of MAPK1 protein] promotes the reaction [FAS protein binds to CASP8 protein]] | 20118622 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tobacco Smoke Pollution results in increased phosphorylation of and results in increased activity of MAPK3 protein] promotes the reaction [FAS protein binds to CASP8 protein]] | 20118622 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [methyl 5-chloro-4,5-didehydrojasmonate results in increased activity of CASP8 protein]" | 20696234 |
C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein] | 19786087 |
C446520 | 2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone | "2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone results in increased activity of CASP8 protein" | 16096431 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CASP8 mRNA" | 19114083 |
C587734 | 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | "2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased cleavage of CASP8 protein" | 26451628 |
C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased cleavage of CASP8 protein]]" | 25432964 |
C416653 | 2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone | 2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone results in increased cleavage of and results in increased activity of CASP8 protein | 23523585 |
C416653 | 2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone | 2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone results in increased expression of CASP8 mRNA | 23523585 |
C416653 | 2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone results in increased cleavage of CASP8 protein] | 23523585 |
C440850 | 2,4,3',5'-tetramethoxystilbene | "2,4,3',5'-tetramethoxystilbene results in increased activity of CASP8 protein" | 20490654 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of CASP8 mRNA" | 20638727 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CASP8 protein" | 20638727 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "wortmannin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CASP8 protein]" | 24726520 |
C562254 | 2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione | "2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in increased cleavage of and results in increased activity of CASP8 protein" | 21741372 |
C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of CASP8 mRNA" | 21346803 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP8 protein | 15850772 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein] | 20856197 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased activity of CASP8 protein] | 27032576 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased activity of CASP8 protein | 15942663 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased activity of CASP8 protein]" | 15942663 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | BCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | TP53 protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
C450643 | (2)-5,6,7,8,4'-pentamethoxyflavanone | "(2)-5,6,7,8,4'-pentamethoxyflavanone results in increased cleavage of CASP8 protein" | 19450678 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP8 protein" | 18444175 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid results in increased cleavage of CASP8 protein" | 18444175 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP8 protein" | 21214929 |
C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP8 protein" | 21214929 |
C007997 | 25-hydroxycholesterol | 25-hydroxycholesterol results in increased activity of CASP8 protein | 25845326 |
C007997 | 25-hydroxycholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein]" | 25845326 |
C007997 | 25-hydroxycholesterol | Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein] | 25845326 |
C007997 | 25-hydroxycholesterol | BAY 11-7085 inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein] | 25845326 |
C007997 | 25-hydroxycholesterol | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein] | 25845326 |
C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of CASP8 mRNA" | 20406850 |
C062897 | 28-deoxonimbolide | 28-deoxonimbolide results in increased activity of CASP8 protein | 21381696 |
C000599179 | 28-O-acetylbetulin-3-ylglucopyranoside | 28-O-acetylbetulin-3-ylglucopyranoside results in increased activity of CASP8 protein | 26772157 |
C000599179 | 28-O-acetylbetulin-3-ylglucopyranoside | 28-O-acetylbetulin-3-ylglucopyranoside results in increased activity of CASP8 protein | 26772157 |
C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of CASP8 mRNA" | 20816883 |
C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of CASP8 mRNA" | 20816883 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate analog results in increased activity of CASP8 protein | 26772157 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate results in increased activity of CASP8 protein | 26772157 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate analog results in increased activity of CASP8 protein | 26772157 |
C000599178 | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate | 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate results in increased activity of CASP8 protein | 26772157 |
C005926 | 2-amino-4-hydroxy-6-formylpteridine | 2-amino-4-hydroxy-6-formylpteridine results in increased activity of CASP8 protein | 16019850 |
C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased activity of CASP8 protein | 12717745|1281561 |
C031278 | 2-chloroethyl ethyl sulfide | Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased activity of CASP8 protein] | 12815614 |
C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of CASP8 mRNA | 12208782 |
C022830 | 2-methoxyestradiol | 2-methoxyestradiol results in increased expression of CASP8 protein modified form | 23967052 |
C433771 | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP8 protein | 11226294 |
C433771 | 2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester | Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP8 protein] | 11226294 |
C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP8 protein] | 26208482 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "3,3',4,5'-tetrahydroxystilbene results in increased activity of CASP8 protein" | 16158945 |
C041525 | 3,3',4,5'-tetrahydroxystilbene | "3,3',4,5'-tetrahydroxystilbene results in increased cleavage of CASP8 protein" | 21167276 |
C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased activity of CASP8 protein]" | 15942663 |
C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [Camptothecin results in increased activity of CASP8 protein]" | 15475000 |
C417520 | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [Etoposide results in increased activity of CASP8 protein]" | 15475000 |
C554666 | 3,4-methylenedioxypyrovalerone | "3,4-methylenedioxypyrovalerone results in increased activity of CASP8 protein" | 27255387 |
C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile results in increased cleavage of and results in increased activity of CASP8 protein | 16173963 |
C524042 | 3,5-bis(2-fluorobenzylidene)piperidin-4-one | "3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]" | 23452621 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein] | 20104024 |
C025946 | 3-methyladenine | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]]] | 20104024 |
C025946 | 3-methyladenine | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]]] | 20104024 |
C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased cleavage of CASP8 protein] | 28803810 |
C033643 | 3-nitrofluoranthene | 3-nitrofluoranthene results in increased activity of CASP8 protein | 19041363 |
C015392 | 3-nitropropionic acid | 3-nitropropionic acid results in increased activity of CASP8 protein | 15571979 |
C000602001 | 4-(3,5-dimethoxystyryl)phenyl acetate | "4-(3,5-dimethoxystyryl)phenyl acetate results in increased cleavage of CASP8 protein" | 26138072 |
C525246 | (4,4-dimethyl-2,2-bipyridine)(acetylacetonate)copper(II) | "(4,4-dimethyl-2,2-bipyridine)(acetylacetonate)copper(II) results in decreased activity of CASP8 protein" | 22540380 |
C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased cleavage of and results in increased activity of CASP8 protein | 12203115 |
C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | TNFSF10 protein promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased cleavage of and results in increased activity of CASP8 protein] | 12203115 |
C405354 | 4,5,6,7-tetrabromobenzotriazole | "[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in increased activity of CASP8 protein" | 16489027 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C568862 | 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline | "4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of CASP8 protein" | 24161432 |
C032538 | 4-cresol | 4-cresol results in increased cleavage of CASP8 protein | 25668154 |
C032538 | 4-cresol | SQSTM1 mutant form inhibits the reaction [4-cresol results in increased cleavage of CASP8 protein] | 25668154 |
C475622 | 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine | "4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP8 protein]" | 26208482 |
C508085 | 4'-demethyldesoxypodophyllotoxin | 4'-demethyldesoxypodophyllotoxin analog results in increased cleavage of CASP8 protein | 25446499 |
C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of CASP8 mRNA | 12419474 |
C015952 | 4-iodo-2,5-dimethoxyphenylisopropylamine | "4-iodo-2,5-dimethoxyphenylisopropylamine results in increased activity of CASP8 protein" | 22983118 |
C585202 | 4-methylethcathinone | 4-methylethcathinone results in increased activity of CASP8 protein | 27255387 |
C549066 | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine | "4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of CASP8 mRNA]" | 26546572 |
C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CASP8 mRNA | 21167638 |
C041594 | 4-nonylphenol | 4-nonylphenol results in increased cleavage of CASP8 protein | 22056370 |
C041594 | 4-nonylphenol | 4-nonylphenol results in decreased expression of CASP8 mRNA | 27087316 |
C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased activity of CASP8 protein | 20156547 |
C029728 | 4-phenylenediamine | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP8 protein] | 20156547 |
C503119 | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone | 5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased cleavage of CASP8 protein | 15831436 |
C110962 | 5,6-dichlorobenzimidazole | "5,6-dichlorobenzimidazole promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein]" | 15688023 |
C080669 | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one | "5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in increased cleavage of CASP8 protein" | 19135124 |
C558288 | 5-methylselenylmethyl-2'-deoxyuridine | 5-methylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP8 protein | 22002103 |
C558288 | 5-methylselenylmethyl-2'-deoxyuridine | CASP8 protein affects the reaction [5-methylselenylmethyl-2'-deoxyuridine results in increased activity of CASP3 protein] | 22002103 |
C580598 | 5-OH-BDE-47 | 5-OH-BDE-47 results in decreased activity of CASP8 protein | 27589474 |
C580598 | 5-OH-BDE-47 | 5-OH-BDE-47 results in decreased expression of CASP8 mRNA | 27589474 |
C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | 5-phenylselenylmethyl-2'-deoxyuridine results in increased cleavage of and results in increased activity of CASP8 protein | 22002103 |
C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | CASP8 protein affects the reaction [5-phenylselenylmethyl-2'-deoxyuridine results in increased activity of CASP3 protein] | 22002103 |
C576268 | 6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide | "6-(3,4-dihydro-1H-isoquinolin-2-yl)-N-(6-methylpyridin-2-yl)nicotinamide analog results in increased activity of CASP8 protein" | 27720946 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C483321 | 6-bromoindirubin-3'-oxime | 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in increased expression of CASP8 protein modified form] | 28414160 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]" | 23711929 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein]" | 25845326 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein]" | 25845326 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased activity of CASP8 protein]" | 19477266 |
C010643 | 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of CASP8 mRNA]" | 19477266 |
C530630 | 6(hydroxymethyl)-1,4-anthracenedione | "6(hydroxymethyl)-1,4-anthracenedione results in increased activity of CASP8 protein" | 17912452 |
C583883 | 6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone | "6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased expression of CASP8 protein" | 23212307 |
C583883 | 6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone | "pyrazolanthrone inhibits the reaction [6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased expression of CASP8 protein]" | 23212307 |
C531937 | 6-O-angeloylenolin | 6-O-angeloylenolin results in increased cleavage of CASP8 protein | 21192922 |
C580599 | 6-OH-BDE-47 | 6-OH-BDE-47 results in decreased activity of CASP8 protein | 27589474 |
C580599 | 6-OH-BDE-47 | 6-OH-BDE-47 results in decreased expression of CASP8 mRNA | 27589474 |
C041398 | 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester | "7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester results in decreased activity of CASP8 protein" | 21467741 |
C553817 | 7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one | "7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-one results in increased expression of CASP8 protein modified form" | 19936915 |
C054852 | 7-hydroxystaurosporine | [7-hydroxystaurosporine co-treated with Sirolimus] results in increased cleavage of CASP8 protein | 15767555 |
C054852 | 7-hydroxystaurosporine | [alvocidib co-treated with 7-hydroxystaurosporine] results in increased cleavage of CASP8 protein | 16012789 |
C054852 | 7-hydroxystaurosporine | pyrazolanthrone inhibits the reaction [[Sirolimus co-treated with 7-hydroxystaurosporine] results in increased cleavage of CASP8 protein] | 15767555 |
C003001 | 7-ketocholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein]" | 25845326 |
C003001 | 7-ketocholesterol | 7-ketocholesterol results in increased activity of CASP8 protein | 25845326 |
C003001 | 7-ketocholesterol | Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein] | 25845326 |
C003001 | 7-ketocholesterol | BAY 11-7085 inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein] | 25845326 |
C003001 | 7-ketocholesterol | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein] | 25845326 |
C574274 | 9-hydroxycanthin-6-one | 9-hydroxycanthin-6-one results in increased cleavage of CASP8 protein | 29225138 |
C025724 | 9-methoxycamptothecin | 9-methoxycamptothecin results in increased activity of CASP8 protein | 23369935 |
C512352 | abexinostat | abexinostat results in increased cleavage of CASP8 protein | 19417023 |
C512352 | abexinostat | Bortezomib promotes the reaction [abexinostat results in increased cleavage of CASP8 protein] | 19417023 |
C496492 | abrine | abrine results in increased cleavage of and results in increased activity of CASP8 protein | 23788630 |
C496492 | abrine | abrine results in increased cleavage of and results in increased activity of CASP8 protein | 23788630 |
C501332 | ABT-737 | 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
C501332 | ABT-737 | 3-methyladenine promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein] | 20104024 |
C501332 | ABT-737 | 3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]] | 20104024 |
C501332 | ABT-737 | [ABT-737 co-treated with Celecoxib] results in increased activity of CASP8 protein | 20104024 |
C501332 | ABT-737 | ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein] | 20104024 |
C501332 | ABT-737 | ABT-737 promotes the reaction [wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
C501332 | ABT-737 | ABT-737 results in increased cleavage of CASP8 protein | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]]] | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]]] | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
C501332 | ABT-737 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]] | 20104024 |
C501332 | ABT-737 | Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein] | 20104024 |
C501332 | ABT-737 | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP8 protein] | 20104024 |
C501332 | ABT-737 | PIK3C3 mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP8 protein] | 20104024 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of CASP8 mRNA | 21420995|2906747 |
D000082 | Acetaminophen | Acetaminophen results in increased activity of CASP8 | 12005112 |
D000082 | Acetaminophen | Acetaminophen affects the expression of CASP8 mRNA | 17562736 |
D000082 | Acetaminophen | [Acetaminophen co-treated with TNF protein] results in increased activity of CASP8 protein | 12085349 |
D000082 | Acetaminophen | Acetaminophen results in increased expression of CASP8 protein | 12540782 |
D000082 | Acetaminophen | "O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of CASP8 protein]" | 12540782 |
C464485 | acetamiprid | acetamiprid results in increased expression of CASP8 mRNA | 29091792 |
C464485 | acetamiprid | [iprodione co-treated with acetamiprid] results in decreased expression of CASP8 mRNA | 29091792 |
C464485 | acetamiprid | [iprodione co-treated with pyrachlostrobin co-treated with acetamiprid co-treated with iprodione] results in increased expression of CASP8 mRNA | 29091792 |
C464485 | acetamiprid | [iprodione co-treated with pyrachlostrobin co-treated with acetamiprid] results in increased expression of CASP8 mRNA | 29091792 |
C464485 | acetamiprid | [iprodione co-treated with pyrimethanil co-treated with acetamiprid] results in increased expression of CASP8 mRNA | 29091792 |
C099158 | acetyl-aspartyl-glutamyl-valyl-aspartal | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein] | 19084044 |
C487680 | acetylbritannilatone | acetylbritannilatone analog results in increased activity of CASP8 protein | 27262408 |
C487680 | acetylbritannilatone | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [acetylbritannilatone analog results in increased activity of CASP8 protein] | 27262408 |
C487680 | acetylbritannilatone | TP53 protein affects the reaction [acetylbritannilatone analog results in increased activity of CASP8 protein] | 27262408 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP8 protein]] | 26375285 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased activity of CASP8 protein] | 12815614 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Biological Products results in increased cleavage of CASP8 protein] | 28219700 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP8 protein] | 16169029 |
D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP8 protein]" | 28087840 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein] | 17574045 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP8 protein] | 21310227 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP8 protein] | 22578287 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP8 protein] | 27313093 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP8 mRNA] | 23867903 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP8 protein] | 19014919 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP8 protein] | 28918123 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP8 protein] | 28548367 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein] | 27313093 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein] | 25034532 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 23711929 |
D000111 | Acetylcysteine | "Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in increased activity of and results in increased cleavage of CASP8 protein]" | 20674558 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cannabidiol hydroxyquinone results in increased activity of CASP8 protein] | 20184945 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP8 protein] | 20576514 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Simvastatin results in increased activity of CASP8 protein] | 20883752 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP8 protein] | 24614525 |
D000111 | Acetylcysteine | [Acetylcysteine co-treated with Atorvastatin Calcium] inhibits the reaction [sodium arsenite results in increased activity of CASP8 protein] | 20946910 |
D000111 | Acetylcysteine | [Acetylcysteine co-treated with Atorvastatin Calcium] inhibits the reaction [sodium arsenite results in increased expression of CASP8 protein] | 20946910 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein] | 25845326 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein] | 25845326 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP8 protein] | 19477266 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP8 mRNA] | 19477266 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8] | 18791325 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of CASP8 protein] | 27484784 |
D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [resveratrol results in increased cleavage of CASP8 protein] | 26849945 |
C081895 | acetyldinaline | acetyldinaline promotes the reaction [decitabine results in increased expression of CASP8 protein] | 21771726 |
C401206 | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [hispanolone analog results in increased activity of CASP8 protein] | 25930665 |
C401206 | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP8 protein]] | 25930665 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal affects the reaction [Cisplatin results in increased activity of CASP8 protein] | 21801448 |
C420218 | acetyl-leucyl-glutamyl-histidyl-aspartal | acetyl-leucyl-glutamyl-histidyl-aspartal inhibits the reaction [Etoposide results in increased activity of CASP8 protein] | 21801448 |
C063261 | acetylleucyl-leucyl-norleucinal | acetylleucyl-leucyl-norleucinal inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
D017255 | Acitretin | Acitretin results in increased activity of CASP8 protein | 18624760 |
D015250 | Aclarubicin | Aclarubicin results in increased activity of CASP8 protein | 20399885 |
D000171 | Acrolein | Acrolein results in increased activity of CASP8 protein | 17196791|1732076 |
D000171 | Acrolein | Acrolein results in increased cleavage of CASP8 protein | 17320762 |
D000171 | Acrolein | Acrolein affects the activity of CASP8 protein | 17222828 |
D000171 | Acrolein | Acrolein affects the alkylation of CASP8 protein | 17222828 |
D000171 | Acrolein | Acrolein affects the cleavage of CASP8 protein | 17222828 |
D000171 | Acrolein | Acrolein inhibits the reaction [FAS protein results in increased activity of CASP8 protein] | 17222828 |
D000171 | Acrolein | Acrolein inhibits the reaction [FAS protein results in increased cleavage of CASP8 protein] | 17222828 |
D000171 | Acrolein | Acrolein promotes the reaction [Zidovudine results in increased cleavage of CASP8 protein] | 27238871 |
D000171 | Acrolein | Acrolein results in increased cleavage of CASP8 protein | 27238871 |
D000171 | Acrolein | Zidovudine promotes the reaction [Acrolein results in increased cleavage of CASP8 protein] | 27238871 |
D000171 | Acrolein | Acrolein results in decreased activity of CASP8 protein | 11803030 |
D000171 | Acrolein | Acrolein results in increased expression of CASP8 protein | 24376112 |
D000171 | Acrolein | capsazepine inhibits the reaction [Acrolein results in increased expression of CASP8 protein] | 24376112 |
D000171 | Acrolein | Glutathione inhibits the reaction [Acrolein results in increased expression of CASP8 protein] | 24376112 |
D020106 | Acrylamide | Acrylamide results in increased expression of CASP8 mRNA | 28959563 |
D000241 | Adenosine | Adenosine results in increased activity of CASP8 protein | 17303086 |
D000241 | Adenosine | Dipyridamole inhibits the reaction [Adenosine results in increased activity of CASP8 protein] | 17303086 |
D000241 | Adenosine | Adenosine results in increased activity of CASP8 protein | 16469385 |
D000255 | Adenosine Triphosphate | Adenosine Triphosphate results in increased activity of CASP8 protein | 17997382 |
D000255 | Adenosine Triphosphate | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate results in increased activity of CASP8 protein] | 17997382 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CASP8 mRNA | 27017951|2894338 |
D016604 | Aflatoxin B1 | [gluconic acid co-treated with Zinc Sulfate] inhibits the reaction [Aflatoxin B1 results in increased expression of CASP8 mRNA] | 27017951 |
D016604 | Aflatoxin B1 | Zinc Sulfate inhibits the reaction [Aflatoxin B1 results in increased expression of CASP8 mRNA] | 27017951 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CASP8 mRNA | 28789997 |
C004363 | alantolactone | alantolactone results in increased cleavage of CASP8 protein | 22721982 |
C054122 | alanylglutamine | "alanylglutamine inhibits the reaction [tcdA protein, Clostridium difficile results in increased activity of CASP8 protein]" | 16368960 |
C012708 | alborixin | alborixin results in increased activity of CASP8 protein | 27378626 |
C103303 | alitretinoin | alitretinoin results in increased activity of CASP8 protein | 16449964 |
C518327 | aloe emodin | aloe emodin results in increased activity of CASP8 protein | 19928967 |
C518327 | aloe emodin | aloe emodin results in increased expression of CASP8 protein modified form | 19928967 |
C518327 | aloe emodin | [Fluorouracil co-treated with aloe emodin] affects the expression of CASP8 | 19928967 |
C518327 | aloe emodin | Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP8 protein modified form] | 19928967 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in decreased expression of CASP8 mRNA | 27732882 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased activity of CASP8 protein | 28070108 |
D000517 | alpha-Chlorohydrin | alpha-Chlorohydrin results in increased expression of and results in increased cleavage of and results in increased activity of CASP8 protein | 27732882 |
D000517 | alpha-Chlorohydrin | quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP8 protein] | 27732882 |
C011512 | alpha-naphthoflavone | alpha-naphthoflavone results in increased activity of CASP8 protein | 18334599 |
D024502 | alpha-Tocopherol | alpha-Tocopherol analog results in increased cleavage of CASP8 protein | 20686688 |
C064176 | alpha-viniferin | alpha-viniferin analog results in increased activity of CASP8 protein | 16158945 |
C064176 | alpha-viniferin | alpha-viniferin results in increased activity of CASP8 protein | 16158945 |
C010845 | aluminum chloride | aluminum chloride results in increased expression of CASP8 protein | 28623112 |
C010845 | aluminum chloride | Chlorogenic Acid inhibits the reaction [aluminum chloride results in increased expression of CASP8 protein] | 28623112 |
C077990 | alvocidib | [alvocidib co-treated with 7-hydroxystaurosporine] results in increased cleavage of CASP8 protein | 16012789 |
C077990 | alvocidib | [alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of CASP8 protein | 15634644 |
C077990 | alvocidib | [alvocidib co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 16951203 |
C077990 | alvocidib | alvocidib results in increased cleavage of CASP8 protein | 10896673|1258903 |
C077990 | alvocidib | [Imatinib Mesylate co-treated with alvocidib] results in increased activity of CASP8 protein | 12231544 |
D000584 | Amiloride | Amiloride promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 15607733 |
D000584 | Amiloride | Amiloride promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | 16059913 |
D000622 | Aminolevulinic Acid | Aminolevulinic Acid analog results in increased activity of CASP8 protein | 21138480 |
D000622 | Aminolevulinic Acid | pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP8 protein] | 21138480 |
D000638 | Amiodarone | [TNFSF10 co-treated with Amiodarone] results in increased cleavage of CASP8 protein | 21292685 |
D000638 | Amiodarone | Amiodarone results in increased expression of CASP8 protein modified form | 21224497 |
D017311 | Amlodipine | [Amlodipine co-treated with Topotecan] results in increased activity of CASP8 protein | 16516327 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CASP8 mRNA | 16483693 |
D000643 | Ammonium Chloride | Ammonium Chloride results in increased activity of CASP8 protein | 18722528 |
D000643 | Ammonium Chloride | Ammonium Chloride results in increased expression of CASP8 protein | 16483693 |
C054105 | ammonium trichloro(dioxoethylene-O,O'-)tellurate | "ammonium trichloro(dioxoethylene-O,O'-)tellurate results in decreased activity of CASP8 protein" | 18571097 |
C088115 | anacardic acid | [anacardic acid co-treated with TNF protein] results in increased cleavage of CASP8 protein | 18349320 |
C030419 | andrographolide | [andrographolide co-treated with Cisplatin] results in increased expression of CASP8 mRNA | 24563380 |
C030419 | andrographolide | andrographolide results in increased activity of CASP8 protein | 19097688 |
C030419 | andrographolide | andrographolide results in increased expression of CASP8 mRNA | 24563380 |
C030419 | andrographolide | CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]] | 19097688 |
C030419 | andrographolide | CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]] | 19097688 |
C030419 | andrographolide | CASP8 results in increased susceptibility to [andrographolide co-treated with Fluorouracil] | 19097688 |
C030419 | andrographolide | Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP8 protein] | 19097688 |
C030419 | andrographolide | andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP8 protein] | 20946909 |
D000841 | Anisomycin | Anisomycin results in increased activity of CASP8 protein | 18241849 |
C540917 | anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione | "anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione results in increased cleavage of CASP8 protein" | 19146838 |
D000970 | Antineoplastic Agents | Antineoplastic Agents results in increased expression of and results in increased cleavage of CASP8 protein | 22010212 |
D000970 | Antineoplastic Agents | CASP8 protein results in increased susceptibility to Antineoplastic Agents | 22010212 |
D000970 | Antineoplastic Agents | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Antineoplastic Agents | 22010212 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CASP8 mRNA | 24449571 |
C102351 | apicidin | apicidin results in increased activity of CASP8 protein | 19070610 |
D047310 | Apigenin | Apigenin results in increased cleavage of CASP8 protein | 15486995 |
D047310 | Apigenin | [TNFSF10 protein results in increased susceptibility to Apigenin] which results in increased cleavage of CASP8 protein | 29247770 |
D047310 | Apigenin | Apigenin promotes the reaction [hydroxygenkwanin results in increased activity of CASP8 protein] | 24144774 |
D047310 | Apigenin | Apigenin results in increased activity of CASP8 protein | 24144774 |
D047310 | Apigenin | hydroxygenkwanin promotes the reaction [Apigenin results in increased activity of CASP8 protein] | 24144774 |
D016718 | Arachidonic Acid | Arachidonic Acid results in increased activity of CASP8 protein | 19720122 |
D016718 | Arachidonic Acid | FADD protein promotes the reaction [Arachidonic Acid results in increased activity of CASP8 protein] | 19720122 |
D001104 | Arbutin | Arbutin results in decreased expression of CASP8 mRNA | 17103032 |
C061640 | arjunolic acid | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased expression of CASP8 protein] | 21420465 |
D001151 | Arsenic | Arsenic affects the methylation of CASP8 gene | 25304211 |
D001151 | Arsenic | Arsenic results in increased expression of CASP8 mRNA | 27838757 |
C006632 | arsenic trioxide | arsenic trioxide affects the expression of CASP8 mRNA | 28454103 |
C006632 | arsenic trioxide | arsenic trioxide affects the activity of CASP8 protein | 16010437 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Bortezomib] results in decreased expression of CASP8 mRNA | 20471514 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Curcumin] results in increased expression of CASP8 protein | 27430728 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP8 protein | 23082001 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein | 21889928 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein | 18359480 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with TNF protein] results in increased cleavage of and results in increased activity of CASP8 protein | 17673311 |
C006632 | arsenic trioxide | [arsenic trioxide co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 24345465 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP8 protein] | 21418039 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [puerarin results in increased expression of CASP8 protein] | 20416161 |
C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | 16434995 |
C006632 | arsenic trioxide | arsenic trioxide results in increased activity of CASP8 protein | 10721769|1214889 |
C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of and results in increased activity of CASP8 protein | 18546268|1940830 |
C006632 | arsenic trioxide | arsenic trioxide results in increased cleavage of CASP8 protein | 18491231|2308200 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CASP8 protein | 27430728 |
C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CASP8 protein modified form | 20953137 |
C006632 | arsenic trioxide | BCL2 inhibits the reaction [[arsenic trioxide co-treated with TNF protein] results in increased activity of CASP8 protein] | 17673311 |
C006632 | arsenic trioxide | BCL2 protein inhibits the reaction [[arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein] | 21889928 |
C006632 | arsenic trioxide | BCL2 protein inhibits the reaction [[arsenic trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein] | 18359480 |
C006632 | arsenic trioxide | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[arsenic trioxide co-treated with TNF protein] results in increased cleavage of and results in increased activity of CASP8 protein] | 17673311 |
C006632 | arsenic trioxide | [Bortezomib co-treated with arsenic trioxide] results in increased expression of CASP8 protein | 24377552 |
C006632 | arsenic trioxide | Bortezomib promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 20471514 |
C006632 | arsenic trioxide | [Buthionine Sulfoximine co-treated with arsenic trioxide] results in increased cleavage of CASP8 protein | 17145888 |
C006632 | arsenic trioxide | [CSF2 protein co-treated with arsenic trioxide] results in decreased expression of and affects the activity of CASP8 protein | 16174796 |
C006632 | arsenic trioxide | Genistein promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP8 protein] | 18546268 |
C006632 | arsenic trioxide | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [arsenic trioxide promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]] | 16434995 |
C006632 | arsenic trioxide | MAPK8 protein affects the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 20534739 |
C006632 | arsenic trioxide | Poly I-C promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 21418039 |
C006632 | arsenic trioxide | pyrazolanthrone inhibits the reaction [[Buthionine Sulfoximine co-treated with arsenic trioxide] results in increased cleavage of CASP8 protein] | 17145888 |
C006632 | arsenic trioxide | pyrazolanthrone promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 16972261 |
C006632 | arsenic trioxide | [sanguinarine co-treated with arsenic trioxide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 24345465 |
C006632 | arsenic trioxide | [sanguinarine co-treated with arsenic trioxide] results in increased activity of CASP8 protein | 24345465 |
C006632 | arsenic trioxide | U 0126 promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 16972261 |
C006632 | arsenic trioxide | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP8 mRNA | 25815518 |
C006632 | arsenic trioxide | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP8 protein | 25815518 |
C006632 | arsenic trioxide | "arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in increased cleavage of CASP8 protein]" | 28587418 |
C006632 | arsenic trioxide | arsenic trioxide results in increased activity of CASP8 protein | 21565247|2541015 |
C006632 | arsenic trioxide | arsenic trioxide results in increased activity of CASP8 protein | 14726646 |
C015001 | arsenite | Acetylcysteine inhibits the reaction [epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP8 protein]] | 26375285 |
C015001 | arsenite | arsenite results in increased activity of CASP8 protein | 26375285 |
C015001 | arsenite | epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP8 protein] | 26375285 |
C519899 | AS602868 | AS602868 results in increased cleavage of and results in increased activity of CASP8 protein | 18182997 |
C519899 | AS602868 | irinotecan promotes the reaction [AS602868 results in increased cleavage of and results in increased activity of CASP8 protein] | 18182997 |
C012195 | asarone | asarone results in increased activity of CASP8 protein | 29174417 |
D017636 | Asbestos, Amphibole | "Asbestos, Amphibole results in increased expression of CASP8 protein" | 20855422 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite inhibits the reaction [Asbestos, Crocidolite results in increased activity of CASP8 protein]" | 22608188 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased activity of CASP8 protein" | 22608188 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CASP8 mRNA" | 23634900 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of CASP8 protein" | 23634900 |
D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 23711929 |
D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with INS1 protein] results in increased expression of CASP8 mRNA | 20400526 |
D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA | 18544905 |
C108637 | aspartyl-glutamyl-valyl-aspartal | aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP8 protein | 10896673 |
D001241 | Aspirin | [Aspirin co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 21171083 |
D001241 | Aspirin | [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 18483385 |
D001241 | Aspirin | Aspirin results in increased activity of CASP8 protein | 11034327 |
D001241 | Aspirin | Aspirin results in increased cleavage of and results in increased activity of CASP8 protein | 15481331 |
D001241 | Aspirin | Aspirin results in increased expression of CASP8 mRNA | 20457246 |
D001241 | Aspirin | CASP8 affects the reaction [Aspirin results in increased cleavage of BID protein] | 15976387 |
D001241 | Aspirin | CASP8 affects the reaction [Aspirin results in increased localization of BAX protein] | 15976387 |
D001241 | Aspirin | [TNFSF10 protein co-treated with Aspirin] results in increased cleavage of CASP8 protein | 16199534 |
D000069059 | Atorvastatin Calcium | [Atorvastatin Calcium co-treated with Celecoxib] results in increased cleavage of CASP8 protein | 18172863 |
D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in increased activity of CASP8 protein | 15705602 |
D000069059 | Atorvastatin Calcium | [Acetylcysteine co-treated with Atorvastatin Calcium] inhibits the reaction [sodium arsenite results in increased activity of CASP8 protein] | 20946910 |
D000069059 | Atorvastatin Calcium | [Acetylcysteine co-treated with Atorvastatin Calcium] inhibits the reaction [sodium arsenite results in increased expression of CASP8 protein] | 20946910 |
D001310 | Auranofin | Auranofin results in decreased expression of and results in increased cleavage of CASP8 protein | 20542334 |
C426023 | austenitic steel | [Nickel co-treated with austenitic steel analog] results in increased expression of CASP8 mRNA | 23638002 |
D001374 | Azacitidine | Azacitidine results in increased expression of CASP8 mRNA | 18082045 |
D001374 | Azacitidine | Azacitidine results in increased expression of CASP8 mRNA | 23395740 |
C010329 | azadirachtin | azadirachtin results in increased expression of CASP8 protein | 20429769 |
C479321 | azadiradione | azadiradione results in increased activity of CASP8 protein | 21381696 |
C099015 | azaspirane | azaspirane results in increased cleavage of and results in increased activity of CASP8 protein | 15705788 |
C517975 | AZD 6244 | AZD 6244 inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP8 protein]] | 27222248 |
C040929 | bafilomycin A1 | bafilomycin A1 inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
C040929 | bafilomycin A1 | bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP8 protein] | 28378122 |
C006680 | baicalein | baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form] | 20850421 |
C012765 | bakuchiol | [TNFSF10 protein co-treated with bakuchiol] results in increased cleavage of CASP8 protein | 27033605 |
C060988 | baohuoside I | baohuoside I results in increased activity of CASP8 protein | 19289254 |
C028559 | bathocuproine sulfonate | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] | 15477007 |
C028559 | bathocuproine sulfonate | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA]] | 15477007 |
C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein] | 25845326 |
C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein] | 25845326 |
C580697 | BDMC-A | BDMC-A results in increased cleavage of CASP8 protein | 24365254 |
C004456 | beauvericin | beauvericin results in increased expression of CASP8 mRNA | 29203277 |
C487081 | belinostat | belinostat results in increased expression of CASP8 mRNA | 26272509 |
C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
D000069461 | Bendamustine Hydrochloride | Bendamustine Hydrochloride results in increased activity of CASP8 protein | 12948851 |
D000069461 | Bendamustine Hydrochloride | Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP8 protein] | 12948851 |
D001554 | Benzene | Benzene results in increased expression of CASP8 protein | 17171516 |
C026487 | benzo(e)pyrene | benzo(e)pyrene results in increased activity of CASP8 protein | 18586875 |
C026487 | benzo(e)pyrene | benzo(e)pyrene results in increased activity of CASP8 protein | 19899995 |
D053119 | Benzophenanthridines | Benzophenanthridines analog results in increased activity of CASP8 protein | 23117580 |
D001564 | Benzo(a)pyrene | AHR mutant form inhibits the reaction [[Benzo(a)pyrene co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein] | 22951985 |
D001564 | Benzo(a)pyrene | AHR mutant form inhibits the reaction [Benzo(a)pyrene promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein]] | 22951985 |
D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein | 22951985 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [FASLG protein results in increased cleavage of CASP8 protein] | 22951985 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased cleavage of CASP8 protein | 16041517 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CASP8 mRNA | 24239969 |
D001564 | Benzo(a)pyrene | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP8 protein] | 16041517 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CASP8 mRNA | 19770486 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CASP8 mRNA | 22228805 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CASP8 mRNA | 28651000 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CASP8 mRNA | 21774909 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased activity of CASP8 protein | 22051199 |
D001564 | Benzo(a)pyrene | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP8 protein] | 22051199 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP8 protein" | 21983885 |
C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Cladribine results in increased cleavage of CASP8 protein] | 15516989 |
C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [fludarabine results in increased cleavage of CASP8 protein] | 15516989 |
C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP8 protein] | 20226831 |
C110772 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [GW 7845 results in increased activity of and results in increased cleavage of CASP8 protein] | 17400580 |
C427308 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP8 protein] | 16777994 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [4-phenylenediamine results in increased activity of CASP8 protein] | 20156547 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [2-(3'-methoxyphenyl)-6-pyrrolidinyl-4-quinazolinone results in increased cleavage of CASP8 protein] | 23523585 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[arsenic trioxide co-treated with TNF protein] results in increased cleavage of and results in increased activity of CASP8 protein] | 17673311 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]] | 20104024 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ciglitazone promotes the reaction [Niflumic Acid results in increased activity of CASP8 protein]] | 21067863 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP8 protein] | 21126053 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Nickel results in increased cleavage of CASP8 protein] | 24840272 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Niflumic Acid promotes the reaction [ciglitazone results in increased activity of CASP8 protein]] | 21067863 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [nimesulide results in increased cleavage of and results in increased activity of CASP8 protein] | 19360361 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | "benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [N,N-dimethylphytosphingosine results in increased cleavage of and results in increased activity of CASP8 protein]" | 19481559 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein] | 19084044 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein] | 19423619 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] | 19423619 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Staurosporine results in increased cleavage of CASP8 protein] | 24658017 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein | 12902349|1456316 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAK1 protein] | 12902349 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAX protein] | 12902349 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | "[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to 1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane" | 20674558 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to flavanone | 22056764 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to Hydrazones | 22056764 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to Plant Extracts | 20229524 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to PRODH protein | 16619034 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to resveratrol | 19561642 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to TNFSF10 protein | 23711929 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP8 protein] | 12831782 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein | 20671745 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 mRNA] | 20671745 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein] | 20671745 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]] | 20671745 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | lactacystin inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]] | 20671745 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP8 protein results in increased susceptibility to Cacodylic Acid] | 15276415 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP8 protein] | 16263807 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein | 15276415 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein | 11212279|1218174 |
C403753 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [methyl jasmonate metabolite results in increased susceptibility to TNFSF10 protein] | 22079975 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein] | 17574045 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Diclofenac results in increased activity of CASP8 protein] | 27313093 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [rubimaillin results in increased activity of CASP8 protein] | 19716835 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein] | 27313093 |
C403754 | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP8 protein] | 12831782 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of and results in increased activity of CASP8 protein | 15498850 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]] | 20671745 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP8 protein] | 15914627 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of CASP8 protein | 20100472|2044972 |
C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP8 protein]] | 15914627 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [acetylbritannilatone analog results in increased activity of CASP8 protein] | 27262408 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein] | 18222423 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein] | 26544897 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Lithocholic Acid results in increased cleavage of and results in increased activity of CASP8 protein] | 19054763 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein] | 18222423 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] affects the localization of CASP8 protein] | 19643600 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] results in increased activity of CASP8 protein] | 19643600 |
C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Zinc Oxide analog results in increased activity of CASP8 protein] | 27544635 |
C103712 | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane analog inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP8 protein] | 12831782 |
D001599 | Berberine | Berberine results in increased activity of CASP8 protein | 20656010 |
D004958 | Estradiol | Estradiol results in decreased expression of CASP8 mRNA | 24349563 |
D004958 | Estradiol | Estradiol results in increased activity of CASP8 protein | 19095654 |
D004958 | Estradiol | ABCC8 protein promotes the reaction [Estradiol results in increased activity of CASP8 protein] | 19095654 |
D004958 | Estradiol | [Caspase Inhibitors results in decreased activity of CASP8 protein] inhibits the reaction [Estradiol results in increased activity of CASP3 protein] | 15545282 |
D004958 | Estradiol | [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP8 protein | 22465879 |
D004958 | Estradiol | Estradiol results in increased cleavage of CASP8 protein | 15545282 |
D004958 | Estradiol | [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP8 mRNA | 20732338 |
C023888 | beta-hexachlorocyclohexane | beta-hexachlorocyclohexane results in increased cleavage of CASP8 protein | 19760616 |
C023888 | beta-hexachlorocyclohexane | beta-hexachlorocyclohexane results in increased expression of CASP8 mRNA | 19175174 |
C023888 | beta-hexachlorocyclohexane | [Dichlorodiphenyl Dichloroethylene co-treated with beta-hexachlorocyclohexane] results in increased expression of CASP8 mRNA | 19175174 |
C026609 | beta-solamarine | beta-solamarine promotes the reaction [Cisplatin results in increased activity of CASP8 protein] | 17619073 |
C026609 | beta-solamarine | beta-solamarine results in increased activity of CASP8 protein | 17619073 |
C002070 | betulinic acid | betulinic acid results in increased activity of CASP8 protein | 26772157 |
C002070 | betulinic acid | betulinic acid results in increased activity of CASP8 protein | 26772157 |
C518477 | BI 2536 | BI 2536 results in increased activity of CASP8 protein | 24403256 |
C099952 | bifenthrin | bifenthrin results in decreased expression of CASP8 mRNA | 26071804 |
C099952 | bifenthrin | bifenthrin results in increased activity of CASP8 protein | 26071804 |
D001688 | Biological Products | Acetylcysteine inhibits the reaction [Biological Products results in increased cleavage of CASP8 protein] | 28219700 |
D001688 | Biological Products | Biological Products results in increased cleavage of CASP8 protein | 28219700 |
C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in increased activity of CASP8 protein | 23458715 |
C482801 | bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) | bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | 21037225 |
C482801 | bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) | TNFRSF10B protein promotes the reaction [bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]] | 21037225 |
D017438 | Bisphenol A-Glycidyl Methacrylate | Bisphenol A-Glycidyl Methacrylate results in increased activity of CASP8 protein | 26756871 |
D017438 | Bisphenol A-Glycidyl Methacrylate | wogonin inhibits the reaction [Bisphenol A-Glycidyl Methacrylate results in increased activity of CASP8 protein] | 26756871 |
C006780 | bisphenol A | bisphenol A affects the expression of CASP8 mRNA | 21786754 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CASP8 protein | 21277958 |
C006780 | bisphenol A | bisphenol A results in increased expression of CASP8 mRNA | 29275510 |
C006780 | bisphenol A | bisphenol A affects the expression of CASP8 mRNA | 26049153|2674610 |
C006780 | bisphenol A | bisphenol A results in increased expression of CASP8 protein | 23900028 |
C006780 | bisphenol A | bisphenol A results in decreased expression of CASP8 mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased activity of CASP8 protein | 25454643 |
C006780 | bisphenol A | bisphenol A results in increased expression of CASP8 mRNA | 27539358 |
C006780 | bisphenol A | Melatonin inhibits the reaction [bisphenol A results in increased activity of CASP8 protein] | 25454643 |
C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of CASP8 mRNA | 24247028 |
C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in increased expression of CASP8 mRNA | 25270620 |
D001761 | Bleomycin | [Polyphenols co-treated with Bleomycin] results in increased expression of CASP8 mRNA | 26800624 |
D001761 | Bleomycin | [Tea co-treated with Bleomycin] results in increased expression of CASP8 mRNA | 26800624 |
D001786 | Blood Glucose | SOD1 protein inhibits the reaction [Blood Glucose results in increased cleavage of CASP8 protein] | 22425406 |
D001786 | Blood Glucose | Blood Glucose results in increased cleavage of CASP8 protein | 22425406 |
C476029 | Boc-D-FMK | Boc-D-FMK inhibits the reaction [sorafenib results in increased cleavage of and results in increased activity of CASP8 protein] | 16007148 |
C005066 | borrelidin | borrelidin results in increased activity of CASP8 protein | 14563161 |
D000069286 | Bortezomib | AKT1 protein inhibits the reaction [[Bortezomib co-treated with TNFSF10 protein] results in increased activity of CASP8 protein] | 19261616 |
D000069286 | Bortezomib | [arsenic trioxide co-treated with Bortezomib] results in decreased expression of CASP8 mRNA | 20471514 |
D000069286 | Bortezomib | "[Bortezomib co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in increased activity of CASP8 protein" | 15070698 |
D000069286 | Bortezomib | [Bortezomib co-treated with arsenic trioxide] results in increased expression of CASP8 protein | 24377552 |
D000069286 | Bortezomib | [Bortezomib co-treated with Butyrates] results in increased cleavage of and results in increased activity of CASP8 protein | 12893773 |
D000069286 | Bortezomib | [Bortezomib co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 19261616|2044229 |
D000069286 | Bortezomib | [Bortezomib co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein | 17510429|1762043 |
D000069286 | Bortezomib | [Bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of CASP8 protein | 16904634 |
D000069286 | Bortezomib | [Bortezomib co-treated with vorinostat] results in increased activity of CASP8 protein | 18005386|1864136 |
D000069286 | Bortezomib | [Bortezomib co-treated with vorinostat] results in increased cleavage of and results in increased activity of CASP8 protein | 12893773 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [abexinostat results in increased cleavage of CASP8 protein] | 19417023 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 20471514 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [Butyrates results in increased activity of CASP8 protein] | 15173093 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 19100720 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | 12902978 |
D000069286 | Bortezomib | Bortezomib promotes the reaction [vorinostat results in increased activity of CASP8 protein] | 15173093 |
D000069286 | Bortezomib | Bortezomib results in increased cleavage of and results in increased activity of CASP8 protein | 16024631|1751042 |
D000069286 | Bortezomib | Bortezomib results in increased cleavage of CASP8 protein | 12393500|1611831 |
D000069286 | Bortezomib | [Bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein] which results in increased cleavage of CASP8 protein | 17326159 |
D000069286 | Bortezomib | [CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased cleavage of ATM protein] | 12393500 |
D000069286 | Bortezomib | [CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased cleavage of MDM2 protein] | 12393500 |
D000069286 | Bortezomib | [CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased cleavage of PRKDC protein] | 12393500 |
D000069286 | Bortezomib | [CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased phosphorylation of TP53 protein] | 12393500 |
D000069286 | Bortezomib | CDKN1A protein affects the reaction [[TNFSF10 protein co-treated with Bortezomib] results in increased cleavage of CASP8 protein] | 15930312 |
D000069286 | Bortezomib | [gambogic acid co-treated with Bortezomib] results in increased activity of CASP8 protein | 24291039 |
D000069286 | Bortezomib | [IFNA2 protein co-treated with Bortezomib] results in increased activity of CASP8 protein | 17172406 |
D000069286 | Bortezomib | [lonafarnib co-treated with Bortezomib] results in increased cleavage of CASP8 protein | 16118318 |
D000069286 | Bortezomib | SCIO-469 promotes the reaction [Bortezomib results in increased cleavage of CASP8 protein] | 16617327 |
D000069286 | Bortezomib | TNFRSF10B mutant form inhibits the reaction [[Bortezomib co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein] | 17510429 |
D000069286 | Bortezomib | TNFRSF10B mutant form inhibits the reaction [Bortezomib results in increased cleavage of CASP8 protein] | 17510429 |
D000069286 | Bortezomib | [TNFSF10 protein co-treated with Bortezomib] results in increased cleavage of CASP8 protein | 15930312 |
D000069286 | Bortezomib | [trichostatin A co-treated with Bortezomib] results in increased cleavage of CASP8 protein | 21345073 |
D000069286 | Bortezomib | [vorinostat co-treated with Bortezomib] results in increased cleavage of CASP8 protein | 17351739 |
D000069286 | Bortezomib | Bortezomib results in increased activity of CASP8 protein | 20026740 |
C053342 | brevetoxin | brevetoxin results in increased activity of CASP8 protein | 19536525 |
C546611 | brevetoxin 2 | brevetoxin 2 results in increased activity of CASP8 protein | 19536525 |
C016274 | bromoacetate | bromoacetate results in decreased expression of CASP8 mRNA | 19753638 |
C016274 | bromoacetate | bromoacetate results in increased expression of CASP8 mRNA | 19753638 |
D016642 | Bupropion | Bupropion results in increased activity of CASP8 protein | 21354251 |
D002066 | Busulfan | Busulfan results in increased activity of CASP8 protein | 18339423 |
D002066 | Busulfan | [decitabine co-treated with Busulfan] results in increased activity of CASP8 protein | 19732952 |
D002066 | Busulfan | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein] | 19732952 |
D019328 | Buthionine Sulfoximine | [Buthionine Sulfoximine co-treated with arsenic trioxide] results in increased cleavage of CASP8 protein | 17145888 |
D019328 | Buthionine Sulfoximine | pyrazolanthrone inhibits the reaction [[Buthionine Sulfoximine co-treated with arsenic trioxide] results in increased cleavage of CASP8 protein] | 17145888 |
D002083 | Butylated Hydroxyanisole | Butylated Hydroxyanisole inhibits the reaction [[TNF protein co-treated with Cycloheximide] results in increased activity of CASP8 protein] | 15950244 |
C027561 | butylbenzyl phthalate | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA | 28013214 |
C026105 | butylidenephthalide | butylidenephthalide results in increased cleavage of CASP8 protein | 16987298 |
C026105 | butylidenephthalide | butylidenephthalide results in increased cleavage of CASP8 protein | 16987298 |
D002087 | Butyrates | [Bortezomib co-treated with Butyrates] results in increased cleavage of and results in increased activity of CASP8 protein | 12893773 |
D002087 | Butyrates | Bortezomib promotes the reaction [Butyrates results in increased activity of CASP8 protein] | 15173093 |
D002087 | Butyrates | Butyrates results in increased activity of CASP8 protein | 15173093 |
D002087 | Butyrates | Butyrates results in increased expression of CASP8 mRNA | 16042588 |
D002087 | Butyrates | [perifosine co-treated with Butyrates] results in increased activity of CASP8 protein | 15781658 |
C400541 | CA 074 methyl ester | CA 074 methyl ester inhibits the reaction [manganese chloride results in increased cleavage of CASP8 protein] | 28378122 |
D002101 | Cacodylic Acid | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [CASP8 protein results in increased susceptibility to Cacodylic Acid] | 15276415 |
D002101 | Cacodylic Acid | CASP8 protein results in increased susceptibility to Cacodylic Acid | 15276415 |
D002104 | Cadmium | Cadmium results in increased activity of CASP8 protein | 22768170 |
D002104 | Cadmium | Cadmium results in increased activity of CASP8 protein | 22692000 |
D002104 | Cadmium | "[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]" | 29111403 |
D002104 | Cadmium | "1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]" | 29111403 |
D002104 | Cadmium | acetylleucyl-leucyl-norleucinal inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
D002104 | Cadmium | bafilomycin A1 inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
D002104 | Cadmium | Cadmium results in increased cleavage of CASP8 protein | 29111403 |
D002104 | Cadmium | calpeptin inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
D002104 | Cadmium | Chloroquine inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
D002104 | Cadmium | Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
D002104 | Cadmium | Cadmium inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP8 protein] | 16263807 |
C028031 | cadmium acetate | Acetylcysteine inhibits the reaction [cadmium acetate results in increased activity of CASP8 protein] | 16169029 |
C028031 | cadmium acetate | cadmium acetate results in increased activity of CASP8 protein | 15450950|1616902 |
C028031 | cadmium acetate | CASP8 affects the reaction [cadmium acetate results in increased cleavage of BID protein] | 15450950|1616902 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP8 protein | 21136600 |
D019256 | Cadmium Chloride | Cadmium Chloride affects the reaction [Fluorouracil results in decreased expression of CASP8 mRNA] | 23941782 |
D019256 | Cadmium Chloride | [Cadmium Chloride co-treated with Fluorouracil] affects the expression of CASP8 protein | 23941782 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of CASP8 mRNA | 19426795|2394178 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of CASP8 protein | 21697648|2348565 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP8 mRNA | 12160620 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP8 protein | 21796402|2429116 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased methylation of CASP8 promoter | 25448810 |
D019256 | Cadmium Chloride | CASP8 results in decreased susceptibility to Cadmium Chloride | 25448810 |
D019256 | Cadmium Chloride | decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of CASP8 mRNA] | 25448810 |
D019256 | Cadmium Chloride | Fluorouracil affects the reaction [Cadmium Chloride results in decreased expression of CASP8 mRNA] | 23941782 |
D019256 | Cadmium Chloride | TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP8 protein] | 28342888 |
D019256 | Cadmium Chloride | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased expression of CASP8 protein] | 21420465 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased activity of CASP8 protein | 16421179|2125239 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased cleavage of CASP8 protein | 19887573 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CASP8 protein | 21420465|2834288 |
D019256 | Cadmium Chloride | [Mercuric Chloride co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased activity of CASP8 protein | 16421179 |
D019256 | Cadmium Chloride | Sirolimus inhibits the reaction [TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP8 protein]] | 28342888 |
D019256 | Cadmium Chloride | TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP8 protein] | 28342888 |
D019256 | Cadmium Chloride | Cadmium Chloride inhibits the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP8 protein] | 16263807 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased cleavage of CASP8 protein | 22457795 |
D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of CASP8 protein | 22457795 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased methylation of CASP8 promoter | 22457795 |
D019256 | Cadmium Chloride | decitabine inhibits the reaction [Cadmium Chloride results in decreased cleavage of CASP8 protein] | 22457795 |
D019256 | Cadmium Chloride | decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of CASP8 protein] | 22457795 |
D019256 | Cadmium Chloride | decitabine inhibits the reaction [Cadmium Chloride results in increased methylation of CASP8 promoter] | 22457795 |
C034939 | cadmium sulfide | cadmium sulfide results in decreased expression of CASP8 mRNA | 27866839 |
C028337 | cadmium telluride | cadmium telluride analog results in increased activity of CASP8 protein | 23485651 |
C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP8 protein] | 18436364 |
C080866 | cagA protein, Helicobacter pylori | "cagA protein, Helicobacter pylori results in decreased cleavage of CASP8 protein" | 26427350 |
C080866 | cagA protein, Helicobacter pylori | "ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in decreased cleavage of CASP8 protein]" | 26427350 |
D000001 | Calcimycin | Calcimycin results in increased activity of CASP8 protein | 25410152 |
D000001 | Calcimycin | Calcimycin results in increased activity of CASP8 protein | 25410152 |
C071482 | calpeptin | calpeptin inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
D002166 | Camptothecin | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [Camptothecin results in increased activity of CASP8 protein]" | 15475000 |
D002166 | Camptothecin | Camptothecin affects the cleavage of CASP8 protein | 10896673 |
D002166 | Camptothecin | [Camptothecin co-treated with FAS protein] results in increased activity of CASP8 protein | 15958570 |
D002166 | Camptothecin | [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP8 protein | 19633536 |
D002166 | Camptothecin | Camptothecin results in increased activity of CASP8 protein | 15475000 |
D002166 | Camptothecin | Lithium inhibits the reaction [Camptothecin results in increased activity of CASP8 protein] | 15475000 |
D002166 | Camptothecin | Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP8 protein] | 19497415 |
C073718 | cannabidiol hydroxyquinone | Acetylcysteine inhibits the reaction [cannabidiol hydroxyquinone results in increased activity of CASP8 protein] | 20184945 |
C073718 | cannabidiol hydroxyquinone | cannabidiol hydroxyquinone results in increased activity of CASP8 protein | 20184945 |
D002193 | Cantharidin | Cantharidin results in increased cleavage of and results in increased activity of CASP8 protein | 27113412 |
D002211 | Capsaicin | [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein | 19939880 |
D002211 | Capsaicin | Capsaicin promotes the reaction [resveratrol results in decreased expression of CASP8 protein] | 19846903 |
D002211 | Capsaicin | Capsaicin promotes the reaction [TNFSF10 results in increased activity of CASP8 protein] | 22200406 |
D002211 | Capsaicin | Capsaicin results in decreased expression of CASP8 protein | 19846903 |
D002211 | Capsaicin | Capsaicin results in increased activity of CASP8 protein | 19502594 |
D002211 | Capsaicin | Capsaicin results in increased expression of CASP8 mRNA | 19502594 |
D002211 | Capsaicin | resveratrol promotes the reaction [Capsaicin results in decreased expression of CASP8 protein] | 19846903 |
C071423 | capsazepine | capsazepine inhibits the reaction [Acrolein results in increased expression of CASP8 protein] | 24376112 |
C104525 | caraway oil | caraway oil inhibits the reaction [Ethanol results in increased cleavage of CASP8 protein] | 25859307 |
D002220 | Carbamazepine | Carbamazepine affects the expression of CASP8 mRNA | 24752500 |
C006698 | carbendazim | carbendazim affects the expression of CASP8 mRNA | 25304545 |
C006698 | carbendazim | carbendazim results in decreased expression of CASP8 mRNA | 26055223 |
D002248 | Carbon Monoxide | Carbon Monoxide results in increased activity of CASP8 protein | 25562542 |
D002251 | Carbon Tetrachloride | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased cleavage of CASP8 protein]]" | 25432964 |
D002251 | Carbon Tetrachloride | caffeic acid phenethyl ester inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP8 protein] | 18436364 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of CASP8 protein | 18291569|1843636 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased cleavage of CASP8 protein | 25432964 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CASP8 protein | 24530446 |
D002251 | Carbon Tetrachloride | Changkil inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP8 protein] | 18291569 |
D002251 | Carbon Tetrachloride | Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased cleavage of CASP8 protein]] | 25432964 |
D002251 | Carbon Tetrachloride | neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased expression of CASP8 protein] | 24530446 |
D002251 | Carbon Tetrachloride | PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased cleavage of CASP8 protein] | 25432964 |
D002251 | Carbon Tetrachloride | SC 560 promotes the reaction [Carbon Tetrachloride results in increased cleavage of CASP8 protein] | 25432964 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased activity of CASP8 protein | 12388182 |
D002251 | Carbon Tetrachloride | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP8 protein] | 12388182 |
D002259 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of CASP8 mRNA | 16039398 |
C111238 | carboxycinnamic acid bishydroxamide | carboxycinnamic acid bishydroxamide results in increased cleavage of CASP8 protein | 15897598 |
C524865 | carfilzomib | [carfilzomib co-treated with vorinostat] results in increased activity of CASP8 protein | 20233973 |
D002336 | Carnosine | Carnosine inhibits the reaction [Cisplatin results in increased cleavage of CASP8 protein] | 29191451 |
C546626 | caseargrewiin F | caseargrewiin F results in increased activity of CASP8 protein | 25452174 |
D061945 | Caspase Inhibitors | Caspase Inhibitors inhibits the reaction [Nocodazole analog results in increased expression of CASP8 protein modified form] | 28412508 |
D061945 | Caspase Inhibitors | Caspase Inhibitors results in decreased activity of CASP8 protein | 28412508 |
D061945 | Caspase Inhibitors | Caspase Inhibitors results in decreased activity of CASP8 protein | 15545282 |
D061945 | Caspase Inhibitors | [Caspase Inhibitors results in decreased activity of CASP8 protein] inhibits the reaction [Estradiol results in increased activity of CASP3 protein] | 15545282 |
C054133 | casticin | casticin results in increased cleavage of and results in increased activity of CASP8 protein | 27862857 |
D002392 | Catechin | Catechin results in increased activity of CASP8 protein | 20206613 |
C034221 | catechol | catechol results in increased activity of CASP8 protein | 23776099 |
C099555 | CD 437 | CD 437 results in increased activity of CASP8 protein | 10766194|1602463 |
C099555 | CD 437 | helenalin inhibits the reaction [CD 437 results in increased activity of CASP8 protein] | 16024638 |
C099555 | CD 437 | NFKBIA protein affects the reaction [CD 437 results in increased activity of CASP8 protein] | 16024638 |
D000068579 | Celecoxib | 3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
D000068579 | Celecoxib | 3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]] | 20104024 |
D000068579 | Celecoxib | 3-methyladenine promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein] | 20104024 |
D000068579 | Celecoxib | [ABT-737 co-treated with Celecoxib] results in increased activity of CASP8 protein | 20104024 |
D000068579 | Celecoxib | ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein] | 20104024 |
D000068579 | Celecoxib | ABT-737 promotes the reaction [wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
D000068579 | Celecoxib | [Atorvastatin Calcium co-treated with Celecoxib] results in increased cleavage of CASP8 protein | 18172863 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]]] | 20104024 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [3-methyladenine promotes the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]]] | 20104024 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
D000068579 | Celecoxib | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein]] | 20104024 |
D000068579 | Celecoxib | Celecoxib analog results in increased activity of CASP8 protein | 15499625 |
D000068579 | Celecoxib | Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP8 protein] | 20104024 |
D000068579 | Celecoxib | Celecoxib results in increased activity of CASP8 protein | 12824303 |
D000068579 | Celecoxib | Celecoxib results in increased cleavage of and results in increased activity of CASP8 protein | 15197583|1557275 |
D000068579 | Celecoxib | Celecoxib results in increased cleavage of CASP8 protein | 20104024 |
D000068579 | Celecoxib | FADD mutant form inhibits the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP8 protein] | 15572759 |
D000068579 | Celecoxib | MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP8 protein] | 20104024 |
D000068579 | Celecoxib | PIK3C3 mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP8 protein] | 20104024 |
D000068579 | Celecoxib | TNFRSF10B mutant form inhibits the reaction [Celecoxib results in increased cleavage of CASP8 protein] | 15572759 |
D000068579 | Celecoxib | TNFSF10 protein promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP8 protein] | 15572759 |
D000068579 | Celecoxib | wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein] | 20104024 |
C086276 | cerivastatin | cerivastatin results in increased activity of CASP8 protein | 15705602 |
D002108 | Ceruletide | Ceruletide results in increased cleavage of and results in increased activity of CASP8 protein | 16339139 |
C119032 | CFM 1 | CFM 1 results in increased activity of CASP8 protein | 23826121 |
D002599 | Chalcone | Chalcone results in increased cleavage of CASP8 protein | 20620131 |
D002599 | Chalcone | MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP8 protein] | 20620131 |
C440574 | Changkil | Changkil inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP8 protein] | 18291569 |
D002699 | Chlorambucil | Chlorambucil results in increased activity of CASP8 protein | 11675354 |
C004656 | chloroacetaldehyde | chloroacetaldehyde results in decreased activity of CASP8 protein | 17035713 |
D017338 | Cladribine | BCL2 inhibits the reaction [Cladribine results in increased cleavage of CASP8 protein] | 15516989 |
D017338 | Cladribine | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Cladribine results in increased cleavage of CASP8 protein] | 15516989 |
D017338 | Cladribine | Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP8 protein] | 12948851 |
D017338 | Cladribine | Cladribine results in increased activity of CASP8 protein | 11672427|1294885 |
D017338 | Cladribine | Cladribine results in increased cleavage of CASP8 protein | 15516989 |
D017338 | Cladribine | [Valproic Acid co-treated with Cladribine] results in increased cleavage of CASP8 protein | 19006566 |
D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of CASP8 mRNA | 23650126 |
D002726 | Chlorogenic Acid | Chlorogenic Acid inhibits the reaction [aluminum chloride results in increased expression of CASP8 protein] | 28623112 |
D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of CASP8 mRNA | 26272509 |
D002738 | Chloroquine | Chloroquine results in increased cleavage of CASP8 protein | 27692344 |
D002738 | Chloroquine | Chloroquine inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
C023676 | chloroquine diphosphate | chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA] | 29133031 |
C023676 | chloroquine diphosphate | chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA]] | 29133031 |
C023676 | chloroquine diphosphate | Doxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA]] | 29133031 |
D002784 | Cholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased activity of CASP8 protein]" | 19477266 |
D002784 | Cholesterol | "6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Cholesterol analog results in increased expression of CASP8 mRNA]" | 19477266 |
D002784 | Cholesterol | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased activity of CASP8 protein] | 19477266 |
D002784 | Cholesterol | Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of CASP8 mRNA] | 19477266 |
D002784 | Cholesterol | Cholesterol analog results in increased activity of CASP8 protein | 19477266 |
D002784 | Cholesterol | Cholesterol analog results in increased expression of CASP8 mRNA | 19477266 |
D002784 | Cholesterol | Cholesterol promotes the reaction [Hydrogen Peroxide results in increased expression of CASP8 protein] | 20946910 |
D002784 | Cholesterol | Cholesterol results in increased expression of CASP8 protein | 20946910 |
D002784 | Cholesterol | Hydrogen Peroxide promotes the reaction [Cholesterol results in increased expression of CASP8 protein] | 20946910 |
D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CASP8 gene | 20938992 |
C529269 | cholix toxin, Vibrio cholerae | "Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP8 protein]" | 28087840 |
C529269 | cholix toxin, Vibrio cholerae | "[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP8 protein" | 28087840 |
C022990 | chromic chloride | chromic chloride results in increased expression of and results in increased activity of CASP8 protein | 14741615 |
D002857 | Chromium | Chromium results in increased expression of CASP8 mRNA | 17692352 |
C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased expression of CASP8 mRNA | 27793765 |
C043561 | chrysin | chrysin inhibits the reaction [Topotecan results in increased activity of CASP8 protein] | 20457140 |
C043561 | chrysin | chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP8 protein] | 21195158 |
C043561 | chrysin | chrysin results in increased cleavage of CASP8 protein | 25770930 |
C043561 | chrysin | [Cisplatin co-treated with chrysin] results in increased cleavage of CASP8 protein | 25770930 |
C039671 | ciglitazone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ciglitazone promotes the reaction [Niflumic Acid results in increased activity of CASP8 protein]] | 21067863 |
C039671 | ciglitazone | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Niflumic Acid promotes the reaction [ciglitazone results in increased activity of CASP8 protein]] | 21067863 |
C039671 | ciglitazone | ciglitazone promotes the reaction [Niflumic Acid results in increased activity of CASP8 protein] | 21067863 |
C039671 | ciglitazone | ciglitazone results in increased activity of CASP8 protein | 21067863 |
C039671 | ciglitazone | DDIT3 mutant form inhibits the reaction [ciglitazone promotes the reaction [Niflumic Acid results in increased activity of CASP8 protein]] | 21067863 |
C039671 | ciglitazone | DDIT3 mutant form inhibits the reaction [Niflumic Acid promotes the reaction [ciglitazone results in increased activity of CASP8 protein]] | 21067863 |
C039671 | ciglitazone | Niflumic Acid promotes the reaction [ciglitazone results in increased activity of CASP8 protein] | 21067863 |
D015377 | Cilastatin | Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP8 protein] | 20435919 |
C045645 | cilostazol | cilostazol inhibits the reaction [Nitroprusside results in increased activity of CASP8 protein] | 18311796 |
D002927 | Cimetidine | Cimetidine results in increased activity of CASP8 protein | 17273750|2012700 |
C012843 | cinnamic aldehyde | cinnamic aldehyde results in increased activity of CASP8 protein | 15964311 |
C063451 | cinobufotalin | cinobufotalin results in increased cleavage of CASP8 protein | 22898211 |
D002939 | Ciprofloxacin | Ciprofloxacin results in increased activity of CASP8 protein | 11875713 |
C057741 | clavulone II | clavulone II results in increased cleavage of and results in increased activity of CASP8 protein | 15920677 |
D002994 | Clofibrate | Clofibrate results in increased expression of CASP8 mRNA | 23811191 |
D002997 | Clomipramine | Clomipramine results in increased activity of CASP8 protein | 28482088 |
D003000 | Clonidine | Clonidine results in increased activity of CASP8 protein | 28115640 |
D003022 | Clotrimazole | Clotrimazole inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
D003022 | Clotrimazole | [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP8 protein] | 16051694 |
C007095 | cobaltiprotoporphyrin | cobaltiprotoporphyrin results in decreased activity of CASP8 protein | 16051694 |
C018021 | cobaltous chloride | cobaltous chloride results in increased activity of CASP8 protein | 16374551 |
C018021 | cobaltous chloride | cobaltous chloride affects the activity of CASP8 protein | 23684559 |
C060728 | cobalt oxide | cobalt oxide results in increased expression of CASP8 protein | 25437709 |
C060728 | cobalt oxide | cobalt oxide results in increased expression of CASP8 protein | 25437709 |
D003042 | Cocaine | Cocaine affects the expression of CASP8 mRNA | 15681117 |
D003042 | Cocaine | Cocaine results in increased activity of CASP8 protein | 11392460|1897485 |
C463759 | codonoposide | codonoposide results in increased activity of CASP8 protein | 15863893 |
C024989 | coenzyme Q10 | coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of CASP8 protein] | 27087047 |
D003078 | Colchicine | Colchicine results in increased expression of CASP8 mRNA | 18255150 |
D003300 | Copper | [Ditiocarb binds to Copper] which results in increased activity of CASP8 protein | 22951949 |
D003300 | Copper | [Thiosemicarbazones binds to Copper] which results in decreased activity of CASP8 protein | 20931265 |
D003300 | Copper | Copper analog results in increased expression of CASP8 protein | 22000994 |
D003300 | Copper | [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of CASP8 protein | 22276220 |
D003300 | Copper | [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of CASP8 protein | 22276220 |
D003300 | Copper | Copper deficiency results in increased expression of CASP8 mRNA | 17418555 |
C464760 | copper-1,10-phenanthroline | "copper-1,10-phenanthroline results in increased cleavage of CASP8 protein" | 24638265 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of CASP8 mRNA | 19549813 |
D019327 | Copper Sulfate | andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP8 protein] | 20946909 |
D019327 | Copper Sulfate | Copper Sulfate results in increased cleavage of and results in increased activity of CASP8 protein | 20946909 |
C058120 | cordycepin | Acetylcysteine inhibits the reaction [cordycepin results in increased activity of CASP8 protein] | 21310227 |
C058120 | cordycepin | cordycepin results in increased activity of CASP8 protein | 21310227 |
C494620 | CPS 11 | CPS 11 results in increased cleavage of CASP8 protein | 15858615 |
C494622 | CPS 49 | CPS 49 results in increased cleavage of CASP8 protein | 15858615 |
C038106 | cucurbitacin I | cucurbitacin I results in increased cleavage of CASP8 protein | 24858077 |
C029892 | cupric chloride | cupric chloride results in decreased expression of CASP8 mRNA | 24650576 |
C029892 | cupric chloride | cupric chloride results in increased expression of CASP8 protein | 23313662 |
D003474 | Curcumin | [arsenic trioxide co-treated with Curcumin] results in increased expression of CASP8 protein | 27430728 |
D003474 | Curcumin | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
D003474 | Curcumin | Curcumin results in decreased expression of CASP8 protein | 17148446 |
D003474 | Curcumin | Curcumin results in increased activity of CASP8 protein | 17096185 |
D003474 | Curcumin | Curcumin results in increased cleavage of and results in increased activity of CASP8 protein | 16173963 |
D003474 | Curcumin | Curcumin results in increased cleavage of CASP8 protein | 14555224 |
D003474 | Curcumin | Curcumin inhibits the reaction [Streptozocin results in increased cleavage of CASP8 protein] | 25541178 |
D003474 | Curcumin | Curcumin inhibits the reaction [Streptozocin results in increased expression of CASP8 mRNA] | 23267840 |
C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of CASP8 mRNA | 23891578 |
C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of CASP8 protein | 23454832 |
D003513 | Cycloheximide | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein] | 18222423 |
D003513 | Cycloheximide | [Cycloheximide co-treated with TNF] results in increased cleavage of and results in increased activity of CASP8 protein | 12925536 |
D003513 | Cycloheximide | [Cycloheximide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 18222423 |
D003513 | Cycloheximide | Cycloheximide promotes the reaction [FAS protein results in increased activity of CASP8 protein] | 12760867 |
D003513 | Cycloheximide | Cycloheximide results in increased activity of CASP8 protein | 15924153 |
D003513 | Cycloheximide | ITPK1 inhibits the reaction [[Cycloheximide co-treated with TNF] results in increased cleavage of and results in increased activity of CASP8 protein] | 12925536 |
D003513 | Cycloheximide | Butylated Hydroxyanisole inhibits the reaction [[TNF protein co-treated with Cycloheximide] results in increased activity of CASP8 protein] | 15950244 |
D003513 | Cycloheximide | Masoprocol inhibits the reaction [[TNF protein co-treated with Cycloheximide] results in increased activity of CASP8 protein] | 15950244 |
D003513 | Cycloheximide | [TNF protein co-treated with Cycloheximide] results in increased activity of CASP8 protein | 15950244 |
D003520 | Cyclophosphamide | CASP8 protein results in increased susceptibility to Cyclophosphamide metabolite | 22010212 |
D003520 | Cyclophosphamide | Cyclophosphamide metabolite results in increased expression of and results in increased cleavage of CASP8 protein | 22010212 |
D003520 | Cyclophosphamide | Cyclophosphamide results in increased cleavage of and results in increased activity of CASP8 protein | 17898787 |
D003520 | Cyclophosphamide | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Cyclophosphamide metabolite | 22010212 |
D016572 | Cyclosporine | Cyclosporine inhibits the reaction [FAS protein results in increased activity of CASP8 protein] | 15548389 |
D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
C089595 | cylindrospermopsin | cylindrospermopsin results in increased expression of CASP8 mRNA | 23726867 |
D003561 | Cytarabine | [Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 12780785 |
D003561 | Cytarabine | Cytarabine promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 18549619 |
D003561 | Cytarabine | Cytarabine results in increased expression of and results in increased cleavage of CASP8 protein | 22010212 |
D003606 | Dacarbazine | Dacarbazine results in increased cleavage of and results in increased activity of CASP8 protein | 17410615 |
D003606 | Dacarbazine | TNFSF10 protein promotes the reaction [Dacarbazine results in increased cleavage of and results in increased activity of CASP8 protein] | 17410615 |
D003609 | Dactinomycin | Dactinomycin results in decreased expression of CASP8 mRNA | 16001973 |
C004315 | danthron | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [danthron results in increased activity of CASP8 protein] | 21126053 |
C004315 | danthron | danthron results in increased activity of and results in increased expression of CASP8 protein | 21126053 |
C004315 | danthron | danthron results in increased expression of CASP8 mRNA | 21126053 |
C109268 | darbufelone | darbufelone results in increased activity of CASP8 protein | 20352217 |
C515055 | darinaparsin | darinaparsin results in increased cleavage of CASP8 protein | 25316819 |
D000069439 | Dasatinib | Dasatinib results in increased activity of CASP8 protein | 19398150 |
D000069439 | Dasatinib | Dasatinib results in increased cleavage of CASP8 protein | 18550857 |
D003630 | Daunorubicin | [Daunorubicin co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 12780785 |
C014347 | decitabine | acetyldinaline promotes the reaction [decitabine results in increased expression of CASP8 protein] | 21771726 |
C014347 | decitabine | CASP8 mRNA affects the reaction [[Valproic Acid co-treated with decitabine] results in increased susceptibility to TNFSF10 protein] | 21771726 |
C014347 | decitabine | [decitabine affects the methylation of CASP8 gene] which affects the expression of CASP8 protein | 18649362|1864936 |
C014347 | decitabine | [decitabine co-treated with Busulfan] results in increased activity of CASP8 protein | 19732952 |
C014347 | decitabine | [decitabine co-treated with IFNG protein] results in increased expression of CASP8 protein | 16607283 |
C014347 | decitabine | [[[decitabine co-treated with IFNG protein] results in increased expression of CASP8 protein] which co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 16607283 |
C014347 | decitabine | [decitabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 18636160 |
C014347 | decitabine | [[decitabine co-treated with trichostatin A] affects the methylation of CASP8 promoter] which affects the expression of CASP8 mRNA | 18819746|1881974 |
C014347 | decitabine | decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of CASP8 mRNA] | 25448810 |
C014347 | decitabine | decitabine results in decreased methylation of CASP8 promoter | 19440673 |
C014347 | decitabine | decitabine results in increased cleavage of CASP8 protein | 18636160 |
C014347 | decitabine | decitabine results in increased expression of CASP8 mRNA | 19214542|1944067 |
C014347 | decitabine | decitabine results in increased expression of CASP8 protein | 19214542|2177172 |
C014347 | decitabine | [Doxorubicin co-treated with decitabine] results in increased cleavage of CASP8 protein | 17283156 |
C014347 | decitabine | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein] | 19732952 |
C014347 | decitabine | Valproic Acid promotes the reaction [decitabine results in increased expression of CASP8 mRNA] | 21771726 |
C014347 | decitabine | Valproic Acid promotes the reaction [decitabine results in increased expression of CASP8 protein] | 21771726 |
C014347 | decitabine | decitabine inhibits the reaction [Cadmium Chloride results in decreased cleavage of CASP8 protein] | 22457795 |
C014347 | decitabine | decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of CASP8 protein] | 22457795 |
C014347 | decitabine | decitabine inhibits the reaction [Cadmium Chloride results in increased methylation of CASP8 promoter] | 22457795 |
D003676 | Deferoxamine | Deferoxamine results in increased activity of CASP8 protein | 16374551 |
D003676 | Deferoxamine | Nitroprusside inhibits the reaction [Deferoxamine results in increased activity of CASP8 protein] | 16374551 |
D003676 | Deferoxamine | Vanadates inhibits the reaction [Deferoxamine results in increased activity of CASP8 protein] | 16374551 |
C107676 | deguelin | [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in decreased expression of and results in increased activity of CASP8 protein | 25242579 |
C464444 | dehydroxymethylepoxyquinomicin | dehydroxymethylepoxyquinomicin results in increased cleavage of CASP8 protein | 15501958 |
C464444 | dehydroxymethylepoxyquinomicin | pyrazolanthrone inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of CASP8 protein] | 15501958 |
D013759 | Dronabinol | Dronabinol results in decreased expression of CASP8 mRNA | 16039398 |
C100698 | demethoxyfumitremorgin C | demethoxyfumitremorgin C results in increased activity of CASP8 protein | 28359723 |
C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CASP8 mRNA | 22846391 |
C007262 | deoxynivalenol | deoxynivalenol results in increased activity of and results in increased cleavage of CASP8 protein | 22491426 |
C040424 | destruxin B | destruxin B results in decreased expression of CASP8 protein | 23751424 |
C040424 | destruxin B | destruxin B results in increased activity of CASP8 protein | 23751424 |
D003907 | Dexamethasone | CASP8 protein results in increased susceptibility to Dexamethasone | 22010212 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 17070682 |
D003907 | Dexamethasone | Dexamethasone results in increased activity of CASP8 protein | 15576458 |
D003907 | Dexamethasone | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Dexamethasone | 22010212 |
D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]] | 17070682 |
D003907 | Dexamethasone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 mRNA] | 20671745 |
D003907 | Dexamethasone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein] | 20671745 |
D003907 | Dexamethasone | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]] | 20671745 |
D003907 | Dexamethasone | CASP8 protein promotes the reaction [Dexamethasone results in increased expression of TSC22D3 protein] | 20671745 |
D003907 | Dexamethasone | Dexamethasone results in increased activity of CASP8 protein | 11399061 |
D003907 | Dexamethasone | lactacystin inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]] | 20671745 |
D003907 | Dexamethasone | Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP8 protein] | 11399061 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP8 protein] | 15388240 |
D020927 | Dexmedetomidine | Dexmedetomidine results in increased activity of CASP8 protein | 18724006 |
D064730 | Dexrazoxane | Dexrazoxane results in increased expression of CASP8 mRNA | 26873546 |
C042577 | diallyl trisulfide | Acetylcysteine inhibits the reaction [diallyl trisulfide results in increased cleavage of CASP8 protein] | 22578287 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased activity of CASP8 protein | 22595511 |
C042577 | diallyl trisulfide | diallyl trisulfide results in increased cleavage of CASP8 protein | 22578287 |
C042577 | diallyl trisulfide | [diallyl trisulfide results in increased susceptibility to TNFSF10 protein] which results in increased cleavage of CASP8 protein | 28571773 |
D003976 | Diazinon | Diazinon results in increased expression of CASP8 mRNA | 27920530 |
D003976 | Diazinon | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA] | 27920530 |
D003976 | Diazinon | Selenium analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA] | 27920530 |
D003976 | Diazinon | Diazinon affects the expression of CASP8 mRNA | 22546817 |
D003993 | Dibutyl Phthalate | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA | 28013214 |
C555408 | dichloridobis(3-imino-2-ethoxyflavanone)ruthenium(II) | dichloridobis(3-imino-2-ethoxyflavanone)ruthenium(II) results in increased activity of CASP8 protein | 21334279 |
C555407 | dichloridobis(3-imino-2-methoxyflavanone)ruthenium(II) | dichloridobis(3-imino-2-methoxyflavanone)ruthenium(II) results in increased activity of CASP8 protein | 21334279 |
D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of CASP8 mRNA | 28962523 |
D002945 | Cisplatin | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein] | 17574045 |
D002945 | Cisplatin | acetyl-leucyl-glutamyl-histidyl-aspartal affects the reaction [Cisplatin results in increased activity of CASP8 protein] | 21801448 |
D002945 | Cisplatin | [andrographolide co-treated with Cisplatin] results in increased expression of CASP8 mRNA | 24563380 |
D002945 | Cisplatin | BCL2 protein inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein] | 17574045 |
D002945 | Cisplatin | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein] | 17574045 |
D002945 | Cisplatin | beta-solamarine promotes the reaction [Cisplatin results in increased activity of CASP8 protein] | 17619073 |
D002945 | Cisplatin | BMI1 inhibits the reaction [Cisplatin results in increased cleavage of CASP8 protein] | 21445297 |
D002945 | Cisplatin | CASP8 inhibits the reaction [CASP8 protein mutant form results in decreased susceptibility to Cisplatin] | 21801448 |
D002945 | Cisplatin | CASP8 protein mutant form results in decreased susceptibility to Cisplatin | 21801448 |
D002945 | Cisplatin | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP8 protein" | 21214929 |
D002945 | Cisplatin | [Cisplatin co-treated with chrysin] results in increased cleavage of CASP8 protein | 25770930 |
D002945 | Cisplatin | [Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein | 17574045 |
D002945 | Cisplatin | [Cisplatin co-treated with fisetin] results in increased cleavage of and results in increased activity of CASP8 protein | 21216935 |
D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of CASP8 mRNA | 27392435 |
D002945 | Cisplatin | [Cisplatin co-treated with panobinostat] affects the expression of CASP8 mRNA | 21791302 |
D002945 | Cisplatin | Cisplatin inhibits the reaction [CASP8 protein results in increased cleavage of BID protein] | 19590723 |
D002945 | Cisplatin | Cisplatin promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | 21037225 |
D002945 | Cisplatin | Cisplatin results in increased activity of CASP8 protein | 16009487|1680352 |
D002945 | Cisplatin | Cisplatin results in increased cleavage of and results in increased activity of CASP8 protein | 21216935 |
D002945 | Cisplatin | Cisplatin results in increased cleavage of CASP8 protein | 17021654|1805880 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP8 mRNA | 21487429|2739243 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP8 protein | 16803524|2148742 |
D002945 | Cisplatin | [Cisplatin results in increased expression of CASP8 protein] which results in increased susceptibility to TNFSF10 protein | 21487429 |
D002945 | Cisplatin | [Cisplatin results in increased expression of SRSF2 protein] which affects the splicing of CASP8 mRNA | 21157427 |
D002945 | Cisplatin | [[Cisplatin results in increased expression of SRSF2 protein] which affects the splicing of CASP8 mRNA] which results in increased activity of CASP8 protein | 21157427|2115742 |
D002945 | Cisplatin | [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP8 protein | 16803524 |
D002945 | Cisplatin | [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP8 protein | 16803524 |
D002945 | Cisplatin | ING4 protein promotes the reaction [Cisplatin results in increased activity of CASP8 protein] | 21052098 |
D002945 | Cisplatin | Progesterone inhibits the reaction [Cisplatin results in increased activity of CASP8 protein] | 23482746 |
D002945 | Cisplatin | Sirolimus promotes the reaction [Cisplatin results in increased cleavage of CASP8 protein] | 18058806 |
D002945 | Cisplatin | [TNFSF10 protein co-treated with Cisplatin] results in increased activity of CASP8 protein | 21252285 |
D002945 | Cisplatin | YAP1 protein inhibits the reaction [Cisplatin results in increased cleavage of CASP8 protein] | 20947521 |
D002945 | Cisplatin | "4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of CASP8 mRNA]" | 26546572 |
D002945 | Cisplatin | Carnosine inhibits the reaction [Cisplatin results in increased cleavage of CASP8 protein] | 29191451 |
D002945 | Cisplatin | Cisplatin results in increased activity of CASP8 protein | 21526214 |
D002945 | Cisplatin | Cisplatin results in increased cleavage of CASP8 protein | 29191451 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP8 mRNA | 26546572 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP8 protein | 21525749 |
D002945 | Cisplatin | Cilastatin inhibits the reaction [Cisplatin results in increased activity of CASP8 protein] | 20435919 |
D002945 | Cisplatin | Cisplatin results in increased activity of CASP8 protein | 20435919 |
D002945 | Cisplatin | Cisplatin results in increased expression of CASP8 | 12712633 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased activity of CASP8 protein | 19545618 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in decreased expression of CASP8 protein | 20025943 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased activity of CASP8 protein | 24576310 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8 mRNA | 19644561|2002594 |
D003633 | Dichlorodiphenyl Dichloroethylene | [Dichlorodiphenyl Dichloroethylene co-treated with beta-hexachlorocyclohexane] results in increased expression of CASP8 mRNA | 19175174 |
D003633 | Dichlorodiphenyl Dichloroethylene | Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8 mRNA | 19175174 |
D004008 | Diclofenac | Acetylcysteine inhibits the reaction [Diclofenac results in increased activity of CASP8 protein] | 27313093 |
D004008 | Diclofenac | Acetylcysteine inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein] | 27313093 |
D004008 | Diclofenac | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Diclofenac results in increased activity of CASP8 protein] | 27313093 |
D004008 | Diclofenac | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [[TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein] | 27313093 |
D004008 | Diclofenac | Diclofenac affects the expression of CASP8 mRNA | 24752500 |
D004008 | Diclofenac | [Diclofenac co-treated with Hyaluronic Acid] results in increased activity of CASP8 protein | 20237495 |
D004008 | Diclofenac | Diclofenac results in increased activity of CASP8 protein | 27313093 |
D004008 | Diclofenac | [TNF protein co-treated with Diclofenac] results in increased activity of CASP8 protein | 27313093 |
D004008 | Diclofenac | Diclofenac results in increased activity of CASP8 protein | 14609740 |
D004026 | Dieldrin | Dieldrin affects the expression of CASP8 mRNA | 22546817 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of CASP8 mRNA | 18042831 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of CASP8 mRNA | 18042831 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased activity of CASP8 protein | 22155658 |
D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in increased expression of CASP8 mRNA | 25701202 |
D004051 | Diethylhexyl Phthalate | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA | 28013214 |
D004052 | Diethylnitrosamine | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA | 18544905 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of CASP8 mRNA | 23830814 |
D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with thiosalicylic acid] results in increased activity of CASP8 protein | 19427195 |
D004052 | Diethylnitrosamine | [DMU-212 co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP8 mRNA | 27048571 |
D004052 | Diethylnitrosamine | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein | 21907755 |
D004052 | Diethylnitrosamine | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA | 21907755 |
D004052 | Diethylnitrosamine | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein] | 21907755 |
D004052 | Diethylnitrosamine | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA] | 21907755 |
C007379 | diethyl phthalate | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA | 28013214 |
D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CASP8 mRNA | 15545218 |
D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CASP8 mRNA | 21658437 |
D004074 | Digitoxin | Digitoxin analog results in increased cleavage of CASP8 protein | 22037315 |
D004074 | Digitoxin | Digitoxin results in increased cleavage of CASP8 protein | 22037315 |
D000875 | Anthralin | Anthralin results in decreased activity of CASP8 protein | 23611293 |
D002117 | Calcitriol | [Calcitriol co-treated with gemcitabine] results in increased expression of CASP8 protein | 20699664 |
D002117 | Calcitriol | Calcitriol affects the expression of CASP8 mRNA | 15138306 |
C025605 | diisobutyl phthalate | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA | 28013214 |
C012125 | diisononyl phthalate | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA | 28013214 |
C002302 | dimethoxon | dimethoxon results in decreased expression of CASP8 mRNA | 26688254 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP8 protein" | 21294050 |
D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP8 protein]" | 21294050 |
C010715 | di-n-octyl phthalate | di-n-octyl phthalate results in decreased expression of CASP8 protein | 29128616 |
D004147 | Dioxins | Dioxins affects the expression of CASP8 mRNA | 20463971 |
C007517 | diphenyleneiodonium | [diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
D004176 | Dipyridamole | Dipyridamole inhibits the reaction [Adenosine results in increased activity of CASP8 protein] | 17303086 |
D004229 | Dithiothreitol | Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP8 protein] | 11226294 |
D004229 | Dithiothreitol | "[1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one co-treated with Dithiothreitol] inhibits the reaction [[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein]]" | 10792026 |
D004050 | Ditiocarb | [Ditiocarb binds to Copper] which results in increased activity of CASP8 protein | 22951949 |
C521792 | DMU-212 | [DMU-212 co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP8 mRNA | 27048571 |
C067311 | docetaxel | docetaxel results in increased activity of CASP8 protein | 16361572 |
D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in increased activity of CASP8 protein | 23523905 |
C076946 | donepezil | donepezil results in increased activity of CASP8 protein | 20522977 |
D004317 | Doxorubicin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein] | 20856197 |
D004317 | Doxorubicin | BCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
D004317 | Doxorubicin | BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
D004317 | Doxorubicin | CASP3 protein promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein] | 17013758 |
D004317 | Doxorubicin | [CASP8 protein co-treated with CASP3 protein] affects the susceptibility to Doxorubicin | 22609468 |
D004317 | Doxorubicin | CASP8 protein results in increased susceptibility to Doxorubicin | 22010212 |
D004317 | Doxorubicin | Doxorubicin affects the activity of CASP8 protein | 15870702 |
D004317 | Doxorubicin | Doxorubicin affects the expression of CASP8 mRNA | 16705698 |
D004317 | Doxorubicin | Doxorubicin analog results in increased cleavage of CASP8 protein | 15981920 |
D004317 | Doxorubicin | [Doxorubicin binds to TF protein] which results in increased activity of CASP8 protein | 24998637 |
D004317 | Doxorubicin | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased cleavage of CASP8 protein" | 21214929 |
D004317 | Doxorubicin | [Doxorubicin co-treated with decitabine] results in increased cleavage of CASP8 protein | 17283156 |
D004317 | Doxorubicin | [Doxorubicin co-treated with FAS protein] results in increased activity of CASP8 protein | 15958570 |
D004317 | Doxorubicin | [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP8 protein | 16168113 |
D004317 | Doxorubicin | [Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP8 protein | 16168113 |
D004317 | Doxorubicin | [Doxorubicin co-treated with Phellinus linteus extract] results in increased cleavage of and results in increased activity of CASP8 protein | 16868541 |
D004317 | Doxorubicin | [Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein] | 17970047 |
D004317 | Doxorubicin | [Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein] | 17970047 |
D004317 | Doxorubicin | Doxorubicin results in increased activity of CASP8 protein | 15868924|1743784 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of and results in increased activity of CASP8 protein | 15897917|1602463 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of CASP8 protein | 18071906|2085619 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of and results in increased cleavage of CASP8 protein | 22010212 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP8 mRNA | 16001973 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP8 protein | 25339540 |
D004317 | Doxorubicin | [Indomethacin results in increased activity of CASP8 protein] which results in increased susceptibility to Doxorubicin | 15812552 |
D004317 | Doxorubicin | LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP8 protein] | 18508926 |
D004317 | Doxorubicin | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Doxorubicin | 22010212 |
D004317 | Doxorubicin | PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein] | 20856197 |
D004317 | Doxorubicin | PRKDC protein affects the reaction [Doxorubicin results in increased activity of CASP8 protein] | 18508926 |
D004317 | Doxorubicin | TNFRSF10A protein affects the reaction [Doxorubicin results in increased activity of CASP8 protein] | 17437844 |
D004317 | Doxorubicin | TP53 protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
D004317 | Doxorubicin | TP53 protein promotes the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
D004317 | Doxorubicin | Doxorubicin results in increased activity of CASP8 protein | 16018998 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP8 mRNA | 26873546 |
D004317 | Doxorubicin | [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP8 protein | 19789217 |
D004317 | Doxorubicin | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein]" | 15799720 |
D004317 | Doxorubicin | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
D004317 | Doxorubicin | chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA]] | 29133031 |
D004317 | Doxorubicin | coenzyme Q10 inhibits the reaction [Doxorubicin results in increased expression of CASP8 protein] | 27087047 |
D004317 | Doxorubicin | Cyclosporine inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
D004317 | Doxorubicin | [diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
D004317 | Doxorubicin | Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA] | 29133031 |
D004317 | Doxorubicin | Doxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA]] | 29133031 |
D004317 | Doxorubicin | Doxorubicin results in increased activity of CASP8 protein | 15799720|1668761 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of and results in increased activity of CASP8 protein | 17651020 |
D004317 | Doxorubicin | Doxorubicin results in increased cleavage of CASP8 protein | 12107157|1570396 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of CASP8 protein | 27087047 |
D004317 | Doxorubicin | GPX1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
D004317 | Doxorubicin | pifithrin inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 16687611 |
D004317 | Doxorubicin | SOD2 protein inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
D004317 | Doxorubicin | TNF protein promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP8 protein] | 17651020 |
C060327 | dracorhodin | dracorhodin analog results in increased activity of CASP8 protein | 15215653|1568447 |
C060327 | dracorhodin | dracorhodin analog results in increased cleavage of CASP8 protein | 15813022 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased activity of CASP8 protein" | 15456542|1580253 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased expression of and results in increased activity of CASP8 protein" | 23239598|2331583 |
D004365 | Drugs, Chinese Herbal | "arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in increased cleavage of CASP8 protein]" | 28587418 |
D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in increased cleavage of CASP8 protein" | 28587418 |
C509867 | E804 bisindole | E804 bisindole inhibits the reaction [Lipopolysaccharides results in increased expression of CASP8 mRNA] | 23107598 |
C509867 | E804 bisindole | E804 bisindole results in increased expression of CASP8 mRNA | 23107598 |
C509867 | E804 bisindole | Lipopolysaccharides inhibits the reaction [E804 bisindole results in increased expression of CASP8 mRNA] | 23107598 |
C022999 | echinocystic acid | echinocystic acid analog results in increased activity of CASP8 protein | 15863893 |
C060311 | eckol | [eckol co-treated with temozolomide] results in increased cleavage of CASP8 protein | 21514314 |
D004533 | Egtazic Acid | "[1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid co-treated with Egtazic Acid] inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein]" | 29111403 |
D004533 | Egtazic Acid | Egtazic Acid inhibits the reaction [Cadmium results in increased cleavage of CASP8 protein] | 29111403 |
C034192 | ellipticine | ellipticine results in increased cleavage of and results in increased activity of CASP8 protein | 21843585 |
D004642 | Emodin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Emodin results in increased activity of CASP8 protein] | 27032576 |
D004642 | Emodin | Emodin results in increased activity of CASP8 protein | 27032576 |
D004642 | Emodin | SB 203580 promotes the reaction [Emodin results in increased activity of CASP8 protein] | 27032576 |
D004642 | Emodin | U 0126 promotes the reaction [Emodin results in increased activity of CASP8 protein] | 27032576 |
C118739 | entinostat | entinostat results in increased expression of CASP8 mRNA | 26272509 |
C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
D015251 | Epirubicin | Epirubicin promotes the reaction [formononetin results in increased activity of CASP8 protein] | 23867903 |
D015251 | Epirubicin | Epirubicin promotes the reaction [formononetin results in increased expression of CASP8 mRNA] | 23867903 |
C045651 | epigallocatechin gallate | Acetylcysteine inhibits the reaction [epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP8 protein]] | 26375285 |
C045651 | epigallocatechin gallate | epigallocatechin gallate promotes the reaction [arsenite results in increased activity of CASP8 protein] | 26375285 |
C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CASP8 mRNA | 22079256 |
C472787 | erucylphospho-N,N,N-trimethylpropylammonium | "erucylphospho-N,N,N-trimethylpropylammonium results in increased cleavage of and results in increased activity of CASP8 protein" | 20177898 |
C007628 | esculetin | [esculetin co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP8 protein | 16051289 |
C007628 | esculetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein] | 19786087 |
C007628 | esculetin | [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein | 19786087 |
C074283 | estradiol 3-benzoate | estradiol 3-benzoate results in increased expression of and results in increased activity of CASP8 protein | 24316378 |
C074283 | estradiol 3-benzoate | estradiol 3-benzoate results in increased expression of CASP8 mRNA | 24316378 |
C074283 | estradiol 3-benzoate | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP8 protein] | 24316378 |
C074283 | estradiol 3-benzoate | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP8 mRNA] | 24316378 |
D004976 | Ethacrynic Acid | [arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP8 protein | 23082001 |
D004976 | Ethacrynic Acid | Ethacrynic Acid results in increased cleavage of CASP8 protein | 23082001 |
D000431 | Ethanol | ALDH2 protein inhibits the reaction [Ethanol results in increased expression of CASP8 protein] | 19429258 |
D000431 | Ethanol | Ethanol results in increased expression of CASP8 protein | 19429258 |
D000431 | Ethanol | caraway oil inhibits the reaction [Ethanol results in increased cleavage of CASP8 protein] | 25859307 |
D000431 | Ethanol | Ethanol results in increased activity of CASP8 protein | 25289771 |
D000431 | Ethanol | Ethanol results in increased cleavage of CASP8 protein | 25859307|2908558 |
D000431 | Ethanol | nymphayol inhibits the reaction [Ethanol results in increased activity of CASP8 protein] | 25289771 |
D000431 | Ethanol | thymoquinone inhibits the reaction [Ethanol results in increased cleavage of CASP8 protein] | 29085585 |
C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | [alvocidib co-treated with ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate] results in increased cleavage of CASP8 protein | 15634644 |
C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein] | 19786087 |
C456800 | ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate | [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein | 19786087 |
D005047 | Etoposide | "3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [Etoposide results in increased activity of CASP8 protein]" | 15475000 |
D005047 | Etoposide | acetyl-leucyl-glutamyl-histidyl-aspartal inhibits the reaction [Etoposide results in increased activity of CASP8 protein] | 21801448 |
D005047 | Etoposide | [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP9 protein] | 21801448 |
D005047 | Etoposide | [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of CASP3 protein] | 21801448 |
D005047 | Etoposide | [CASP8 co-treated with TP53] affects the reaction [Etoposide results in increased cleavage of PARP1 protein] | 21801448 |
D005047 | Etoposide | [CASP8 co-treated with TP53] inhibits the reaction [CASP8 protein mutant form results in decreased susceptibility to Etoposide] | 21801448 |
D005047 | Etoposide | CASP8 mutant form inhibits the reaction [Etoposide results in increased cleavage of CASP3 protein] | 21801448 |
D005047 | Etoposide | CASP8 mutant form inhibits the reaction [Etoposide results in increased cleavage of CASP9 protein] | 21801448 |
D005047 | Etoposide | CASP8 protein mutant form results in decreased susceptibility to Etoposide | 21801448 |
D005047 | Etoposide | CASP8 protein results in increased susceptibility to Etoposide | 22010212 |
D005047 | Etoposide | Etoposide results in increased activity of CASP8 protein | 15475000 |
D005047 | Etoposide | Etoposide results in increased cleavage of and results in increased activity of CASP8 protein | 21745461 |
D005047 | Etoposide | Etoposide results in increased cleavage of CASP8 protein | 21801448 |
D005047 | Etoposide | Etoposide results in increased expression of and results in increased cleavage of CASP8 protein | 22010212 |
D005047 | Etoposide | Lithium inhibits the reaction [Etoposide results in increased activity of CASP8 protein] | 15475000 |
D005047 | Etoposide | nimesulide inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP8 protein] | 21745461 |
D005047 | Etoposide | TP73 mutant form inhibits the reaction [Etoposide results in increased cleavage of CASP8 protein] | 21801448 |
C496966 | Eudragit RSPO | Eudragit RSPO results in decreased expression of CASP8 mRNA | 22119964 |
C060802 | fangchinoline | fangchinoline results in increased cleavage of CASP8 protein | 28754437 |
C020326 | ferric nitrilotriacetate | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein | 21907755 |
C020326 | ferric nitrilotriacetate | [ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA | 21907755 |
C020326 | ferric nitrilotriacetate | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein] | 21907755 |
C020326 | ferric nitrilotriacetate | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA] | 21907755 |
D000068876 | Fingolimod Hydrochloride | Fingolimod Hydrochloride results in increased cleavage of CASP8 protein | 25939952 |
D000068876 | Fingolimod Hydrochloride | SQSTM1 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of CASP8 protein] | 25939952 |
C017875 | fisetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [fisetin results in increased activity of CASP8 protein] | 21964635 |
C017875 | fisetin | [Cisplatin co-treated with fisetin] results in increased cleavage of and results in increased activity of CASP8 protein | 21216935 |
C017875 | fisetin | fisetin results in increased activity of CASP8 protein | 21964635|2818138 |
C017875 | fisetin | fisetin results in increased cleavage of and results in increased activity of CASP8 protein | 21216935 |
C028610 | flavanone | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to flavanone | 22056764 |
C028610 | flavanone | flavanone results in increased cleavage of and results in increased activity of CASP8 protein | 22056764 |
D047309 | Flavones | Flavones analog results in increased activity of CASP8 protein | 20674374 |
D044948 | Flavonols | Flavonols results in increased activity of and results in increased cleavage of CASP8 protein | 28235426 |
C548902 | FLLL 32 | FLLL 32 results in increased activity of CASP8 protein | 20576164 |
C024352 | fludarabine | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with fludarabine] results in increased cleavage of CASP8 protein | 15850772 |
C024352 | fludarabine | BCL2 inhibits the reaction [fludarabine results in increased cleavage of CASP8 protein] | 15516989 |
C024352 | fludarabine | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [fludarabine results in increased cleavage of CASP8 protein] | 15516989 |
C024352 | fludarabine | [fludarabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 12780785 |
C024352 | fludarabine | fludarabine results in increased activity of CASP8 protein | 11675354 |
C024352 | fludarabine | fludarabine results in increased cleavage of CASP8 protein | 15516989 |
C024352 | fludarabine | [LAQ824 co-treated with fludarabine] results in increased activity of CASP8 protein | 18852132 |
C024352 | fludarabine | [Valproic Acid co-treated with fludarabine] results in increased cleavage of CASP8 protein | 19006566 |
D005472 | Fluorouracil | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein] | 26544897 |
D005472 | Fluorouracil | Cadmium Chloride affects the reaction [Fluorouracil results in decreased expression of CASP8 mRNA] | 23941782 |
D005472 | Fluorouracil | [Cadmium Chloride co-treated with Fluorouracil] affects the expression of CASP8 protein | 23941782 |
D005472 | Fluorouracil | CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP3 protein]] | 19097688 |
D005472 | Fluorouracil | CASP8 affects the reaction [Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP9 protein]] | 19097688 |
D005472 | Fluorouracil | CASP8 results in increased susceptibility to [andrographolide co-treated with Fluorouracil] | 19097688 |
D005472 | Fluorouracil | [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP8 protein | 16168113 |
D005472 | Fluorouracil | FAS protein affects the reaction [Fluorouracil results in increased activity of CASP8 protein] | 17056233 |
D005472 | Fluorouracil | Fluorouracil affects the reaction [Cadmium Chloride results in decreased expression of CASP8 mRNA] | 23941782 |
D005472 | Fluorouracil | [Fluorouracil co-treated with aloe emodin] affects the expression of CASP8 | 19928967 |
D005472 | Fluorouracil | [Fluorouracil co-treated with Cisplatin] results in increased activity of CASP8 protein | 16803524 |
D005472 | Fluorouracil | [Fluorouracil co-treated with Cisplatin] results in increased expression of CASP8 protein | 16803524 |
D005472 | Fluorouracil | [Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein | 26544897 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [aloe emodin results in increased expression of CASP8 protein modified form] | 19928967 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [andrographolide results in increased activity of CASP8 protein] | 19097688 |
D005472 | Fluorouracil | Fluorouracil promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | 20876774 |
D005472 | Fluorouracil | Fluorouracil results in decreased expression of CASP8 mRNA | 23941782 |
D005472 | Fluorouracil | Fluorouracil results in increased activity of CASP8 protein | 10779637|1089139 |
D005472 | Fluorouracil | Fluorouracil results in increased cleavage of CASP8 protein | 19816940|2654489 |
D005472 | Fluorouracil | Fluorouracil results in increased expression of CASP8 mRNA | 17637740 |
D005472 | Fluorouracil | Fluorouracil results in increased expression of CASP8 protein | 15585135|1680352 |
D005472 | Fluorouracil | IFNA1 promotes the reaction [Fluorouracil results in increased expression of CASP8 protein] | 21474236 |
D005472 | Fluorouracil | IFNA1 protein promotes the reaction [Fluorouracil results in increased activity of CASP8 protein] | 17016659 |
D005472 | Fluorouracil | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Fluorouracil results in increased activity of CASP8 protein] | 14607657 |
D005472 | Fluorouracil | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 mRNA] | 17637740 |
D005472 | Fluorouracil | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CASP8 protein] | 17637740 |
D005472 | Fluorouracil | Fluorouracil results in increased activity of CASP8 protein | 10568827 |
D005473 | Fluoxetine | Fluoxetine results in increased activity of CASP8 protein | 28482088 |
D005485 | Flutamide | Flutamide results in decreased expression of CASP8 mRNA | 21126777 |
D000068298 | Fluticasone | [Fluticasone co-treated with Salmeterol Xinafoate] results in increased activity of CASP8 protein | 15536434 |
C065180 | fluvastatin | fluvastatin results in increased activity of CASP8 protein | 24964743 |
C065180 | fluvastatin | Mevalonic Acid inhibits the reaction [fluvastatin results in increased activity of CASP8 protein] | 24964743 |
D005492 | Folic Acid | Folic Acid affects the expression of CASP8 mRNA | 16361273 |
D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CASP8 gene | 20938992 |
D005557 | Formaldehyde | Formaldehyde results in increased activity of CASP8 protein | 20448356 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of CASP8 mRNA | 20448356 |
C007768 | formononetin | Acetylcysteine inhibits the reaction [formononetin results in increased expression of CASP8 mRNA] | 23867903 |
C007768 | formononetin | Epirubicin promotes the reaction [formononetin results in increased activity of CASP8 protein] | 23867903 |
C007768 | formononetin | Epirubicin promotes the reaction [formononetin results in increased expression of CASP8 mRNA] | 23867903 |
C007768 | formononetin | formononetin results in increased activity of CASP8 protein | 23867903 |
C007768 | formononetin | formononetin results in increased expression of CASP8 mRNA | 23867903 |
C058728 | fosbretabulin | fosbretabulin analog results in increased cleavage of CASP8 protein | 25529822 |
D005620 | Freund's Adjuvant | Freund's Adjuvant results in decreased expression of CASP8 mRNA | 20846436 |
C039281 | furan | furan results in increased expression of CASP8 mRNA | 27387713 |
D005665 | Furosemide | Furosemide affects the expression of CASP8 mRNA | 17497460 |
C002469 | fusarenon-X | fusarenon-X results in increased expression of CASP8 mRNA | 24983900 |
C000600490 | G226 compound | G226 compound results in increased activity of CASP8 protein | 25066322 |
D005688 | Galactosamine | baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form] | 20850421 |
D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP8 protein | 21146893 |
D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP8 protein | 20558151 |
D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP8 protein modified form | 20558151 |
D005688 | Galactosamine | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP8 protein] | 20558151 |
D005688 | Galactosamine | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP8 protein modified form] | 20558151 |
D005688 | Galactosamine | "[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP8 protein" | 24830863 |
D005688 | Galactosamine | [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form | 20850421 |
D005688 | Galactosamine | "Rotenone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP8 protein]" | 24830863 |
D005688 | Galactosamine | Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form] | 20850421 |
D005688 | Galactosamine | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP8 protein] | 21146893 |
D005707 | Gallic Acid | Gallic Acid results in increased expression of CASP8 protein | 22245431 |
D005708 | Gallium | Gallium results in increased activity of CASP8 protein | 21194614 |
C052659 | gambogic acid | [gambogic acid co-treated with Bortezomib] results in increased activity of CASP8 protein | 24291039 |
C052659 | gambogic acid | [Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP8 protein | 24373880 |
C000591222 | gardenin B | gardenin B results in increased cleavage of and results in increased activity of CASP8 protein | 27423764 |
C505531 | GCS-100 | GCS-100 results in increased cleavage of and results in increased activity of CASP8 protein | 16166312 |
C106014 | gedunin | gedunin results in increased activity of CASP8 protein | 21381696 |
C056507 | gemcitabine | [Calcitriol co-treated with gemcitabine] results in increased expression of CASP8 protein | 20699664 |
C056507 | gemcitabine | [gemcitabine co-treated with TNFRSF10B] affects the activity of CASP8 protein | 18089714 |
C056507 | gemcitabine | gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein | 26894857 |
C056507 | gemcitabine | gemcitabine results in increased activity of CASP8 protein | 12479703|1715960 |
C056507 | gemcitabine | gemcitabine results in increased cleavage of CASP8 protein | 14750167 |
C056507 | gemcitabine | SFN protein inhibits the reaction [gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein] | 26894857 |
C056507 | gemcitabine | [TNFSF10 co-treated with gemcitabine] results in increased activity of CASP8 protein | 17671697 |
C056507 | gemcitabine | YAP1 protein affects the reaction [gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein] | 26894857 |
D019833 | Genistein | [Genistein co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 19497411 |
D019833 | Genistein | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
D019833 | Genistein | Genistein promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP8 protein] | 18546268 |
D005839 | Gentamicins | Gentamicins results in increased activity of CASP8 protein | 17132701 |
D005839 | Gentamicins | tetramethylpyrazine inhibits the reaction [Gentamicins results in increased activity of CASP8 protein] | 17132701 |
D005839 | Gentamicins | tetramethylpyrazine inhibits the reaction [TNF protein promotes the reaction [Gentamicins results in increased expression of CASP8 protein]] | 17132701 |
D005839 | Gentamicins | TNF protein promotes the reaction [Gentamicins results in increased expression of CASP8 protein] | 17132701 |
C012997 | gentiopicroside | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP8 protein] | 20558151 |
C012997 | gentiopicroside | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP8 protein modified form] | 20558151 |
C007836 | geraniol | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased cleavage of and results in decreased expression of CASP8 protein] | 21907755 |
C007836 | geraniol | geraniol inhibits the reaction [[ferric nitrilotriacetate co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA] | 21907755 |
C007845 | gingerol | Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein] | 25034532 |
C007845 | gingerol | gingerol results in increased cleavage of CASP8 protein | 28249781 |
C007845 | gingerol | [TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein | 25034532 |
C007845 | gingerol | gingerol affects the activity of CASP8 protein | 17454143 |
C097367 | ginsenoside Rg3 | "ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in decreased cleavage of CASP8 protein]" | 26427350 |
C030691 | gluconic acid | [gluconic acid co-treated with Zinc Sulfate] inhibits the reaction [Aflatoxin B1 results in increased expression of CASP8 mRNA] | 27017951 |
D005947 | Glucose | Glucose results in increased activity of CASP8 protein | 18973755 |
D005947 | Glucose | Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8] | 18791325 |
D005947 | Glucose | Glucose results in increased activity of CASP8 | 18791325 |
D005978 | Glutathione | "Glutathione inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of CASP8 protein]" | 24515801 |
D005978 | Glutathione | Glutathione inhibits the reaction [NR4A1 protein affects the cleavage of CASP8 protein] | 24515801 |
D005978 | Glutathione | Glutathione inhibits the reaction [Acrolein results in increased expression of CASP8 protein] | 24376112 |
C071834 | glycidamide | CASP8 gene polymorphism affects the susceptibility to glycidamide | 27062911 |
D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in increased cleavage of CASP8 protein | 25125499 |
D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in increased activity of CASP8 protein | 12873810|1576724 |
D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP8 protein] | 22051199 |
D006046 | Gold | Gold results in increased expression of CASP8 mRNA | 22178767 |
C103280 | goniothalamin | goniothalamin results in increased cleavage of CASP8 protein | 21810437 |
C058858 | grifolin | grifolin results in increased activity of CASP8 protein | 15949805 |
C401311 | GW 7845 | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [GW 7845 results in increased activity of and results in increased cleavage of CASP8 protein] | 17400580 |
C401311 | GW 7845 | GW 7845 results in increased activity of and results in increased cleavage of CASP8 protein | 17400580 |
C001329 | helenalin | helenalin inhibits the reaction [CD 437 results in increased activity of CASP8 protein] | 16024638 |
D006571 | Heterocyclic Compounds | Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP8 protein] | 19014919 |
D006571 | Heterocyclic Compounds | [Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP8 protein | 19014919 |
D006575 | Heterocyclic Compounds, 3-Ring | "Heterocyclic Compounds, 3-Ring results in increased activity of CASP8 protein" | 21500194 |
C089796 | hexabromocyclododecane | hexabromocyclododecane results in increased activity of CASP8 protein | 24780359 |
D006581 | Hexachlorobenzene | Hexachlorobenzene results in increased activity of CASP8 protein | 21787832|2370840 |
C501367 | hispanolone | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [hispanolone analog results in increased activity of CASP8 protein] | 25930665 |
C501367 | hispanolone | acetyl-isoleucyl-glutamyl-threonyl-aspartyl-aldehyde inhibits the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP8 protein]] | 25930665 |
C501367 | hispanolone | hispanolone analog results in increased activity of CASP8 protein | 25930665 |
C501367 | hispanolone | TNFRSF10A protein affects the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP8 protein]] | 25930665 |
C501367 | hispanolone | TNFRSF10B protein affects the reaction [TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP8 protein]] | 25930665 |
C501367 | hispanolone | TNFSF10 protein promotes the reaction [hispanolone analog results in increased activity of CASP8 protein] | 25930665 |
C005499 | honokiol | honokiol results in increased activity of CASP8 protein | 15802533 |
D017313 | Fenretinide | [Fenretinide co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 17273769 |
D006812 | Humic Substances | Humic Substances results in decreased expression of CASP8 mRNA | 23042718 |
D006812 | Humic Substances | Humic Substances results in increased cleavage of CASP8 protein | 18683188 |
D006820 | Hyaluronic Acid | [Diclofenac co-treated with Hyaluronic Acid] results in increased activity of CASP8 protein | 20237495 |
D006835 | Hydrazones | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to Hydrazones | 22056764 |
D006835 | Hydrazones | Hydrazones results in increased cleavage of and results in increased activity of CASP8 protein | 22056764 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of CASP8 protein | 21179406 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of CASP8 protein | 21431366 |
D006861 | Hydrogen Peroxide | Melatonin promotes the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein] | 21431366 |
D006861 | Hydrogen Peroxide | "1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein]" | 15799720 |
D006861 | Hydrogen Peroxide | Cholesterol promotes the reaction [Hydrogen Peroxide results in increased expression of CASP8 protein] | 20946910 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide promotes the reaction [Cholesterol results in increased expression of CASP8 protein] | 20946910 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of CASP8 protein | 15799720|1615729 |
D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CASP8 protein | 20946910|2752527 |
D006861 | Hydrogen Peroxide | Luteolin inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP8 protein] | 27525270 |
D006861 | Hydrogen Peroxide | [mitoquinol co-treated with mitoquinone] inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein] | 15799720 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein] | 16647178 |
D006861 | Hydrogen Peroxide | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP8 protein] | 27525270 |
C012353 | hydroperoxyisophosphamide | BAX promotes the reaction [hydroperoxyisophosphamide results in increased activity of CASP8 protein] | 11723234 |
C012353 | hydroperoxyisophosphamide | BCL2 inhibits the reaction [hydroperoxyisophosphamide results in increased activity of CASP8 protein] | 11723234 |
C012353 | hydroperoxyisophosphamide | hydroperoxyisophosphamide results in increased activity of CASP8 protein | 11723234 |
C031927 | hydroquinone | hydroquinone results in increased activity of CASP8 protein | 23776099 |
C031927 | hydroquinone | MPO protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein] | 15777082 |
C051414 | hydroxygenkwanin | Apigenin promotes the reaction [hydroxygenkwanin results in increased activity of CASP8 protein] | 24144774 |
C051414 | hydroxygenkwanin | hydroxygenkwanin promotes the reaction [Apigenin results in increased activity of CASP8 protein] | 24144774 |
C051414 | hydroxygenkwanin | hydroxygenkwanin results in increased activity of CASP8 protein | 24144774 |
C013038 | hydroxyhydroquinone | hydroxyhydroquinone results in increased activity of CASP8 protein | 23776099 |
C559745 | hyperforin dicyclohexylammonium | hyperforin dicyclohexylammonium results in increased activity of CASP8 protein | 21376709 |
C467077 | ilimaquinone | ilimaquinone results in increased cleavage of CASP8 protein | 24930757 |
D000068877 | Imatinib Mesylate | [Imatinib Mesylate co-treated with alvocidib] results in increased activity of CASP8 protein | 12231544 |
D000068877 | Imatinib Mesylate | [tetraarsenic tetrasulfide co-treated with Imatinib Mesylate] results in increased expression of CASP8 mRNA | 19208803 |
D007099 | Imipramine | Imipramine inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C428264 | indioside D | CASP8 protein affects the susceptibility to indioside D | 18376857 |
C428264 | indioside D | indioside D results in increased activity of CASP8 protein | 18376857 |
C428264 | indioside D | indioside D results in increased cleavage of CASP8 protein | 18376857 |
C474021 | indirubin-3'-monoxime | [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CASP8 mRNA | 18958680 |
D007213 | Indomethacin | [Indomethacin results in increased activity of CASP8 protein] which results in increased susceptibility to Doxorubicin | 15812552 |
D007213 | Indomethacin | Indomethacin results in increased cleavage of and results in increased activity of CASP8 protein | 15812552 |
D007213 | Indomethacin | Indomethacin results in increased expression of and results in increased activity of CASP8 protein | 15265368 |
D007213 | Indomethacin | Indomethacin results in decreased activity of CASP8 protein | 19615346 |
D007213 | Indomethacin | Indomethacin results in increased activity of CASP8 protein | 18375387 |
D007213 | Indomethacin | Lansoprazole inhibits the reaction [Indomethacin results in increased activity of CASP8 protein] | 18375387 |
D015759 | Ionomycin | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] | 15477007 |
D015759 | Ionomycin | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA]] | 15477007 |
D015759 | Ionomycin | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP8 protein | 12165276 |
D015759 | Ionomycin | pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] | 15477007 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA | 15477007 |
D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA | 25613284 |
C033148 | iprodione | [iprodione co-treated with acetamiprid] results in decreased expression of CASP8 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrachlostrobin co-treated with acetamiprid co-treated with iprodione] results in increased expression of CASP8 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrachlostrobin co-treated with acetamiprid] results in increased expression of CASP8 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrachlostrobin] results in decreased expression of CASP8 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrimethanil co-treated with acetamiprid] results in increased expression of CASP8 mRNA | 29091792 |
C033148 | iprodione | [iprodione co-treated with pyrimethanil] results in decreased expression of CASP8 mRNA | 29091792 |
C051890 | irinotecan | irinotecan promotes the reaction [AS602868 results in increased cleavage of and results in increased activity of CASP8 protein] | 18182997 |
C051890 | irinotecan | irinotecan results in increased activity of CASP8 protein | 16432164 |
C051890 | irinotecan | irinotecan results in increased cleavage of and results in increased activity of CASP8 protein | 18182997 |
C051890 | irinotecan | Ursodeoxycholic Acid promotes the reaction [irinotecan results in increased activity of CASP8 protein] | 16432164 |
D007529 | Isoflavones | Isoflavones results in increased expression of CASP8 mRNA | 25035168 |
D007530 | Isoflurane | Isoflurane results in increased activity of CASP8 protein | 23922164 |
D007530 | Isoflurane | resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP8 protein] | 23922164 |
C425644 | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [arsenic trioxide promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]] | 16434995 |
C425644 | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Fluorouracil results in increased activity of CASP8 protein] | 14607657 |
C425644 | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone | isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein | 11464216 |
C040920 | isoliquiritigenin | isoliquiritigenin results in increased activity of CASP8 protein | 16158945 |
D007545 | Isoproterenol | Isoproterenol results in increased expression of CASP8 mRNA | 25794854|2699654 |
D007545 | Isoproterenol | Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA] | 26996544 |
D007545 | Isoproterenol | Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA] | 25794854 |
C545474 | JAI-51 | JAI-51 results in increased activity of CASP8 protein | 24134853 |
C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of CASP8 mRNA | 27392435 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound analog promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | 26415225 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | 26415225 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CASP8 mRNA | 26830473 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CASP8 protein | 26830473 |
C561695 | (+)-JQ1 compound | [TNFSF10 protein co-treated with (+)-JQ1 compound] results in increased cleavage of CASP8 protein | 26415225 |
C005134 | juglone | juglone results in increased activity of CASP8 protein | 20138029 |
C046438 | kahweol acetate | CFLAR protein inhibits the reaction [[TNFSF10 protein co-treated with kahweol acetate] results in increased activity of CASP8 protein] | 20403343 |
C046438 | kahweol acetate | [TNFSF10 protein co-treated with kahweol acetate] results in increased activity of CASP8 protein | 20403343 |
C047382 | kamebakaurin | kamebakaurin promotes the reaction [TNF protein results in increased activity of CASP8 protein] | 11877450 |
D007649 | Ketamine | Ketamine results in increased expression of CASP8 mRNA | 28716577 |
C011890 | kojic acid | [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA | 18544905 |
C000620717 | kuntai capsule | kuntai capsule results in increased expression of CASP8 protein | 27597876 |
C067713 | lactacystin | lactacystin inhibits the reaction [[benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [Dexamethasone results in increased expression of TSC22D3 protein]] | 20671745 |
D064747 | Lansoprazole | Lansoprazole inhibits the reaction [Indomethacin results in increased activity of CASP8 protein] | 18375387 |
C477361 | LAQ824 | [LAQ824 co-treated with fludarabine] results in increased activity of CASP8 protein | 18852132 |
C008261 | lead acetate | "1,3-dimethylthiourea inhibits the reaction [lead acetate results in increased activity of CASP8 protein]" | 22033380 |
C008261 | lead acetate | Clotrimazole inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C008261 | lead acetate | Imipramine inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C008261 | lead acetate | lead acetate results in increased activity of CASP8 protein | 22033380 |
C008261 | lead acetate | [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C008261 | lead acetate | S-allylcysteine inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C018584 | linalool | linalool results in increased expression of CASP8 mRNA | 26703569 |
D044243 | Linoleic Acids, Conjugated | "Linoleic Acids, Conjugated results in increased expression of CASP8 protein" | 20155912 |
C482199 | lipopolysaccharide, E coli O55-B5 | "[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP8 protein" | 24830863 |
C482199 | lipopolysaccharide, E coli O55-B5 | "Rotenone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP8 protein]" | 24830863 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CASP8 protein | 21844306 |
D008070 | Lipopolysaccharides | baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form] | 20850421 |
D008070 | Lipopolysaccharides | E804 bisindole inhibits the reaction [Lipopolysaccharides results in increased expression of CASP8 mRNA] | 23107598 |
D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP8 protein | 21146893 |
D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP8 protein | 20558151 |
D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP8 protein modified form | 20558151 |
D008070 | Lipopolysaccharides | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased cleavage of and results in increased activity of CASP8 protein] | 20558151 |
D008070 | Lipopolysaccharides | gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased expression of CASP8 protein modified form] | 20558151 |
D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form | 20850421 |
D008070 | Lipopolysaccharides | Lipopolysaccharides inhibits the reaction [E804 bisindole results in increased expression of CASP8 mRNA] | 23107598 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of CASP8 protein | 23170834 |
D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CASP8 mRNA | 23107598 |
D008070 | Lipopolysaccharides | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased activity of CASP8 protein] | 23170834 |
D008070 | Lipopolysaccharides | Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form] | 20850421 |
D008070 | Lipopolysaccharides | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP8 protein] | 21146893 |
C054164 | lipstatin | lipstatin analog results in increased cleavage of and results in increased activity of CASP8 protein | 20577697 |
D008094 | Lithium | Lithium inhibits the reaction [Camptothecin results in increased activity of CASP8 protein] | 15475000 |
D008094 | Lithium | Lithium inhibits the reaction [Etoposide results in increased activity of CASP8 protein] | 15475000 |
D008095 | Lithocholic Acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Lithocholic Acid results in increased cleavage of and results in increased activity of CASP8 protein] | 19054763 |
D008095 | Lithocholic Acid | [[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein | 19054763 |
D008095 | Lithocholic Acid | [[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein | 19054763 |
D008095 | Lithocholic Acid | [[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein | 19054763 |
D008095 | Lithocholic Acid | [[[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein | 19054763 |
D008095 | Lithocholic Acid | Lithocholic Acid results in increased cleavage of and results in increased activity of CASP8 protein | 19054763 |
C115354 | lonafarnib | [lonafarnib co-treated with Bortezomib] results in increased cleavage of CASP8 protein | 16118318 |
C016371 | lonidamine | [arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein | 21889928 |
C016371 | lonidamine | BCL2 protein inhibits the reaction [[arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein] | 21889928 |
D017336 | Loratadine | Loratadine results in increased cleavage of CASP8 protein | 20570632 |
D019808 | Losartan | Losartan results in decreased activity of CASP8 protein | 23875703 |
D008148 | Lovastatin | Lovastatin results in increased activity of CASP8 protein | 15705602 |
D008148 | Lovastatin | Lovastatin results in increased activity of CASP8 protein | 15180944 |
D047311 | Luteolin | [Luteolin co-treated with Paclitaxel] results in increased cleavage of CASP8 protein | 24525192 |
D047311 | Luteolin | Luteolin promotes the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP8 protein] | 15334063 |
D047311 | Luteolin | Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 16140950 |
D047311 | Luteolin | Luteolin inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP8 protein] | 27525270 |
C015329 | lycopene | lycopene results in decreased expression of CASP8 mRNA | 16886892 |
C015329 | lycopene | lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
C015329 | lycopene | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
C048341 | mafosfamide | BAX promotes the reaction [mafosfamide results in increased activity of CASP8 protein] | 11723234 |
C048341 | mafosfamide | BCL2 inhibits the reaction [mafosfamide results in increased activity of CASP8 protein] | 11723234 |
C048341 | mafosfamide | mafosfamide results in increased activity of CASP8 protein | 11723234 |
D008277 | Magnesium Oxide | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA] | 27920530 |
D008294 | Malathion | Malathion results in increased activity of CASP8 protein | 12505448 |
C013099 | mancozeb | mancozeb results in increased activity of CASP8 protein | 22289270|2282450 |
D008344 | Maneb | Maneb results in increased activity of CASP8 protein | 22824503 |
C025340 | manganese chloride | bafilomycin A1 inhibits the reaction [manganese chloride results in increased cleavage of CASP8 protein] | 28378122 |
C025340 | manganese chloride | CA 074 methyl ester inhibits the reaction [manganese chloride results in increased cleavage of CASP8 protein] | 28378122 |
C025340 | manganese chloride | manganese chloride results in increased cleavage of CASP8 protein | 21704098|2837812 |
C025340 | manganese chloride | pepstatin inhibits the reaction [manganese chloride results in increased cleavage of CASP8 protein] | 28378122 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[resveratrol co-treated with panobinostat] results in increased cleavage of CASP8 protein] | 22923501 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[resveratrol co-treated with vorinostat] results in increased cleavage of CASP8 protein] | 22923501 |
C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP8 protein] | 19464277 |
C021053 | mangostin | mangostin results in increased activity of CASP8 protein | 24480042 |
D009637 | Masoprocol | [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 17645780 |
D009637 | Masoprocol | Masoprocol results in increased expression of CASP8 protein | 17645780 |
D009637 | Masoprocol | Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP8 protein] | 10203695 |
D009637 | Masoprocol | Masoprocol inhibits the reaction [[TNF protein co-treated with Cycloheximide] results in increased activity of CASP8 protein] | 15950244 |
D008550 | Melatonin | Melatonin promotes the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein] | 21431366 |
D008550 | Melatonin | Melatonin results in increased activity of CASP8 protein | 19012662 |
D008550 | Melatonin | Melatonin inhibits the reaction [bisphenol A results in increased activity of CASP8 protein] | 25454643 |
D008555 | Melitten | Melitten results in increased expression of CASP8 protein modified form | 22027265 |
C042720 | mercuric bromide | mercuric bromide results in increased expression of CASP8 mRNA | 26272509 |
C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
D008627 | Mercuric Chloride | Mercuric Chloride affects the expression of CASP8 mRNA | 20353558 |
D008627 | Mercuric Chloride | [Mercuric Chloride co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased activity of CASP8 protein | 16421179 |
D008627 | Mercuric Chloride | Mercuric Chloride results in increased activity of CASP8 protein | 16421179 |
D008687 | Metformin | Metformin results in decreased activity of CASP8 protein | 15531508 |
D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CASP8 gene | 20938992 |
D008727 | Methotrexate | Methotrexate results in increased expression of and results in increased cleavage of CASP8 protein | 22010212 |
D008727 | Methotrexate | Methotrexate results in increased expression of CASP8 mRNA | 17400583|1763774 |
D008727 | Methotrexate | Methotrexate results in increased expression of CASP8 protein | 17637740|2533030 |
D008727 | Methotrexate | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Antineoplastic Agents | 22010212 |
D008727 | Methotrexate | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Cyclophosphamide metabolite | 22010212 |
D008727 | Methotrexate | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Dexamethasone | 22010212 |
D008727 | Methotrexate | [Methotrexate results in increased expression of CASP8 protein] which results in increased susceptibility to Doxorubicin | 22010212 |
D008727 | Methotrexate | SOD2 protein polymorphism affects the reaction [Methotrexate results in increased expression of CASP8 mRNA] | 25330300 |
D008727 | Methotrexate | SOD2 protein polymorphism affects the reaction [Methotrexate results in increased expression of CASP8 protein] | 25330300 |
D008727 | Methotrexate | TP53 protein promotes the reaction [Methotrexate results in increased expression of CASP8 mRNA] | 17637740 |
D008727 | Methotrexate | TP53 protein promotes the reaction [Methotrexate results in increased expression of CASP8 protein] | 17637740|2201021 |
D008727 | Methotrexate | Methotrexate results in increased expression of CASP8 protein modified form | 23406595 |
D008731 | Methoxychlor | Methoxychlor results in increased activity of CASP8 protein | 20568958 |
D008730 | Methoxsalen | Methoxsalen results in decreased expression of CASP8 protein | 22796345 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | "methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in decreased expression of CASP8 protein" | 25246272 |
C587228 | methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate | methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate results in increased activity of CASP8 protein | 24291674 |
C555027 | methyl 5-chloro-4,5-didehydrojasmonate | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [methyl 5-chloro-4,5-didehydrojasmonate results in increased activity of CASP8 protein]" | 20696234 |
C555027 | methyl 5-chloro-4,5-didehydrojasmonate | "methyl 5-chloro-4,5-didehydrojasmonate results in increased activity of and results in increased cleavage of CASP8 protein" | 20696234 |
C072239 | methyl jasmonate | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [methyl jasmonate metabolite results in increased susceptibility to TNFSF10 protein] | 22079975 |
C072239 | methyl jasmonate | methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in decreased expression of CASP8 protein] | 22079975 |
C072239 | methyl jasmonate | methyl jasmonate metabolite promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 22079975 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CASP8 mRNA | 23458150 |
C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of CASP8 mRNA | 28001369 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased activity of CASP8 protein" | 22983118|2725538 |
D008769 | Methylnitronitrosoguanidine | lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
D008769 | Methylnitronitrosoguanidine | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein | 16030430 |
D008769 | Methylnitronitrosoguanidine | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
D008769 | Methylnitronitrosoguanidine | S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
D008770 | Methylnitrosourea | [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP8 protein | 22465879 |
D008770 | Methylnitrosourea | [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP8 mRNA | 20732338 |
D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of CASP8 mRNA | 28688903 |
C400939 | methylone | methylone results in increased activity of CASP8 protein | 27255387 |
C008493 | methylselenic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP8 protein" | 18444175 |
C008493 | methylselenic acid | [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP8 protein | 18790785 |
C008493 | methylselenic acid | [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein | 18790785 |
C008493 | methylselenic acid | methylselenic acid results in increased cleavage of CASP8 protein | 18790785 |
C008493 | methylselenic acid | [methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein | 18790785 |
D008798 | Mevalonic Acid | Mevalonic Acid inhibits the reaction [fluvastatin results in increased activity of CASP8 protein] | 24964743 |
D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein]] | 17070682 |
D015735 | Mifepristone | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein]] | 12645856 |
D008911 | Minocycline | Minocycline inhibits the reaction [HTT protein mutant form results in increased activity of CASP8 protein] | 12930891 |
D008911 | Minocycline | Minocycline results in decreased expression of and results in decreased activity of CASP8 protein | 14998631 |
D008911 | Minocycline | Minocycline results in decreased expression of CASP8 mRNA | 14998631 |
D016685 | Mitomycin | Mitomycin results in increased activity of CASP8 protein | 10960761|1709445 |
D016685 | Mitomycin | Mitomycin results in increased cleavage of and results in increased activity of CASP8 protein | 12181741 |
D016685 | Mitomycin | Mitomycin results in increased cleavage of CASP8 protein | 16019139|1702165 |
D016685 | Mitomycin | BCL2 protein inhibits the reaction [Mitomycin results in increased cleavage of and results in increased activity of CASP8 protein] | 12181741 |
C429015 | mitoquinol | [diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
C429015 | mitoquinol | [mitoquinol co-treated with mitoquinone] inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein] | 15799720 |
C429014 | mitoquinone | [diphenyleneiodonium co-treated with mitoquinol co-treated with mitoquinone] inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 15799720 |
C429014 | mitoquinone | [mitoquinol co-treated with mitoquinone] inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein] | 15799720 |
D008942 | Mitoxantrone | Mitoxantrone results in increased activity of CASP8 protein | 12948851 |
D008982 | Molybdenum | Molybdenum analog results in increased activity of CASP8 protein | 26391003 |
D009020 | Morphine | ARRB2 protein inhibits the reaction [Morphine results in decreased expression of CASP8 protein alternative form] | 19239323 |
D009020 | Morphine | Morphine results in decreased expression of CASP8 protein alternative form | 19239323 |
D009020 | Morphine | Morphine results in increased activity of CASP8 protein | 19070643 |
D009020 | Morphine | Morphine results in increased activity of CASP8 protein | 11590188 |
D009151 | Mustard Gas | benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Mustard Gas results in increased activity of CASP8 protein] | 20226831 |
D009151 | Mustard Gas | CALM1 protein promotes the reaction [Mustard Gas results in increased cleavage of and results in increased activity of CASP8 protein] | 16935404 |
D009151 | Mustard Gas | FADD protein affects the reaction [Mustard Gas results in increased cleavage of CASP8 protein] | 12482751 |
D009151 | Mustard Gas | Mustard Gas results in increased activity of CASP8 protein | 16738803|2022683 |
D009151 | Mustard Gas | Mustard Gas results in increased cleavage of and results in increased activity of CASP8 protein | 12482751|1693540 |
D009151 | Mustard Gas | Mustard Gas results in increased expression of CASP8 mRNA | 18955075 |
C058815 | N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide | N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide affects the localization of and results in increased cleavage of and results in increased activity of CASP8 protein | 15520213 |
C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP8 protein | 12414664 |
C064769 | N-acetylsphingosine | N-acetylsphingosine promotes the reaction [TNF protein results in increased activity of CASP8 protein] | 10792026 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CASP8 mRNA" | 23634900 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CASP8 protein" | 23634900 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of CASP8 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CASP8 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CASP8 mRNA" | 26146619 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased activity of CASP8 protein" | 19827037 |
D009285 | Naphthoquinones | Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP8 protein] | 19497415 |
C498045 | NCX 4040 | NCX 4040 results in increased expression of CASP8 mRNA | 20188076 |
C002443 | neem oil | neem oil results in increased cleavage of and results in increased activity of CASP8 protein | 22915764 |
D019888 | Nelfinavir | Nelfinavir results in increased activity of CASP8 protein | 20105315 |
C013613 | neohesperidin dihydrochalcone | neohesperidin dihydrochalcone inhibits the reaction [Carbon Tetrachloride results in increased expression of CASP8 protein] | 24530446 |
C011947 | neoxanthin | neoxanthin results in increased activity of CASP8 protein | 17186379 |
D009532 | Nickel | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Nickel results in increased cleavage of CASP8 protein] | 24840272 |
D009532 | Nickel | [Nickel co-treated with austenitic steel analog] results in increased expression of CASP8 mRNA | 23638002 |
D009532 | Nickel | Nickel results in decreased expression of CASP8 protein | 28330870 |
D009532 | Nickel | Nickel results in increased cleavage of CASP8 protein | 24840272 |
D009532 | Nickel | Nickel results in increased expression of CASP8 mRNA | 21054559 |
D009532 | Nickel | Nickel analog results in increased expression of CASP8 mRNA | 27257140 |
C022838 | nickel chloride | nickel chloride affects the expression of CASP8 mRNA | 22546817 |
D009538 | Nicotine | Nicotine affects the expression of CASP8 mRNA | 20426880 |
D009544 | Niflumic Acid | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [ciglitazone promotes the reaction [Niflumic Acid results in increased activity of CASP8 protein]] | 21067863 |
D009544 | Niflumic Acid | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Niflumic Acid promotes the reaction [ciglitazone results in increased activity of CASP8 protein]] | 21067863 |
D009544 | Niflumic Acid | ciglitazone promotes the reaction [Niflumic Acid results in increased activity of CASP8 protein] | 21067863 |
D009544 | Niflumic Acid | DDIT3 mutant form inhibits the reaction [ciglitazone promotes the reaction [Niflumic Acid results in increased activity of CASP8 protein]] | 21067863 |
D009544 | Niflumic Acid | DDIT3 mutant form inhibits the reaction [Niflumic Acid promotes the reaction [ciglitazone results in increased activity of CASP8 protein]] | 21067863 |
D009544 | Niflumic Acid | Niflumic Acid promotes the reaction [ciglitazone results in increased activity of CASP8 protein] | 21067863 |
D009544 | Niflumic Acid | Niflumic Acid results in increased activity of CASP8 protein | 21067863 |
C042198 | nimbolide | nimbolide results in increased expression of CASP8 protein | 20429769 |
C012655 | nimesulide | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [nimesulide results in increased cleavage of and results in increased activity of CASP8 protein] | 19360361 |
C012655 | nimesulide | nimesulide inhibits the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP8 protein] | 21745461 |
C012655 | nimesulide | nimesulide results in increased activity of and results in increased cleavage of CASP8 protein | 19360361 |
D015376 | Nimustine | Nimustine results in increased cleavage of CASP8 protein | 26418950 |
D009569 | Nitric Oxide | Nitric Oxide results in increased activity of CASP8 protein | 15126337 |
D009569 | Nitric Oxide | [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP8 protein | 22878015 |
D009569 | Nitric Oxide | Nitric Oxide results in decreased cleavage of and results in decreased activity of CASP8 protein | 10358093 |
D009569 | Nitric Oxide | "[1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one co-treated with Dithiothreitol] inhibits the reaction [[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein]]" | 10792026 |
D009569 | Nitric Oxide | "1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein]]" | 10792026 |
D009569 | Nitric Oxide | [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein] | 10792026 |
D009589 | Nitrogen Oxides | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP8 protein] | 16041517 |
D009599 | Nitroprusside | Nitroprusside inhibits the reaction [Deferoxamine results in increased activity of CASP8 protein] | 16374551 |
D009599 | Nitroprusside | [Nitroprusside results in increased abundance of Nitric Oxide] which results in increased activity of CASP8 protein | 22878015 |
D009599 | Nitroprusside | cilostazol inhibits the reaction [Nitroprusside results in increased activity of CASP8 protein] | 18311796 |
D009599 | Nitroprusside | Nitroprusside results in increased activity of CASP8 protein | 18311796 |
D026423 | S-Nitroso-N-Acetylpenicillamine | "[1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one co-treated with Dithiothreitol] inhibits the reaction [[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein]]" | 10792026 |
D026423 | S-Nitroso-N-Acetylpenicillamine | "1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein]]" | 10792026 |
D026423 | S-Nitroso-N-Acetylpenicillamine | [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [TNF protein results in increased activity of CASP8 protein] | 10792026 |
D026422 | S-Nitrosoglutathione | S-Nitrosoglutathione results in increased activity of CASP8 protein | 20153346 |
C542681 | N,N-dimethylphytosphingosine | "1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [N,N-dimethylphytosphingosine results in increased activity of CASP8 protein]" | 19481559 |
C542681 | N,N-dimethylphytosphingosine | "benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [N,N-dimethylphytosphingosine results in increased cleavage of and results in increased activity of CASP8 protein]" | 19481559 |
C542681 | N,N-dimethylphytosphingosine | "N,N-dimethylphytosphingosine results in increased cleavage of and results in increased activity of CASP8 protein" | 19481559 |
C542681 | N,N-dimethylphytosphingosine | "Quercetin inhibits the reaction [N,N-dimethylphytosphingosine results in increased activity of CASP8 protein]" | 19481559 |
C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of CASP8 protein | 15816005 |
C044387 | N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine | "N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased activity of CASP8 protein" | 17979179 |
D015739 | Nocodazole | Caspase Inhibitors inhibits the reaction [Nocodazole analog results in increased expression of CASP8 protein modified form] | 28412508 |
D015739 | Nocodazole | Nocodazole analog results in increased cleavage of CASP8 protein | 28412508 |
C063998 | nodularin | nodularin results in increased expression of CASP8 mRNA | 27061667 |
C063998 | nodularin | sauchinone inhibits the reaction [nodularin results in increased expression of CASP8 mRNA] | 27061667 |
C063998 | nodularin | nodularin results in increased activity of CASP8 protein | 25192816 |
C069741 | norcantharidin | norcantharidin results in increased activity of CASP8 protein | 20040369|2126619 |
D009638 | Norepinephrine | Norepinephrine affects the activity of CASP8 protein | 25437044 |
C072936 | notoginsenoside R1 | notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased activity of CASP8 protein] | 23170834 |
C404397 | NSC 680410 | NSC 680410 results in increased cleavage of and results in increased activity of CASP8 protein | 14647418 |
C404397 | NSC 680410 | NSC 680410 results in increased cleavage of CASP8 protein | 16481037 |
C520337 | NSC 74859 | NSC 74859 results in decreased expression of CASP8 protein | 24525192 |
C520337 | NSC 74859 | Paclitaxel promotes the reaction [NSC 74859 results in decreased expression of CASP8 protein] | 24525192 |
C482205 | nutlin 3 | nutlin 3 results in increased cleavage of and results in increased activity of CASP8 protein | 16014563 |
C000594859 | nymphayol | nymphayol inhibits the reaction [Ethanol results in increased activity of CASP8 protein] | 25289771 |
D009761 | Nystatin | Nystatin inhibits the reaction [resveratrol affects the localization of CASP8 protein] | 12902349 |
C107010 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate | "O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of CASP8 protein]" | 12540782 |
C067207 | obacunone | obacunone results in decreased expression of CASP8 protein | 21333732 |
C067207 | obacunone | obacunone results in increased cleavage of CASP8 protein | 25592883 |
C411188 | obacunone glucoside | obacunone glucoside results in increased cleavage of CASP8 protein | 25592883 |
C464660 | obeticholic acid | obeticholic acid results in increased expression of CASP8 mRNA | 27939613 |
C025589 | ochratoxin A | ochratoxin A results in decreased expression of CASP8 mRNA | 17316727|2475539 |
C025589 | ochratoxin A | ochratoxin A results in increased activity of CASP8 protein | 27193732 |
D015242 | Ofloxacin | Ofloxacin results in increased expression of CASP8 mRNA | 24582689 |
D015242 | Ofloxacin | TNFRSF1A mutant form inhibits the reaction [Ofloxacin results in increased expression of CASP8 mRNA] | 24582689 |
D019319 | Okadaic Acid | acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein] | 19084044 |
D019319 | Okadaic Acid | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein] | 19084044 |
D019319 | Okadaic Acid | Okadaic Acid results in increased cleavage of and results in increased activity of CASP8 protein | 19084044 |
C531550 | olaparib | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein] | 26544897 |
C531550 | olaparib | [Fluorouracil co-treated with olaparib] results in increased cleavage of CASP8 protein | 26544897 |
C021065 | oleandrin | oleandrin results in increased activity of CASP8 protein | 24172227 |
D009828 | Oleanolic Acid | Oleanolic Acid results in increased activity of CASP8 protein | 20005942 |
C484027 | oligofectamine | oligofectamine results in increased expression of CASP8 mRNA | 14668052 |
D009853 | Omeprazole | Omeprazole analog results in increased cleavage of CASP8 protein | 18336733 |
C016340 | o,p'-DDT | "o,p'-DDT analog results in decreased expression of CASP8 mRNA" | 22937105 |
C016340 | o,p'-DDT | "o,p'-DDT results in increased expression of CASP8 mRNA" | 22937105 |
D009942 | Organometallic Compounds | Organometallic Compounds results in increased activity of CASP8 | 18760261 |
D009942 | Organometallic Compounds | Organometallic Compounds results in increased activity of CASP8 protein | 21194614|2639100 |
D009942 | Organometallic Compounds | Organometallic Compounds results in decreased activity of CASP8 protein | 18571097 |
C055122 | orlistat | orlistat analog results in increased cleavage of and results in increased activity of CASP8 protein | 20577697 |
C055122 | orlistat | orlistat results in increased cleavage of and results in increased activity of CASP8 protein | 18796435 |
C030110 | oxaliplatin | [oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased cleavage of and results in increased activity of CASP8 protein | 19728331 |
C030110 | oxaliplatin | pifithrin inhibits the reaction [[oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased activity of CASP8 protein] | 19728331 |
C030110 | oxaliplatin | TP53 mutant form inhibits the reaction [[oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased activity of CASP8 protein] | 19728331 |
D010100 | Oxygen | "3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA]" | 23452621 |
D010100 | Oxygen | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
D010100 | Oxygen | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
D010100 | Oxygen | Oxygen deficiency results in increased expression of CASP8 mRNA | 23452621 |
D010100 | Oxygen | Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
D010100 | Oxygen | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
D017239 | Paclitaxel | [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP8 protein | 16168113 |
D017239 | Paclitaxel | [Doxorubicin co-treated with Paclitaxel] results in increased activity of CASP8 protein | 16168113 |
D017239 | Paclitaxel | [esculetin co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP8 protein | 16051289 |
D017239 | Paclitaxel | [Luteolin co-treated with Paclitaxel] results in increased cleavage of CASP8 protein | 24525192 |
D017239 | Paclitaxel | Paclitaxel promotes the reaction [NSC 74859 results in decreased expression of CASP8 protein] | 24525192 |
D017239 | Paclitaxel | Paclitaxel results in increased activity of CASP8 protein | 11716366 |
D017239 | Paclitaxel | Paclitaxel results in increased cleavage of CASP8 protein | 18071906|1809827 |
D017239 | Paclitaxel | Paclitaxel results in increased expression of CASP8 mRNA | 18058816 |
D017239 | Paclitaxel | Paclitaxel results in increased expression of CASP8 protein | 15907983 |
D017239 | Paclitaxel | [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP8 protein | 14749477 |
D017239 | Paclitaxel | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of CASP8 protein | 18098270 |
D017239 | Paclitaxel | [TYMP mutant form co-treated with Paclitaxel] results in increased cleavage of CASP8 protein | 15492279 |
D017239 | Paclitaxel | Paclitaxel results in increased expression of CASP8 mRNA | 26091902 |
C000588809 | paederosidic acid | MAPK8 protein affects the reaction [paederosidic acid results in increased cleavage of CASP8 protein] | 28185768 |
C000588809 | paederosidic acid | paederosidic acid results in increased cleavage of CASP8 protein | 28185768 |
D000073878 | Palm Oil | Palm Oil results in decreased expression of CASP8 mRNA | 18042831 |
D000073878 | Palm Oil | Palm Oil results in increased expression of CASP8 mRNA | 18042831 |
C482884 | panduratin A | panduratin A results in increased cleavage of CASP8 protein | 16497706 |
C496932 | panobinostat | CASP8 protein affects the susceptibility to [resveratrol co-treated with panobinostat] | 22923501 |
C496932 | panobinostat | [Cisplatin co-treated with panobinostat] affects the expression of CASP8 mRNA | 21791302 |
C496932 | panobinostat | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[resveratrol co-treated with panobinostat] results in increased cleavage of CASP8 protein] | 22923501 |
C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C496932 | panobinostat | [panobinostat co-treated with vorinostat] results in increased cleavage of CASP8 protein | 22923501 |
C496932 | panobinostat | panobinostat results in increased expression of CASP8 mRNA | 26272509 |
C496932 | panobinostat | [resveratrol co-treated with panobinostat] results in increased cleavage of CASP8 protein | 22923501 |
D010261 | Paraoxon | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP8 protein] | 12831782 |
D010261 | Paraoxon | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP8 protein] | 12831782 |
D010261 | Paraoxon | benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane analog inhibits the reaction [Paraoxon results in increased cleavage of and results in increased activity of CASP8 protein] | 12831782 |
D010261 | Paraoxon | Paraoxon results in increased cleavage of and results in increased activity of CASP8 protein | 12831782 |
D010269 | Paraquat | Paraquat results in increased expression of CASP8 mRNA | 27288846 |
D010269 | Paraquat | 6-bromoindirubin-3'-oxime promotes the reaction [Paraquat results in increased expression of CASP8 protein modified form] | 28414160 |
D010269 | Paraquat | Paraquat promotes the reaction [TNFRSF10B protein binds to CASP8 protein] | 28414160 |
D010269 | Paraquat | Paraquat results in decreased expression of CASP8 mRNA | 26468117 |
D010269 | Paraquat | Paraquat results in increased cleavage of CASP8 protein | 28414160 |
D010269 | Paraquat | Paraquat results in increased expression of CASP8 mRNA | 20883675 |
D010269 | Paraquat | Paraquat results in increased expression of CASP8 mRNA alternative form | 17064354 |
D010269 | Paraquat | Paraquat results in increased activity of CASP8 protein | 17561093|2491263 |
D010269 | Paraquat | Sodium Salicylate inhibits the reaction [Paraquat results in increased activity of CASP8 protein] | 17561093 |
D017374 | Paroxetine | Paroxetine results in increased activity of CASP8 protein | 28482088 |
C022097 | parthenin | parthenin analog results in increased activity of CASP8 protein | 25196075 |
C002669 | parthenolide | [parthenolide results in decreased activity of RELA protein] which results in increased activity of CASP8 protein | 20154269 |
C002669 | parthenolide | [[parthenolide results in decreased activity of RELA protein] which results in increased activity of CASP8 protein] which results in increased susceptibility to Tamoxifen | 20154269 |
D052638 | Particulate Matter | Particulate Matter results in increased expression of CASP8 protein | 21371539 |
C000610380 | p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane | "p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane results in increased cleavage of CASP8 protein" | 26035713 |
C074968 | pentaacetyl geniposide | pentaacetyl geniposide results in increased activity of CASP8 protein | 15975050 |
C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased activity of CASP8 protein | 18453545 |
C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of CASP8 mRNA | 23948077 |
D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of CASP8 mRNA | 19442831 |
C572410 | pentedrone | pentedrone results in increased activity of CASP8 protein | 27255387 |
D010424 | Pentobarbital | Pentobarbital results in decreased expression of CASP8 mRNA | 16978161 |
D010431 | Pentoxifylline | Pentoxifylline promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 20804743 |
C031375 | pepstatin | pepstatin inhibits the reaction [manganese chloride results in increased cleavage of CASP8 protein] | 28378122 |
C101816 | perfluoro-n-nonanoic acid | perfluoro-n-nonanoic acid results in decreased expression of CASP8 protein | 19878704 |
C101816 | perfluoro-n-nonanoic acid | perfluoro-n-nonanoic acid results in increased activity of CASP8 protein | 19646514 |
C105905 | perifosine | [perifosine co-treated with Butyrates] results in increased activity of CASP8 protein | 15781658 |
C105905 | perifosine | [perifosine co-treated with trichostatin A] results in increased activity of CASP8 protein | 15781658 |
C105905 | perifosine | [perifosine co-treated with vorinostat] results in increased activity of CASP8 protein | 15781658 |
D015232 | Dinoprostone | Dinoprostone inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CASP8 mRNA] | 18463360 |
D015232 | Dinoprostone | Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased cleavage of CASP8 protein]] | 25432964 |
C526145 | Phellinus linteus extract | [Doxorubicin co-treated with Phellinus linteus extract] results in increased cleavage of and results in increased activity of CASP8 protein | 16868541 |
C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in increased activity of CASP8 protein | 16054126 |
D010634 | Phenobarbital | [DMU-212 co-treated with Diethylnitrosamine co-treated with Phenobarbital] affects the expression of CASP8 mRNA | 27048571 |
D019800 | Phenol | Phenol results in increased activity of CASP8 protein | 23776099 |
D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of CASP8 mRNA | 26272509 |
C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased expression of CASP8 protein | 17967739 |
D010713 | Phosphatidylcholines | [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP8 protein | 21695227 |
C107448 | phthalocyanine Pc 4 | phthalocyanine Pc 4 results in increased cleavage of and results in increased activity of CASP8 protein | 16007152 |
C522973 | PI103 | BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
C522973 | PI103 | PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein] | 20856197 |
C522973 | PI103 | TP53 protein promotes the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]] | 20856197 |
C121565 | pifithrin | pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein] | 19732952 |
C121565 | pifithrin | pifithrin inhibits the reaction [[oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased activity of CASP8 protein] | 19728331 |
C121565 | pifithrin | pifithrin inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP8 protein] | 16777994 |
C121565 | pifithrin | pifithrin inhibits the reaction [Doxorubicin results in increased activity of CASP8 protein] | 16687611 |
D020110 | Pinacidil | Pinacidil results in decreased expression of CASP8 mRNA | 17612592 |
C006253 | pirinixic acid | NCF1 protein affects the reaction [pirinixic acid results in decreased expression of CASP8 protein] | 17483499 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CASP8 mRNA | 19710929 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of CASP8 protein | 17483499 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of CASP8 mRNA | 18301758|2381119 |
C006253 | pirinixic acid | PPARA protein affects the reaction [pirinixic acid results in decreased expression of CASP8 protein] | 17483499 |
D010936 | Plant Extracts | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to Plant Extracts | 20229524 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
D010936 | Plant Extracts | Plant Extracts inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 20971099 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of CASP8 mRNA | 21920417 |
D010936 | Plant Extracts | Plant Extracts results in decreased expression of CASP8 protein | 24021570 |
D010936 | Plant Extracts | Plant Extracts results in increased activity of CASP8 protein | 18070620|2060080 |
D010936 | Plant Extracts | Plant Extracts results in increased cleavage of and results in increased activity of CASP8 protein | 17619071 |
D010936 | Plant Extracts | Plant Extracts results in increased cleavage of CASP8 protein | 20229524|2544919 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of and results in increased activity of CASP8 protein | 24677778 |
D010936 | Plant Extracts | Plant Extracts results in increased expression of CASP8 protein | 24534064 |
D010936 | Plant Extracts | Plant Extracts results in increased activity of CASP8 protein | 24991116 |
C014758 | plumbagin | Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP8 protein] | 20576514 |
C014758 | plumbagin | plumbagin results in increased activity of CASP8 protein | 20576514 |
D011070 | Poly I-C | Poly I-C results in increased activity of CASP8 protein | 19563882 |
D011070 | Poly I-C | arsenic trioxide promotes the reaction [Poly I-C results in increased activity of CASP8 protein] | 21418039 |
D011070 | Poly I-C | Poly I-C promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 21418039 |
D011070 | Poly I-C | Poly I-C results in increased activity of CASP8 protein | 21418039 |
D059808 | Polyphenols | [Polyphenols co-treated with Bleomycin] results in increased expression of CASP8 mRNA | 26800624 |
D059808 | Polyphenols | Polyphenols results in decreased expression of CASP8 protein | 24021570 |
D059808 | Polyphenols | Polyphenols results in increased activity of CASP8 protein | 24021570 |
C472086 | polyphenon E | polyphenon E results in increased cleavage of CASP8 protein | 23285096 |
D011166 | Porphyrins | Porphyrins results in increased expression of CASP8 mRNA | 26468117 |
C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CASP8 mRNA | 22079256 |
C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of CASP8 mRNA | 22079256 |
D011224 | Prazosin | Prazosin results in increased activity of CASP8 protein | 26449523 |
C023617 | pregna-4,17-diene-3,16-dione | "pregna-4,17-diene-3,16-dione results in increased activity of CASP8 protein" | 17475222 |
D011353 | Prodigiosin | Prodigiosin results in increased cleavage of CASP8 protein | 15746575 |
D011374 | Progesterone | Progesterone inhibits the reaction [Cisplatin results in increased activity of CASP8 protein] | 23482746 |
D011374 | Progesterone | Progesterone results in increased expression of CASP8 mRNA | 21549006 |
D011374 | Progesterone | [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP8 protein | 22465879 |
D011374 | Progesterone | [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP8 mRNA | 20732338 |
D011374 | Progesterone | Progesterone results in increased expression of CASP8 mRNA | 21770760 |
D015742 | Propofol | Propofol results in increased expression of CASP8 mRNA | 26103940 |
D011429 | Propolis | Propolis results in increased activity of CASP8 protein | 26367700 |
D015237 | Dinoprost | Dinoprost inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CASP8 mRNA] | 18463360 |
C028025 | protoporphyrin IX | protoporphyrin IX results in decreased activity of CASP8 protein | 16051694 |
C498383 | psymberin | CASP8 protein results in increased susceptibility to psymberin | 20920557 |
C107773 | pterostilbene | pterostilbene results in increased cleavage of and results in increased activity of CASP8 protein | 20681671 |
C033607 | puerarin | arsenic trioxide promotes the reaction [puerarin results in increased expression of CASP8 protein] | 20416161 |
C033607 | puerarin | puerarin results in increased expression of CASP8 protein | 20416161 |
C115642 | punicalagin | punicalagin results in increased expression of CASP8 protein | 28709945 |
C572726 | pycnidione | pycnidione results in increased activity of and results in increased cleavage of CASP8 protein | 22450442 |
C513428 | pyrachlostrobin | [iprodione co-treated with pyrachlostrobin co-treated with acetamiprid co-treated with iprodione] results in increased expression of CASP8 mRNA | 29091792 |
C513428 | pyrachlostrobin | [iprodione co-treated with pyrachlostrobin co-treated with acetamiprid] results in increased expression of CASP8 mRNA | 29091792 |
C513428 | pyrachlostrobin | [iprodione co-treated with pyrachlostrobin] results in decreased expression of CASP8 mRNA | 29091792 |
C432165 | pyrazolanthrone | "pyrazolanthrone inhibits the reaction [6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased expression of CASP8 protein]" | 23212307 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Aminolevulinic Acid analog results in increased activity of CASP8 protein] | 21138480 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [[Buthionine Sulfoximine co-treated with arsenic trioxide] results in increased cleavage of CASP8 protein] | 17145888 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of CASP8 protein] | 15501958 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [Quercetin results in increased cleavage of CASP8 protein] | 21165570 |
C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [[Sirolimus co-treated with 7-hydroxystaurosporine] results in increased cleavage of CASP8 protein] | 15767555 |
C432165 | pyrazolanthrone | pyrazolanthrone promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 16972261 |
C432165 | pyrazolanthrone | pyrazolanthrone promotes the reaction [FAS protein results in increased cleavage of and results in increased activity of CASP8 protein] | 16061660 |
D011736 | Pyridoxine | Pyridoxine results in increased expression of CASP8 mRNA | 28716455 |
D011739 | Pyrimethamine | Pyrimethamine results in increased activity of CASP8 protein | 18593930 |
C108337 | pyrimethanil | [iprodione co-treated with pyrimethanil co-treated with acetamiprid] results in increased expression of CASP8 mRNA | 29091792 |
C108337 | pyrimethanil | [iprodione co-treated with pyrimethanil] results in decreased expression of CASP8 mRNA | 29091792 |
C108337 | pyrimethanil | pyrimethanil results in decreased expression of CASP8 mRNA | 29091792 |
C009131 | pyrimidin-2-one beta-ribofuranoside | pyrimidin-2-one beta-ribofuranoside results in increased activity of CASP8 protein | 23320119 |
C010423 | pyrithione zinc | pyrithione zinc results in increased activity of CASP8 protein | 20151177 |
C010423 | pyrithione zinc | pyrithione zinc results in increased expression of CASP8 mRNA | 21424779 |
D011748 | Pyrogallol | Pyrogallol results in increased activity of CASP8 protein | 19000662 |
C020972 | pyrrolidine dithiocarbamic acid | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] | 15477007 |
C020972 | pyrrolidine dithiocarbamic acid | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA]] | 15477007 |
C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] | 15477007 |
D011794 | Quercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased cleavage of CASP8 protein] | 21165570 |
D011794 | Quercetin | [arsenic trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein | 18359480 |
D011794 | Quercetin | BCL2 protein inhibits the reaction [[arsenic trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein] | 18359480 |
D011794 | Quercetin | pyrazolanthrone inhibits the reaction [Quercetin results in increased cleavage of CASP8 protein] | 21165570 |
D011794 | Quercetin | Quercetin affects the localization of CASP8 protein | 17876056 |
D011794 | Quercetin | "Quercetin inhibits the reaction [N,N-dimethylphytosphingosine results in increased activity of CASP8 protein]" | 19481559 |
D011794 | Quercetin | Quercetin promotes the reaction [TNFSF10 protein affects the localization of CASP8 protein] | 17876056 |
D011794 | Quercetin | Quercetin promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 18377872 |
D011794 | Quercetin | Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | 17548900|2009629 |
D011794 | Quercetin | Quercetin results in increased activity of CASP8 protein | 16158945|2080312 |
D011794 | Quercetin | Quercetin results in increased cleavage of CASP8 protein | 18455702|2009629 |
D011794 | Quercetin | Quercetin results in increased expression of CASP8 protein | 25339540 |
D011794 | Quercetin | TNFSF10 protein promotes the reaction [Quercetin results in increased cleavage of CASP8 protein] | 24612139 |
D011794 | Quercetin | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP8 protein]" | 21294050 |
D011794 | Quercetin | Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP8 protein]] | 15914627 |
D011794 | Quercetin | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of and results in increased activity of CASP8 protein] | 24316378 |
D011794 | Quercetin | Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of CASP8 mRNA] | 24316378 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP8 protein] | 16647178 |
D011794 | Quercetin | Quercetin inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP8 protein] | 27525270 |
C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [TNFSF10 protein results in increased activity of CASP8 protein] | 23711929 |
C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [25-hydroxycholesterol results in increased activity of CASP8 protein] | 25845326 |
C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [7-ketocholesterol results in increased activity of CASP8 protein] | 25845326 |
C012526 | quercitrin | quercitrin results in increased expression of CASP8 mRNA | 25193878 |
C468548 | quinoline-val-asp(OMe)-CH2-OPH | quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP8 protein] | 27732882 |
D017382 | Reactive Oxygen Species | [[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein | 19054763 |
D017382 | Reactive Oxygen Species | [[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein | 19054763 |
D017382 | Reactive Oxygen Species | [[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein | 19054763 |
D017382 | Reactive Oxygen Species | [[[[[Lithocholic Acid results in increased abundance of Reactive Oxygen Species] which results in increased localization of and results in increased activity of FAS protein] which results in increased activity of CASP8 protein] which results in increased cleavage of BID protein] which results in increased activity of CASP9 protein] which results in increased activity of CASP3 protein | 19054763 |
D017382 | Reactive Oxygen Species | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP8 protein] | 19464277 |
D017382 | Reactive Oxygen Species | [XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP8 protein | 19464277 |
D012110 | Reserpine | IAPP protein inhibits the reaction [Reserpine results in increased activity of CASP8 protein] | 19463876 |
D012110 | Reserpine | Reserpine results in increased activity of CASP8 protein | 19463876 |
D012116 | Resins, Plant | "Resins, Plant results in increased activity of CASP8 protein" | 27268964 |
C059514 | resveratrol | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP8 protein" | 18444175 |
C059514 | resveratrol | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein] | 19423619 |
C059514 | resveratrol | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein] | 19423619 |
C059514 | resveratrol | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAK1 protein] | 12902349 |
C059514 | resveratrol | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] inhibits the reaction [resveratrol results in increased localization of BAX protein] | 12902349 |
C059514 | resveratrol | [benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone results in decreased activity of CASP8 protein] which results in decreased susceptibility to resveratrol | 19561642 |
C059514 | resveratrol | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein] | 18222423 |
C059514 | resveratrol | Capsaicin promotes the reaction [resveratrol results in decreased expression of CASP8 protein] | 19846903 |
C059514 | resveratrol | CASP8 protein affects the susceptibility to resveratrol | 22923501 |
C059514 | resveratrol | CASP8 protein affects the susceptibility to [resveratrol co-treated with panobinostat] | 22923501 |
C059514 | resveratrol | CASP8 protein affects the susceptibility to [resveratrol co-treated with vorinostat] | 22923501 |
C059514 | resveratrol | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[resveratrol co-treated with panobinostat] results in increased cleavage of CASP8 protein] | 22923501 |
C059514 | resveratrol | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[resveratrol co-treated with vorinostat] results in increased cleavage of CASP8 protein] | 22923501 |
C059514 | resveratrol | Nystatin inhibits the reaction [resveratrol affects the localization of CASP8 protein] | 12902349 |
C059514 | resveratrol | resveratrol affects the localization of CASP8 protein | 12902349 |
C059514 | resveratrol | [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP8 protein | 14749477 |
C059514 | resveratrol | [resveratrol co-treated with panobinostat] results in increased cleavage of CASP8 protein | 22923501 |
C059514 | resveratrol | [resveratrol co-treated with SB 203580] results in increased activity of CASP8 protein | 22644961 |
C059514 | resveratrol | [resveratrol co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 15763656 |
C059514 | resveratrol | [resveratrol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 18222423 |
C059514 | resveratrol | [resveratrol co-treated with vorinostat] results in increased cleavage of CASP8 protein | 22923501 |
C059514 | resveratrol | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CASP8 mRNA] | 23452621 |
C059514 | resveratrol | resveratrol promotes the reaction [Capsaicin results in decreased expression of CASP8 protein] | 19846903 |
C059514 | resveratrol | resveratrol promotes the reaction [FAS protein binds to CASP8 protein] | 12902349 |
C059514 | resveratrol | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein] | 20097879 |
C059514 | resveratrol | resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | 17823925 |
C059514 | resveratrol | resveratrol results in decreased activity of CASP8 protein | 12925042 |
C059514 | resveratrol | resveratrol results in decreased expression of CASP8 protein | 18089832|1984690 |
C059514 | resveratrol | resveratrol results in increased activity of CASP8 protein | 18276737|1942361 |
C059514 | resveratrol | [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP3 protein | 19423619 |
C059514 | resveratrol | [resveratrol results in increased activity of CASP8 protein] which results in increased activity of CASP9 protein | 19423619 |
C059514 | resveratrol | [resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein | 18276737|1942361 |
C059514 | resveratrol | resveratrol results in increased cleavage of and results in increased activity of CASP8 protein | 12902349|1661705 |
C059514 | resveratrol | resveratrol results in increased cleavage of CASP8 protein | 18347188|2292350 |
C059514 | resveratrol | resveratrol results in increased localization of and results in increased activity of CASP8 protein | 19561642 |
C059514 | resveratrol | resveratrol inhibits the reaction [Isoflurane results in increased activity of CASP8 protein] | 23922164 |
C059514 | resveratrol | resveratrol results in increased cleavage of CASP8 protein | 17872969 |
C059514 | resveratrol | resveratrol results in increased expression of CASP8 mRNA | 22610192 |
C059514 | resveratrol | resveratrol results in decreased expression of CASP8 protein modified form | 24040416 |
C059514 | resveratrol | resveratrol results in increased activity of CASP8 protein | 24534837|2466925 |
C059514 | resveratrol | Acetylcysteine inhibits the reaction [resveratrol results in increased cleavage of CASP8 protein] | 26849945 |
C059514 | resveratrol | resveratrol results in increased cleavage of CASP8 protein | 26849945 |
D015474 | Isotretinoin | Isotretinoin results in increased cleavage of CASP8 protein | 16135400 |
D012254 | Ribavirin | Ribavirin promotes the reaction [FAS protein results in increased activity of CASP8 protein] | 12760867 |
D012293 | Rifampin | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein]] | 12645856 |
D012293 | Rifampin | Rifampin inhibits the reaction [FAS protein results in increased activity of CASP8 protein] | 11958592|1264585 |
D019782 | Riluzole | Riluzole results in increased activity of CASP8 protein | 19528481 |
D000068296 | Risedronate Sodium | Risedronate Sodium results in increased activity of CASP8 protein | 19505369 |
C064758 | Ro 31-8220 | Ro 31-8220 results in increased activity of CASP8 protein | 18054255 |
C064758 | Ro 31-8220 | TNF protein promotes the reaction [Ro 31-8220 results in increased activity of CASP8 protein] | 18054255 |
D012402 | Rotenone | "Rotenone inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Galactosamine] results in increased activity of CASP8 protein]" | 24830863 |
D012402 | Rotenone | Rotenone results in increased expression of CASP8 mRNA | 23186747 |
D012402 | Rotenone | Rotenone results in increased expression of CASP8 protein | 25502462 |
D012402 | Rotenone | Ursodeoxycholic Acid inhibits the reaction [Rotenone results in increased expression of CASP8 protein] | 25502462 |
C046245 | rubimaillin | BCL2L1 protein inhibits the reaction [rubimaillin results in increased activity of CASP8 protein] | 19716835 |
C046245 | rubimaillin | benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [rubimaillin results in increased activity of CASP8 protein] | 19716835 |
C046245 | rubimaillin | rubimaillin results in increased activity of CASP8 protein | 19716835 |
C079905 | rubitecan | [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP8 protein | 21695227 |
C079905 | rubitecan | rubitecan results in increased expression of CASP8 protein | 21695227 |
D012431 | Rutin | [Rutin binds to Zinc] which results in increased expression of CASP8 mRNA | 26091902 |
D012431 | Rutin | Rutin results in increased expression of CASP8 mRNA | 26091902 |
C039961 | S-(1,2-dichlorovinyl)cysteine | "S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP8 protein" | 29129777 |
C049705 | S-1,2-dichlorovinyl-N-acetylcysteine | "S-1,2-dichlorovinyl-N-acetylcysteine affects the expression of CASP8 mRNA" | 16844155 |
D012451 | Safrole | Safrole results in increased expression of CASP8 mRNA | 21591240 |
C413684 | salicylaldehyde isonicotinoyl hydrazone | salicylaldehyde isonicotinoyl hydrazone analog results in increased activity of CASP8 protein | 22521999 |
C010327 | salinomycin | salinomycin results in decreased expression of CASP8 mRNA | 19682730 |
C065299 | S-allylcysteine | [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C065299 | S-allylcysteine | S-allylcysteine inhibits the reaction [lead acetate results in increased activity of CASP8 protein] | 22033380 |
C065299 | S-allylcysteine | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
C065299 | S-allylcysteine | S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
D000068299 | Salmeterol Xinafoate | [Fluticasone co-treated with Salmeterol Xinafoate] results in increased activity of CASP8 protein | 15536434 |
C018381 | salvin | Acetylcysteine inhibits the reaction [salvin results in increased cleavage of CASP8 protein] | 28918123 |
C018381 | salvin | salvin results in increased cleavage of CASP8 protein | 28918123 |
C005705 | sanguinarine | [sanguinarine co-treated with arsenic trioxide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 24345465 |
C005705 | sanguinarine | [sanguinarine co-treated with arsenic trioxide] results in increased activity of CASP8 protein | 24345465 |
C005705 | sanguinarine | [sanguinarine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 24345465 |
C005705 | sanguinarine | sanguinarine results in increased activity of CASP8 protein | 19346183|2366033 |
C410958 | sauchinone | sauchinone inhibits the reaction [nodularin results in increased expression of CASP8 mRNA] | 27061667 |
C093642 | SB 203580 | [resveratrol co-treated with SB 203580] results in increased activity of CASP8 protein | 22644961 |
C093642 | SB 203580 | SB 203580 promotes the reaction [Emodin results in increased activity of CASP8 protein] | 27032576 |
C115461 | SC 560 | SC 560 promotes the reaction [Carbon Tetrachloride results in increased cleavage of CASP8 protein] | 25432964 |
C499748 | SCIO-469 | SCIO-469 promotes the reaction [Bortezomib results in increased cleavage of CASP8 protein] | 16617327 |
D012643 | Selenium | [Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein] | 17970047 |
D012643 | Selenium | [Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein] | 17970047 |
D012643 | Selenium | Selenium analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA] | 27920530 |
D012643 | Selenium | Selenium results in decreased expression of CASP8 mRNA | 19244175 |
D012643 | Selenium | Selenium results in increased activity of CASP8 protein | 12432279 |
C002979 | selenomethylselenocysteine | selenomethylselenocysteine metabolite results in increased expression of CASP8 protein modified form | 25321483 |
C025583 | sesamol | sesamol results in increased activity of CASP8 protein | 27270451 |
D012717 | Sesquiterpenes | Sesquiterpenes results in increased activity of CASP8 protein | 18070620 |
C440975 | silybin | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP8 protein] | 16777994 |
C440975 | silybin | pifithrin inhibits the reaction [silybin results in increased cleavage of and results in increased activity of CASP8 protein] | 16777994 |
C440975 | silybin | silybin results in increased cleavage of and results in increased activity of CASP8 protein | 16777994 |
D012838 | Silymarin | Silymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form] | 20850421 |
D019821 | Simvastatin | Simvastatin results in increased activity of CASP8 protein | 15705602 |
D019821 | Simvastatin | Simvastatin results in increased cleavage of and results in increased activity of CASP8 protein | 21910007 |
D019821 | Simvastatin | Simvastatin results in increased cleavage of CASP8 protein | 12962723|2046444 |
D019821 | Simvastatin | Acetylcysteine inhibits the reaction [Simvastatin results in increased activity of CASP8 protein] | 20883752 |
D019821 | Simvastatin | Simvastatin results in increased activity of CASP8 protein | 20883752 |
C574383 | sinularin | Acetylcysteine inhibits the reaction [sinularin results in increased cleavage of CASP8 protein] | 28548367 |
C574383 | sinularin | sinularin results in increased cleavage of CASP8 protein | 28548367 |
D020123 | Sirolimus | [7-hydroxystaurosporine co-treated with Sirolimus] results in increased cleavage of CASP8 protein | 15767555 |
D020123 | Sirolimus | pyrazolanthrone inhibits the reaction [[Sirolimus co-treated with 7-hydroxystaurosporine] results in increased cleavage of CASP8 protein] | 15767555 |
D020123 | Sirolimus | Sirolimus promotes the reaction [Cisplatin results in increased cleavage of CASP8 protein] | 18058806 |
D020123 | Sirolimus | Sirolimus results in increased cleavage of CASP8 protein | 25307878 |
D020123 | Sirolimus | [tanespimycin co-treated with Sirolimus] results in increased cleavage of CASP8 protein | 17121904 |
D020123 | Sirolimus | Sirolimus inhibits the reaction [TGFB1 protein inhibits the reaction [Cadmium Chloride results in increased expression of CASP8 protein]] | 28342888 |
C534922 | SNX 2112 | SNX 2112 results in increased activity of CASP8 protein | 23777986 |
C009277 | sodium arsenate | sodium arsenate results in decreased expression of CASP8 mRNA | 24349563 |
C017947 | sodium arsenite | sodium arsenite results in decreased methylation of CASP8 gene | 25199682 |
C017947 | sodium arsenite | sodium arsenite results in increased cleavage of CASP8 protein | 24100277 |
C017947 | sodium arsenite | [Mercuric Chloride co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased activity of CASP8 protein | 16421179 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of CASP8 mRNA | 14691202 |
C017947 | sodium arsenite | sodium arsenite results in increased activity of CASP8 protein | 16421179|2000668 |
C017947 | sodium arsenite | [Acetylcysteine co-treated with Atorvastatin Calcium] inhibits the reaction [sodium arsenite results in increased activity of CASP8 protein] | 20946910 |
C017947 | sodium arsenite | [Acetylcysteine co-treated with Atorvastatin Calcium] inhibits the reaction [sodium arsenite results in increased expression of CASP8 protein] | 20946910 |
C017947 | sodium arsenite | sodium arsenite results in increased activity of CASP8 protein | 20946910 |
C017947 | sodium arsenite | sodium arsenite results in increased expression of CASP8 protein | 20946910 |
C016104 | sodium bichromate | sodium bichromate results in increased activity of CASP8 protein | 18544562 |
C016104 | sodium bichromate | CAT protein inhibits the reaction [sodium bichromate results in increased degradation of CASP8 protein] | 20298709 |
C016104 | sodium bichromate | sodium bichromate results in decreased expression of CASP8 protein | 21047991 |
C016104 | sodium bichromate | sodium bichromate results in increased degradation of CASP8 protein | 20298709 |
C016104 | sodium bichromate | TRP53 mutant form inhibits the reaction [sodium bichromate results in increased degradation of CASP8 protein] | 20298709 |
D012965 | Sodium Chloride | Sodium Chloride results in increased expression of CASP8 mRNA | 23634900 |
D012965 | Sodium Chloride | lycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
D012965 | Sodium Chloride | [Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein | 16030430 |
D012965 | Sodium Chloride | [S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
D012965 | Sodium Chloride | S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of CASP8 protein] | 16030430 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased cleavage of and results in increased activity of CASP8 protein | 21708216 |
D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of CASP8 mRNA | 19852076 |
D012980 | Sodium Salicylate | Sodium Salicylate inhibits the reaction [Paraquat results in increased activity of CASP8 protein] | 17561093 |
D012980 | Sodium Salicylate | Sodium Salicylate results in increased activity of CASP8 protein | 17561093 |
D018038 | Sodium Selenite | Sodium Selenite results in increased expression of CASP8 mRNA | 19363675 |
D018038 | Sodium Selenite | Sodium Selenite results in decreased activity of CASP8 protein | 18209489 |
D053260 | Soot | Soot results in decreased expression of CASP8 mRNA | 26551751 |
C471405 | sorafenib | ATG5 protein inhibits the reaction [[sorafenib co-treated with vorinostat] results in increased cleavage of CASP8 protein] | 18787411 |
C471405 | sorafenib | Boc-D-FMK inhibits the reaction [sorafenib results in increased cleavage of and results in increased activity of CASP8 protein] | 16007148 |
C471405 | sorafenib | EIF2AK3 protein promotes the reaction [[sorafenib co-treated with vorinostat] promotes the reaction [CASP8 protein binds to ATG5 protein binds to HSPA5 protein binds to FAS protein]] | 18787411 |
C471405 | sorafenib | EIF2AK3 protein promotes the reaction [[sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to FADD protein binds to CASP8 protein]] | 18787411 |
C471405 | sorafenib | EIF2AK3 protein promotes the reaction [[sorafenib co-treated with vorinostat] results in increased cleavage of CASP8 protein] | 18787411 |
C471405 | sorafenib | FADD protein promotes the reaction [[sorafenib co-treated with vorinostat] promotes the reaction [CASP8 protein binds to ATG5 protein binds to HSPA5 protein binds to FAS protein]] | 18787411 |
C471405 | sorafenib | sorafenib affects the localization of CASP8 protein modified form | 17909059 |
C471405 | sorafenib | [sorafenib co-treated with TNFSF10 protein] promotes the reaction [CASP8 protein modified form results in increased cleavage of BID protein] | 17909059 |
C471405 | sorafenib | [sorafenib co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 17909059 |
C471405 | sorafenib | [sorafenib co-treated with TNFSF10 protein] results in increased cleavage of CASP8 protein | 20071162 |
C471405 | sorafenib | [sorafenib co-treated with Vitamin K 1] results in increased cleavage of CASP8 protein | 20301194 |
C471405 | sorafenib | [sorafenib co-treated with vorinostat] promotes the reaction [CASP8 protein binds to FAS protein binds to FADD protein] | 18787411 |
C471405 | sorafenib | [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] | 18787411 |
C471405 | sorafenib | [sorafenib co-treated with vorinostat] results in increased cleavage of CASP8 protein | 18787411 |
C471405 | sorafenib | sorafenib results in increased cleavage of and results in increased activity of CASP8 protein | 16007148|1610971 |
C471405 | sorafenib | sorafenib results in increased cleavage of CASP8 protein | 18200035 |
D013012 | Sorbitol | Sorbitol results in increased activity of CASP8 protein | 20609311 |
D013012 | Sorbitol | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP8 protein]] | 20609311 |
D013012 | Sorbitol | Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP8 protein] | 20609311 |
D013096 | Spermine | Spermine inhibits the reaction [Dexamethasone results in increased activity of CASP8 protein] | 11399061 |
D013148 | Spironolactone | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP8 protein]] | 20609311 |
C485419 | spiruchostatin A | spiruchostatin A results in increased activity of CASP8 protein | 25078973 |
C529984 | spiruchostatin B | spiruchostatin B results in increased activity of CASP8 protein | 25078973 |
D019311 | Staurosporine | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Staurosporine results in increased cleavage of CASP8 protein] | 24658017 |
D019311 | Staurosporine | Staurosporine results in increased activity of CASP8 protein | 19352495 |
D019311 | Staurosporine | Staurosporine results in increased cleavage of and results in increased activity of CASP8 protein | 16007152 |
D019311 | Staurosporine | Staurosporine results in increased cleavage of CASP8 protein | 24658017 |
D013311 | Streptozocin | Curcumin inhibits the reaction [Streptozocin results in increased cleavage of CASP8 protein] | 25541178 |
D013311 | Streptozocin | Curcumin inhibits the reaction [Streptozocin results in increased expression of CASP8 mRNA] | 23267840 |
D013311 | Streptozocin | INS1 protein inhibits the reaction [Streptozocin results in increased expression of CASP8 mRNA] | 23267840 |
D013311 | Streptozocin | Streptozocin results in increased cleavage of CASP8 protein | 25541178 |
D013311 | Streptozocin | Streptozocin results in increased expression of CASP8 mRNA | 23267840 |
D020058 | Styrene | Styrene results in increased activity of CASP8 protein | 17420221 |
C061636 | suillin | suillin results in increased cleavage of and results in increased activity of CASP8 protein | 19616521 |
C016766 | sulforafan | sulforafan results in increased expression of and results in increased activity of CASP8 protein | 26833863 |
D013458 | Sulfur Dioxide | Sulfur Dioxide results in increased expression of and results in increased activity of CASP8 protein | 19621461 |
D013458 | Sulfur Dioxide | Sulfur Dioxide results in increased expression of CASP8 mRNA | 19621461 |
D013467 | Sulindac | [Sulindac co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 21171083 |
C025462 | sulindac sulfide | BAX protein affects the reaction [TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein]] | 12203115 |
C025462 | sulindac sulfide | PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP8 protein] | 12414664 |
C025462 | sulindac sulfide | sulindac sulfide results in increased activity of CASP8 protein | 11559570|1241466 |
C025462 | sulindac sulfide | sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein | 12203115 |
C025462 | sulindac sulfide | TNFSF10 protein promotes the reaction [sulindac sulfide results in increased cleavage of and results in increased activity of CASP8 protein] | 12203115 |
C025462 | sulindac sulfide | sulindac sulfide results in increased activity of CASP8 protein | 16886631 |
C025463 | sulindac sulfone | sulindac sulfone results in increased activity of CASP8 protein | 11559570 |
D013605 | T-2 Toxin | T-2 Toxin results in increased expression of CASP8 mRNA | 26141394 |
C112689 | TAC 101 | TAC 101 results in increased activity of CASP8 protein | 17436592 |
D016559 | Tacrolimus | Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein] | 15548389 |
D013629 | Tamoxifen | Tamoxifen results in increased expression of CASP8 mRNA | 26908177 |
D013629 | Tamoxifen | [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP8 protein | 18790785 |
D013629 | Tamoxifen | [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein | 18790785 |
D013629 | Tamoxifen | [[parthenolide results in decreased activity of RELA protein] which results in increased activity of CASP8 protein] which results in increased susceptibility to Tamoxifen | 20154269 |
D013629 | Tamoxifen | [Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of CASP8 protein modified form | 17767197 |
D013629 | Tamoxifen | Tamoxifen results in increased expression of CASP8 protein | 17767197 |
C112765 | tanespimycin | [tanespimycin co-treated with Sirolimus] results in increased cleavage of CASP8 protein | 17121904 |
C112765 | tanespimycin | tanespimycin results in increased cleavage of CASP8 protein | 17121904 |
C021751 | tanshinone | tanshinone promotes the reaction [TNFSF10 protein results in increased cleavage of CASP8 protein] | 26203587 |
D013656 | Taurocholic Acid | Taurocholic Acid inhibits the reaction [Carbon Tetrachloride results in increased activity of CASP8 protein] | 12388182 |
C041348 | tcdA protein, Clostridium difficile | "alanylglutamine inhibits the reaction [tcdA protein, Clostridium difficile results in increased activity of CASP8 protein]" | 16368960 |
C041348 | tcdA protein, Clostridium difficile | "tcdA protein, Clostridium difficile results in increased activity of CASP8 protein" | 16368960 |
D013662 | Tea | [Tea co-treated with Bleomycin] results in increased expression of CASP8 mRNA | 26800624 |
D013691 | Tellurium | Tellurium results in decreased activity of CASP8 protein | 18571097 |
C047246 | temozolomide | [eckol co-treated with temozolomide] results in increased cleavage of CASP8 protein | 21514314 |
C047246 | temozolomide | temozolomide results in increased cleavage of CASP8 protein | 26418950 |
D016593 | Terfenadine | Terfenadine results in increased activity of CASP8 protein | 16569656 |
D016593 | Terfenadine | Terfenadine results in increased cleavage of CASP8 protein | 20570632 |
D016593 | Terfenadine | Terfenadine results in increased activity of CASP8 protein | 15288570 |
D013739 | Testosterone | Spironolactone inhibits the reaction [Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP8 protein]] | 20609311 |
D013739 | Testosterone | Testosterone inhibits the reaction [Sorbitol results in increased activity of CASP8 protein] | 20609311 |
D013739 | Testosterone | Testosterone results in increased cleavage of CASP8 protein | 24658017 |
D013739 | Testosterone | FADD protein promotes the reaction [Testosterone results in increased expression of CASP8] | 16845445 |
D013739 | Testosterone | Testosterone results in increased expression of CASP8 mRNA | 16845445 |
D013739 | Testosterone | Testosterone results in increased expression of CASP8 protein | 16845445 |
C534735 | tetraarsenic tetrasulfide | [tetraarsenic tetrasulfide co-treated with Imatinib Mesylate] results in increased expression of CASP8 mRNA | 19208803 |
C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in increased expression of and results in increased cleavage of CASP8 protein | 27484784 |
C000591600 | tetrachlorobenzoquinone | Acetylcysteine inhibits the reaction [tetrachlorobenzoquinone results in increased cleavage of CASP8 protein] | 27484784 |
C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone promotes the reaction [TNFRSF10B protein binds to FADD protein binds to CASP8 protein] | 27484784 |
C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in increased cleavage of CASP8 protein | 27484784 |
C000591600 | tetrachlorobenzoquinone | TNFRSF10B protein promotes the reaction [tetrachlorobenzoquinone results in increased cleavage of CASP8 protein] | 27484784 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CASP8 mRNA | 24349563 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CASP8 mRNA | 16039398 |
D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CASP8 protein] | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CASP8 mRNA | 21570461 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CASP8 mRNA | 22666406 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of CASP8 protein | 21846477 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased cleavage of and affects the activity of CASP8 protein | 15664267 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CASP8 mRNA | 12167310|1531085 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CASP8 protein | 15972635 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CASP8 mRNA | 19520675 |
D013755 | Tetradecanoylphorbol Acetate | [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] | 15477007 |
D013755 | Tetradecanoylphorbol Acetate | bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA]] | 15477007 |
D013755 | Tetradecanoylphorbol Acetate | [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CASP8 mRNA | 18958680 |
D013755 | Tetradecanoylphorbol Acetate | [Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP8 protein | 12165276 |
D013755 | Tetradecanoylphorbol Acetate | pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA] | 15477007 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA | 15477007 |
D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA | 25613284 |
C050950 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate results in increased activity of CASP8 protein] | 17997382 |
C050950 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in decreased activity of CASP8 protein | 17997382 |
C017953 | tetramethylpyrazine | tetramethylpyrazine inhibits the reaction [Gentamicins results in increased activity of CASP8 protein] | 17132701 |
C017953 | tetramethylpyrazine | tetramethylpyrazine inhibits the reaction [TNF protein promotes the reaction [Gentamicins results in increased expression of CASP8 protein]] | 17132701 |
C009438 | tetrandrine | tetrandrine results in increased cleavage of and results in increased activity of CASP8 protein | 26822499 |
C009438 | tetrandrine | tetrandrine results in increased cleavage of CASP8 protein | 25266202 |
C020809 | tetrathiomolybdate | [Copper deficiency co-treated with tetrathiomolybdate] results in increased cleavage of CASP8 protein | 22276220 |
C020809 | tetrathiomolybdate | [Copper deficiency co-treated with tetrathiomolybdate] results in increased expression of CASP8 protein | 22276220 |
C531352 | tetrazolium violet | tetrazolium violet results in increased activity of CASP8 protein | 18547555 |
D013792 | Thalidomide | Thalidomide analog results in increased cleavage of CASP8 protein | 15858615 |
D013792 | Thalidomide | Thalidomide results in decreased expression of CASP8 mRNA | 26217789 |
C042172 | thallium nitrate | EGF protein inhibits the reaction [thallium nitrate analog results in increased activity of CASP8 protein] | 27412756 |
C042172 | thallium nitrate | thallium nitrate analog results in increased activity of CASP8 protein | 19371624|2741275 |
D019284 | Thapsigargin | Thapsigargin results in increased activity of CASP8 protein | 16018998 |
D013827 | Thiabendazole | Thiabendazole results in increased activity of CASP8 protein | 26748015 |
D013844 | Thiazoles | Acetylcysteine inhibits the reaction [[Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP8 protein] | 19014919 |
D013844 | Thiazoles | [Heterocyclic Compounds binds to Thiazoles] which results in increased activity of CASP8 protein | 19014919 |
C022616 | thiazolyl blue | thiazolyl blue results in increased activity of CASP8 protein | 22401948 |
D013853 | Thioacetamide | Thioacetamide results in increased expression of CASP8 mRNA | 16456712 |
D013853 | Thioacetamide | chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA] | 29133031 |
D013853 | Thioacetamide | chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA]] | 29133031 |
D013853 | Thioacetamide | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of CASP8 mRNA | 23830814 |
D013853 | Thioacetamide | Doxorubicin inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA] | 29133031 |
D013853 | Thioacetamide | Doxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in decreased expression of CASP8 mRNA]] | 29133031 |
D013853 | Thioacetamide | Thioacetamide results in decreased expression of CASP8 mRNA | 29133031 |
D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [Zinc Oxide analog results in increased activity of CASP8 protein] | 27544635 |
D008063 | Thioctic Acid | [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of CASP8 mRNA | 23830814 |
D013866 | Thioguanine | CASP8 protein results in increased susceptibility to Thioguanine | 22010212 |
D013866 | Thioguanine | Thioguanine results in increased expression of CASP8 protein | 22010212 |
C441201 | thiosalicylic acid | [Diethylnitrosamine co-treated with thiosalicylic acid] results in increased activity of CASP8 protein | 19427195 |
D013882 | Thiosemicarbazones | [Thiosemicarbazones binds to Copper] which results in decreased activity of CASP8 protein | 20931265 |
C100040 | thiosulfinic acids | thiosulfinic acids results in increased activity of CASP8 protein | 19446247 |
D013943 | Thymol | Thymol results in increased activity of CASP8 protein | 21640085 |
D013943 | Thymol | Thymol inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA] | 26996544 |
C003466 | thymoquinone | thymoquinone inhibits the reaction [Ethanol results in increased cleavage of CASP8 protein] | 29085585 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX inhibits the reaction [FASLG protein results in increased activity of CASP8 protein] | 16051694 |
C032628 | tin protoporphyrin IX | tin protoporphyrin IX results in decreased activity of CASP8 protein | 16051694 |
D014028 | Tobacco Smoke Pollution | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tobacco Smoke Pollution results in increased phosphorylation of and results in increased activity of MAPK1 protein] promotes the reaction [FAS protein binds to CASP8 protein]] | 20118622 |
D014028 | Tobacco Smoke Pollution | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tobacco Smoke Pollution results in increased phosphorylation of and results in increased activity of MAPK3 protein] promotes the reaction [FAS protein binds to CASP8 protein]] | 20118622 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution inhibits the reaction [Tobacco Smoke Pollution results in increased activity of CASP8 protein] | 20118622 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution promotes the reaction [FAS protein binds to CASP8 protein] | 20118622 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased activity of CASP8 protein | 20118622 |
D014028 | Tobacco Smoke Pollution | [Tobacco Smoke Pollution results in increased phosphorylation of and results in increased activity of MAPK1 protein] promotes the reaction [FAS protein binds to CASP8 protein] | 20118622 |
D014028 | Tobacco Smoke Pollution | [Tobacco Smoke Pollution results in increased phosphorylation of and results in increased activity of MAPK3 protein] promotes the reaction [FAS protein binds to CASP8 protein] | 20118622 |
D019772 | Topotecan | [Amlodipine co-treated with Topotecan] results in increased activity of CASP8 protein | 16516327 |
D019772 | Topotecan | chrysin inhibits the reaction [Topotecan results in increased activity of CASP8 protein] | 20457140 |
D019772 | Topotecan | Topotecan results in increased activity of CASP8 protein | 20457140 |
D014118 | Toxins, Biological | "Toxins, Biological affects the expression of CASP8 mRNA" | 19682533 |
D014212 | Tretinoin | TGFB1 protein inhibits the reaction [Tretinoin results in increased cleavage of and results in increased activity of CASP8 protein] | 16242776 |
D014212 | Tretinoin | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of CASP8 protein | 18098270 |
D014212 | Tretinoin | Tretinoin results in increased cleavage of and results in increased activity of CASP8 protein | 16242776 |
D014212 | Tretinoin | Tretinoin results in increased cleavage of CASP8 protein | 16135400 |
D014222 | Triamcinolone Acetonide | Triamcinolone Acetonide results in increased activity of CASP8 protein | 15987869 |
C011559 | tributyltin | tributyltin results in decreased expression of CASP8 protein | 28707438 |
C011559 | tributyltin | tributyltin results in increased expression of CASP8 protein | 23743147 |
C012589 | trichostatin A | [Bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of CASP8 protein | 16904634 |
C012589 | trichostatin A | [[decitabine co-treated with trichostatin A] affects the methylation of CASP8 promoter] which affects the expression of CASP8 mRNA | 18819746|1881974 |
C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C012589 | trichostatin A | [perifosine co-treated with trichostatin A] results in increased activity of CASP8 protein | 15781658 |
C012589 | trichostatin A | [trichostatin A co-treated with Bortezomib] results in increased cleavage of CASP8 protein | 21345073 |
C012589 | trichostatin A | trichostatin A results in increased expression of CASP8 mRNA | 24935251|2627250 |
C046498 | tricyclodecane-9-yl-xanthogenate | tricyclodecane-9-yl-xanthogenate inhibits the reaction [TNF protein results in increased activity of CASP8 protein] | 10792026 |
C020946 | triethylene glycol dimethacrylate | triethylene glycol dimethacrylate results in increased activity of CASP8 protein | 24307521 |
D014271 | Trifluridine | Trifluridine results in increased cleavage of CASP8 protein | 19816940 |
C050414 | tripterine | tripterine results in decreased expression of CASP8 mRNA | 27374097 |
C050414 | tripterine | tripterine results in increased cleavage of CASP8 protein | 21466843 |
C001899 | triptolide | triptolide results in increased expression of and results in increased activity of CASP8 protein | 26990902 |
C057693 | troglitazone | troglitazone results in decreased expression of CASP8 mRNA | 19631733 |
C057693 | troglitazone | troglitazone results in increased activity of CASP8 protein | 14508522 |
C057693 | troglitazone | troglitazone results in increased expression of CASP8 | 12680223 |
C057693 | troglitazone | troglitazone results in increased expression of CASP8 mRNA | 19631733 |
C057693 | troglitazone | troglitazone results in increased expression of CASP8 protein modified form | 16820965 |
C057693 | troglitazone | troglitazone results in increased expression of CASP8 mRNA | 28973697 |
C080163 | trovafloxacin | [trovafloxacin co-treated with TNF protein] results in increased activity of CASP8 protein | 24097668 |
D014361 | Trypsin Inhibitors | Trypsin Inhibitors results in increased activity of CASP8 protein | 19481592 |
C113580 | U 0126 | U 0126 promotes the reaction [arsenic trioxide results in increased activity of CASP8 protein] | 16972261 |
C113580 | U 0126 | U 0126 promotes the reaction [Emodin results in increased activity of CASP8 protein] | 27032576 |
C113580 | U 0126 | U 0126 results in increased cleavage of CASP8 protein | 20301194 |
C005460 | uranyl acetate | uranyl acetate results in increased activity of CASP8 protein | 19096828 |
D014580 | Ursodeoxycholic Acid | FADD mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased activity of CASP8 protein] | 21362627 |
D014580 | Ursodeoxycholic Acid | [oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased cleavage of and results in increased activity of CASP8 protein | 19728331 |
D014580 | Ursodeoxycholic Acid | pifithrin inhibits the reaction [[oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased activity of CASP8 protein] | 19728331 |
D014580 | Ursodeoxycholic Acid | RIPK1 mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased activity of CASP8 protein] | 21362627 |
D014580 | Ursodeoxycholic Acid | TNFRSF10B mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased activity of CASP8 protein] | 21362627 |
D014580 | Ursodeoxycholic Acid | TP53 mutant form inhibits the reaction [[oxaliplatin co-treated with Ursodeoxycholic Acid] results in increased activity of CASP8 protein] | 19728331 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid promotes the reaction [irinotecan results in increased activity of CASP8 protein] | 16432164 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid results in increased activity of CASP8 protein | 21362627 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP8 protein] | 21146893 |
D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Rotenone results in increased expression of CASP8 protein] | 25502462 |
C005466 | ursolic acid | ursolic acid results in increased activity of CASP8 protein | 20005942 |
D014635 | Valproic Acid | CASP8 mRNA affects the reaction [[Valproic Acid co-treated with decitabine] results in increased susceptibility to TNFSF10 protein] | 21771726 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of CASP8 mRNA | 25979313 |
D014635 | Valproic Acid | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP8 mRNA | 25815518 |
D014635 | Valproic Acid | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CASP8 protein | 25815518 |
D014635 | Valproic Acid | [Valproic Acid co-treated with Cladribine] results in increased cleavage of CASP8 protein | 19006566 |
D014635 | Valproic Acid | [Valproic Acid co-treated with fludarabine] results in increased cleavage of CASP8 protein | 19006566 |
D014635 | Valproic Acid | Valproic Acid promotes the reaction [decitabine results in increased expression of CASP8 mRNA] | 21771726 |
D014635 | Valproic Acid | Valproic Acid promotes the reaction [decitabine results in increased expression of CASP8 protein] | 21771726 |
D014635 | Valproic Acid | Valproic Acid results in increased cleavage of and results in increased activity of CASP8 protein | 22814014 |
D014635 | Valproic Acid | Valproic Acid results in increased cleavage of CASP8 protein | 19006566 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CASP8 mRNA | 21771726|2317975 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CASP8 protein | 21771726 |
D014635 | Valproic Acid | Valproic Acid affects the expression of CASP8 mRNA | 17292431 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of CASP8 mRNA | 24896083 |
D014638 | Vanadates | Vanadates inhibits the reaction [Deferoxamine results in increased activity of CASP8 protein] | 16374551 |
D017968 | Vanadium Compounds | Vanadium Compounds results in increased activity of CASP8 protein | 26391003 |
D014641 | Vanillic Acid | Vanillic Acid inhibits the reaction [Isoproterenol results in increased expression of CASP8 mRNA] | 25794854 |
C551177 | vemurafenib | AZD 6244 inhibits the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP8 protein]] | 27222248 |
C551177 | vemurafenib | [KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP8 protein] | 27222248 |
C551177 | vemurafenib | RAF1 protein affects the reaction [[KRAS protein mutant form affects the susceptibility to vemurafenib] promotes the reaction [TNFRSF10B protein results in increased cleavage of CASP8 protein]] | 27222248 |
D014700 | Verapamil | [Verapamil co-treated with gambogic acid] results in increased cleavage of and results in increased activity of CASP8 protein | 24373880 |
D014750 | Vincristine | CASP8 protein results in increased susceptibility to Vincristine | 22010212 |
D014750 | Vincristine | Vincristine results in increased expression of and results in increased cleavage of CASP8 protein | 22010212 |
D014750 | Vincristine | Vincristine results in increased expression of CASP8 mRNA | 16001973 |
D014757 | Viper Venoms | Viper Venoms results in increased cleavage of CASP8 protein | 25417048 |
D012256 | Riboflavin | Riboflavin analog results in increased activity of CASP8 protein | 20688149 |
D010837 | Vitamin K 1 | [sorafenib co-treated with Vitamin K 1] results in increased cleavage of CASP8 protein | 20301194 |
C111237 | vorinostat | ATG5 protein inhibits the reaction [[sorafenib co-treated with vorinostat] results in increased cleavage of CASP8 protein] | 18787411 |
C111237 | vorinostat | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] affects the localization of CASP8 protein] | 19643600 |
C111237 | vorinostat | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] results in increased activity of CASP8 protein] | 19643600 |
C111237 | vorinostat | [Bortezomib co-treated with vorinostat] results in increased activity of CASP8 protein | 18005386|1864136 |
C111237 | vorinostat | [Bortezomib co-treated with vorinostat] results in increased cleavage of and results in increased activity of CASP8 protein | 12893773 |
C111237 | vorinostat | Bortezomib promotes the reaction [vorinostat results in increased activity of CASP8 protein] | 15173093 |
C111237 | vorinostat | CASP8 protein affects the susceptibility to [resveratrol co-treated with vorinostat] | 22923501 |
C111237 | vorinostat | EIF2AK3 protein promotes the reaction [[sorafenib co-treated with vorinostat] promotes the reaction [CASP8 protein binds to ATG5 protein binds to HSPA5 protein binds to FAS protein]] | 18787411 |
C111237 | vorinostat | EIF2AK3 protein promotes the reaction [[sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to FADD protein binds to CASP8 protein]] | 18787411 |
C111237 | vorinostat | EIF2AK3 protein promotes the reaction [[sorafenib co-treated with vorinostat] results in increased cleavage of CASP8 protein] | 18787411 |
C111237 | vorinostat | FADD protein promotes the reaction [[sorafenib co-treated with vorinostat] promotes the reaction [CASP8 protein binds to ATG5 protein binds to HSPA5 protein binds to FAS protein]] | 18787411 |
C111237 | vorinostat | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[resveratrol co-treated with vorinostat] results in increased cleavage of CASP8 protein] | 22923501 |
C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASP8 mRNA" | 27188386 |
C111237 | vorinostat | [panobinostat co-treated with vorinostat] results in increased cleavage of CASP8 protein | 22923501 |
C111237 | vorinostat | [perifosine co-treated with vorinostat] results in increased activity of CASP8 protein | 15781658 |
C111237 | vorinostat | [resveratrol co-treated with vorinostat] results in increased cleavage of CASP8 protein | 22923501 |
C111237 | vorinostat | [sorafenib co-treated with vorinostat] promotes the reaction [CASP8 protein binds to FAS protein binds to FADD protein] | 18787411 |
C111237 | vorinostat | [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] | 18787411 |
C111237 | vorinostat | [sorafenib co-treated with vorinostat] results in increased cleavage of CASP8 protein | 18787411 |
C111237 | vorinostat | TNFSF10 protein promotes the reaction [vorinostat results in increased cleavage of and results in increased activity of CASP8 protein] | 17410615 |
C111237 | vorinostat | [vorinostat co-treated with Bortezomib] results in increased cleavage of CASP8 protein | 17351739 |
C111237 | vorinostat | [vorinostat co-treated with TNFSF10 protein] affects the localization of CASP8 protein | 19643600 |
C111237 | vorinostat | [vorinostat co-treated with TNFSF10 protein] results in increased activity of CASP8 protein | 19509267|1964360 |
C111237 | vorinostat | [vorinostat co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein | 19643600 |
C111237 | vorinostat | vorinostat results in increased activity of CASP8 protein | 15173093|1802528 |
C111237 | vorinostat | vorinostat results in increased cleavage of and results in increased activity of CASP8 protein | 17410615 |
C111237 | vorinostat | vorinostat results in increased cleavage of CASP8 protein | 15897598|1735173 |
C111237 | vorinostat | vorinostat results in increased expression of CASP8 mRNA | 26272509 |
C111237 | vorinostat | [carfilzomib co-treated with vorinostat] results in increased activity of CASP8 protein | 20233973 |
D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in increased expression of CASP8 mRNA" | 23063069 |
C085514 | wogonin | wogonin inhibits the reaction [IL1B protein results in increased cleavage of CASP8 protein] | 28688942 |
C085514 | wogonin | wogonin results in decreased cleavage of CASP8 protein | 28688942 |
C085514 | wogonin | wogonin inhibits the reaction [Bisphenol A-Glycidyl Methacrylate results in increased activity of CASP8 protein] | 26756871 |
C009687 | wortmannin | ABT-737 promotes the reaction [wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein]] | 20104024 |
C009687 | wortmannin | wortmannin promotes the reaction [Celecoxib results in increased cleavage of CASP8 protein] | 20104024 |
C009687 | wortmannin | "wortmannin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased activity of CASP8 protein]" | 24726520 |
C104426 | WP 631 | WP 631 results in increased activity of CASP8 protein | 24287111 |
C104536 | xanthohumol | xanthohumol results in increased activity of CASP8 protein | 26297991 |
C104536 | xanthohumol | xanthohumol results in increased cleavage of and results in increased activity of CASP8 protein | 15995977 |
C488234 | XCT790 | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP8 protein] | 19464277 |
C488234 | XCT790 | [XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP8 protein | 19464277 |
C108830 | Y 27632 | Y 27632 inhibits the reaction [TNF protein results in increased cleavage of CASP8 protein] | 28743511 |
D015215 | Zidovudine | Acrolein promotes the reaction [Zidovudine results in increased cleavage of CASP8 protein] | 27238871 |
D015215 | Zidovudine | Zidovudine promotes the reaction [Acrolein results in increased cleavage of CASP8 protein] | 27238871 |
D015215 | Zidovudine | Zidovudine results in increased cleavage of CASP8 protein | 27238871 |
D015032 | Zinc | [Rutin binds to Zinc] which results in increased expression of CASP8 mRNA | 26091902 |
D015034 | Zinc Oxide | Zinc Oxide affects the expression of CASP8 protein | 28648595 |
D015034 | Zinc Oxide | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Zinc Oxide analog results in increased activity of CASP8 protein] | 27544635 |
D015034 | Zinc Oxide | Thioctic Acid inhibits the reaction [Zinc Oxide analog results in increased activity of CASP8 protein] | 27544635 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased activity of CASP8 protein | 27544635 |
D015034 | Zinc Oxide | Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP8 protein] | 24614525 |
D015034 | Zinc Oxide | Zinc Oxide analog results in increased cleavage of CASP8 protein | 24614525 |
C017803 | zinc protoporphyrin | zinc protoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP8 protein] | 16051694 |
D019287 | Zinc Sulfate | [gluconic acid co-treated with Zinc Sulfate] inhibits the reaction [Aflatoxin B1 results in increased expression of CASP8 mRNA] | 27017951 |
D019287 | Zinc Sulfate | Zinc Sulfate inhibits the reaction [Aflatoxin B1 results in increased expression of CASP8 mRNA] | 27017951 |
D019287 | Zinc Sulfate | 3-methyladenine inhibits the reaction [Zinc Sulfate results in increased cleavage of CASP8 protein] | 28803810 |
D019287 | Zinc Sulfate | Zinc Sulfate results in increased cleavage of CASP8 protein | 28803810 |
D015039 | Ziram | Ziram results in increased activity of CASP8 protein | 22159898 |
C000588918 | ziyuglycoside II | ziyuglycoside II results in increased activity of CASP8 protein | 24680927 |
C000588918 | ziyuglycoside II | ziyuglycoside II results in increased cleavage of and results in increased activity of CASP8 protein | 24680927 |
C088658 | zoledronic acid | zoledronic acid results in increased expression of CASP8 mRNA | 19036117|2097792 |
C088658 | zoledronic acid | [zoledronic acid co-treated with Doxorubicin] results in increased activity of CASP8 protein | 19789217 |